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Motivazione e risultati della ricerca 
 
La presente ricerca si inquadra nell’ ambito della risoluzione dei problemi legati 
alla chirurgia ossea, per la cura e la sostituzione di parti di osso in seguito a fratture, lesioni 
gravi, malformazioni e patologie quali osteoporosi, tumori, etc… 
Vi è un numero elevatissimo di casi nel mondo in cui si rende necessaria la sostituzione di 
porzioni di tessuto osseo e questo numero è sempre crescente per via del progressivo 
invecchiamento della popolazione. Questo tipo di intervento è spesso molto invasivo e 
traumatizzante per il paziente soprattutto nei casi in cui sono coinvolte le ossa principali 
degli arti o del cranio. Spesso il chirurgo deve intervenire nuovamente a distanza di mesi o 
di anni, con tutti i traumi legati a simili interventi chirurgici, comportando perciò una 
sensibile riduzione della qualità della vita del paziente. 
Il problema più importante in questo ambito riguarda i materiali in uso per la sostituzione 
del tessuto osseo. Esiste prova che fin dai tempi più antichi l’ uomo ha utilizzato parti 
sostitutive in metallo mentre successivamente, in tempi più recenti, manufatti in ceramica 
ne hanno largamente preso il posto per via delle numerose problematiche legate all’ intro-
duzione di metalli all’ interno dell’ organismo. Fin qui, la sostituzione di parti di osso era 
stata eseguita con il semplice scopo di mantenere la funzione strutturale della parte 
mancante. Tuttavia, il tessuto osseo è un’ entità molto sofisticata, sia da un punto di vista 
della sua composizione che della sua struttura morfologica, e questo gli conferisce 
proprietà uniche di adattabilità alle varie sollecitazioni meccaniche, che lo rendono al 
tempo stesso leggero, resistente ed elastico e soprattutto in grado di autorigenerarsi 
localmente in seguito a traumi di estensione limitata. Nelle ultime decadi quindi, con l’ au-
mentare dell’ aspettativa di vita e dell’ accresciuto benessere, è diventato via via più 
rilevante il ricorso a soluzioni in grado di garantire la massima funzionalità della parte 
sostituita e quindi di consentire al paziente di tornare in breve tempo ad una vita attiva e 
soddisfacente. In molti casi, quando è possibile, si ricorre al trapianto di osso autologo, che 
consiste nell’ asportazione e nel successivo trapianto di piccole parti di osso dallo stesso 
individuo, laddove è possibile, spesso dalla cresta iliaca; questa tecnica permette solo il 
trapianto di piccole parti di osso e comporta tuttavia un notevole disagio poiché il paziente 
deve sottoporsi a due interventi chirurgici. In alternativa è anche possibile il trapianto di 
osso eterologo, ovvero di porzioni di osso provenienti da altro animale; in questo caso, 
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tuttavia, non sono pochi i casi di rigetto ed infezione. La soluzione in grado di evitare tutti 
questi problemi è la realizzazione di un materiale sintetico capace di riprodurre il 
comportamento dell’ osso naturale sia da un punto di vista chimico che strutturale e da 
ormai quasi cinquanta anni considerevoli sforzi sono in atto da parte della comunità 
scientifica per ottenere questo risultato. 
Il tessuto osseo è costituito per il 70% da una sostanza minerale, l’ idrossiapatite, a base di 
calcio, fosforo e piccole quantità di carbonato, magnesio, silicati e altre sostanze in tracce, 
organizzata in una struttura porosa e complessa, tale da rendere efficiente la distribuzione 
degli sforzi meccanici; questa struttura minerale è permeata di cellule specializzate, gli 
osteociti, in grado di regolare l’ attività biomeccanica dell’ intero osso, grazie alle varie 
sostanze presenti nella parte minerale. Questa componente minerale nuclea su una matrice 
proteica a base di collagene, che conferisce all’ osso le sue uniche proprietà di elasticità e 
flessibilità. 
Buona parte della comunità scientifica è dunque orientata alla realizzazione di materiali di 
sintesi biomimetici, ovvero in grado di riprodurre la composizione chimica, morfologica e 
strutturale dell’ osso naturale. Da un punto di vista chimico, questo consente di stimolare i 
processi naturali di rigenerazione del tessuto osseo e nel contempo provoca il 
riassorbimento dell’ impianto di sintesi da parte dell’ organismo. Da un punto di vista 
morfologico-strutturale, l’ ottenimento di impianti di morfologia complessa e dall’ ade-
guata resistenza meccanica favorisce l’ abitazione e la proliferazione delle cellule e la 
formazione di nuovo tessuto osseo in grado di sostituire progressivamente l’ impalcatura di 
sintesi impiantata dal chirurgo. La resistenza meccanica è tanto più importante quanto più 
la porzione di osso sostituito ha funzioni strutturali di sostegno dell’ intero scheletro, quali 
le ossa lunghe delle gambe e delle braccia. 
La ricerca scientifica ha finora ottenuto materiali con struttura di idrossiapatite in grado di 
esibire vari livelli di biomimetismo di tipo chimico, ossia materiali calcio fosfatici 
contenenti carbonato e/o magnesio e/o silicio in quantità adeguate per l’ attività cellulare, 
mostrando una più intensa attività di ricostituzione e rimodellamento del tessuto osseo in 
confronto con materiali di composizione chimica differente; tuttavia, una perfetta 
riproduzione della composizione chimica dell’ osso non è ancora stata raggiunta. 
Analogamente, strutture tridimensionali ceramiche con una distribuzione anisotropa dei 
pori e delle loro dimensioni sono state altresì ottenute, tuttavia le tecniche di 
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consolidamento necessarie ad ottenere tali strutture e le limitazioni tecnologiche alla 
possibilità di ottenere morfologie complesse simili a quelle dell’ osso hanno impedito 
finora di realizzare impalcature per sostituti ossei aventi proprietà analoghe a quelle del 
tessuto osseo naturale. 
Infine, la resistenza meccanica intrinseca dei materiali bioattivi, cioè in grado di indurre 
una risposta biologica positiva nell’ organismo, è spesso insufficiente per sopportare gli 
sforzi e le sollecitazioni biomeccaniche naturali, cosicché si deve ricorrere all’ impiego di 
materiali ceramici inerti che non sono tuttavia in grado di essere riassorbiti dall’ or-
ganismo.  
Per quanto riguarda l’ aspetto chimico, il ruolo fondamentale dello ione carbonato nell’ a-
patite biologica è da tempo noto, così come quello del magnesio; in tempi più recenti 
tuttavia gli studi si sono concentrati sugli effetti positivi del silicio sulla stimolazione del- 
l’ attività cellulare e su tecniche in grado di incorporarlo nella struttura dei materiali 
destinati ad impianto. 
Nella presente ricerca il problema dell’ ottenimento di sostituti ossei biomimetici è stato 
affrontato da tre differenti prospettive. 
In una prospettiva biochimica, si sono sperimentate ed attuate delle metodologie per 
ottenere polveri di idrossiapatite calcio-fosfatica contenente simultaneamente i sostituti 
ionici più rilevanti per la stimolazione dei processi naturali di rigenerazione ossea 
(carbonato, magnesio e silicio), in quantità ritenute adeguate sulla base di precedenti 
ricerche sul metabolismo cellulare di queste sostanze. 
In prospettiva di applicazioni strutturali sono state anche sperimentate ed attuate tecnologie 
di consolidamento di miscele di polveri di idrossiapatite con silicati di calcio bioattivi per 
ottenere materiali ad elevata resistenza meccanica da utilizzare in seguito per la 
realizzazione di ceramici porosi. 
Il problema del biomimetismo della morfologia dell’ osso è stato infine affrontato 
prendendo spunto dalla Natura, in particolare da strutture vegetali come legni e piante che 
esibiscono naturalmente strutture porose gerarchiche estremamente complesse, grazie alle 
quali proprietà di resistenza meccanica ed efficiente distribuzione degli sforzi sono 
coniugate con una elevata leggerezza. In questo modo nel presente lavoro si sono esplorate 
metodologie del tutto nuove per ottenere strutture ceramiche di idrossiapatite a partire da 
sostanze naturali, mantenendo la loro medesima morfologia. 
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I risultati ottenuti nel corso della presente ricerca sono stati positivi ed incoraggianti sotto 
tutti e tre gli aspetti investigati. 
In primo luogo, da un punto di vista chimico, si sono ottenute polveri di idrossiapatite ad 
accresciuto biomimetismo, come dimostrato dalle varie metodologie di indagine impiegate 
e dal loro comportamento in ambiente fisiologico e in coltura cellulare. Il procedimento di 
sintesi ha permesso il controllo del tenore di ioni sostituenti nella struttura dell’ idros-
siapatite, consentendo di ottenere specifiche composizioni sulla base dell’ applicazione 
desiderata. 
In secondo luogo, materiali bioattivi con superiori proprietà meccaniche sono stati ottenuti 
grazie all’ impiego di silicati di calcio come materiali di rinforzo dell’ idrossiapatite.        
L’ impiego di tali materiali contenenti silicio ha inoltre aperto la prospettiva di ottenere 
materiali con accresciuto biomimetismo, oltre che dotati di accresciuta resistenza, grazie ai 
possibili fenomeni di migrazione di ioni silicio all’ interno della struttura dell’ idros-
siapatite durante i trattamenti termici con cui vengono ottenuti i ceramici finali. Questo 
fenomeno, se confermato, potrà essere applicato ad una numerosa serie di materiali a base 
di silicati di calcio contenenti anche altri ioni influenti nel biomimetismo osseo, come il 
magnesio, consentendo di ottenere allo stesso tempo materiali ad accresciuto 
biomimetismo e resistenza meccanica. 
Infine, specifici processi chimici e termici sono stati applicati ad alcune strutture lignee 
naturali quali abete, pino e larice, consentendo di trasformarli in idrossiapatite, mantenendo 
nel contempo l’ originaria morfologia porosa e gerarchicamente organizzata. Questo 
risultato è di assoluta novità, essendo stato applicato in passato solo per l’ ottenimento di 
sostanze dalla composizione più semplice, come il carburo di silicio (che può essere 
considerato peraltro un materiale bioinerte). Un’ idrossiapatite caratterizzata da una 
struttura gerarchica simile all’ osso costituisce potenzialmente la migliore soluzione per 
una rapida ed efficiente integrazione del nuovo tessuto osseo nell’ impianto di sintesi. Allo 
scopo di migliorare la riassorbibilità di simili impianti, l’ idrossiapatite deve presentare 
differenti sostituzioni ioniche, pertanto le ricerche future in questo campo dovranno essere 
orientate all’ incorporazione di ioni nelle strutture gerarchiche di idrossiapatite derivate da 
strutture lignee, oltre che alla determinazione delle loro proprietà meccaniche in relazione 
alla morfologia. 
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I tre aspetti del biomimetismo affrontati in questo lavoro, chimico, strutturale e 
morfologico, hanno delineato tre vie maestre che sono orientate a convergere nella 
realizzazione del sostituto osseo ideale. La ricerca futura dovrà essere rivolta 
particolarmente alla convergenza dei tre differenti risultati ottenuti, superando le difficoltà 
che questo comporta. Infatti un accresciuto biomimetismo è associato ad una ridotta 
stabilità chimica da parte dell’ idrossiapatite, analogamente a quanto avviene nell’ apatite 
naturale dell’ osso; questa instabilità si verifica soprattutto alle alte temperature, dove 
hanno luogo i processi di realizzazione di materiali bioattivi strutturalmente resistenti 
(sinterizzazione); da un punto di vista morfologico inoltre, una volta accertata la fattibilità 
delle trasformazioni chimiche di legni e piante in ceramici porosi a base di idrossiapatite, 
la ricerca dovrà essere rivolta alla selezione delle strutture legnose più adeguate in base alla 
loro porosità e resistenza meccanica intrinseca, e all’ adeguamento dei processi chimici e 
termici messi a punto nel presente lavoro allo scopo di migliorarne il biomimetismo 
chimico e meccanico. 
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CHAPTER 1 
 
GENERAL TOPICS 
1.1 Biology of bone tissue 
Bones are rigid organs that form part of the endoskeleton of vertebrates. They 
function to move, support, and protect the various organs of the body, produce red and 
white blood cells and store minerals. Because bones come in a variety of shapes and have a 
complex internal and external structure, they are lightweight, yet strong and hard, in 
addition to fulfilling their many other functions. One of the types of tissues that makes up 
bone is the mineralized osseous tissue, also called bone tissue, that gives it rigidity and 
honeycomb-like three-dimensional internal structure. Other types of tissue found in bones 
include marrow, endosteum and periosteum, nerves, blood vessels and cartilage. There are 
206 bones in the adult body and about 300 bones in the infant body. 
Bone tissue consists of cells embedded in a fibrous, organic matrix, the osteoid, which is 
primarily constituted by Type I collagen (90%) and 10% amorphous ground substance 
(primarily glycosaminoglycans and glycoproteins). Osteoid comprises approximately 50% 
of bone by volume and 25% by weight. 
Osteoblasts (from the Greek words for "bone” and "germ" or embryonic) are mono-
nucleate cells, descending from osteoprogenitor cells, that are responsible for the secretion 
of osteoid, and subsequent bone formation through the mineralization of the osteoid 
matrix.  
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Figure 1.1. Schematic drawing of an osteoblast. 
Osteoblasts are located on the surface of osteoid seams and also manufacture hormones, 
such as prostaglandins, to act on the bone itself (see Fig. 1.1). They robustly produce 
alkaline phosphatase, an enzyme that has a role in the mineralisation of bone, as well as 
many matrix proteins. Osteoblasts are the immature bone cells. When osteoblasts are 
trapped in the bone matrix which they themselves produced they become star-shaped cells 
named osteocytes, the most abundant cell found in bone. 
Osteocytes are mature bone cells, networked to each other via long processes that occupy 
tiny canals called canaliculi, which are used for exchange of nutrients and waste (see Fig. 
1.2). The space that an osteocyte occupies is called a lacuna (Latin for a pit). Although 
osteocytes have reduced synthetic activity and, like osteoblasts are not capable of mitotic 
division, they are actively involved in the maintenance of bony matrix, through various 
mechanosensory mechanisms regulating the bone's response to stress.  
Bone is a dynamic tissue that is constantly being reshaped by osteoblasts, cells which build 
bone, and osteoclasts, which resorb bone. 
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Figure 1.2. Schematic drawing of the cross section of an osteocyte. 
Osteoclast (from the Greek words for "bone" and "broken") are multi-nucleated cells 
responsible for the resorption of bone through the removal of the bone's mineralized matrix 
(see Fig. 1.3). The removal process begins with the attachment of the osteoclast to the 
osteon (predominant structures found in compact bone, see later); the osteoclast then 
induces an infolding of its cell membrane and secretes collagenase and other enzymes 
important in the resorption process, such as tartrate resistant acid phosphatase, secreted 
against the mineral substrate. High levels of calcium, magnesium, phosphate and products 
of collagen will be released into the extracellular fluid as the osteoclasts tunnel into the 
mineralized bone, also resulting in a transfer of calcium from bone fluid to the blood. 
During childhood, bone formation exceeds resorption, but as the aging process occurs, 
resorption exceeds formation.  
The characteristic rigidity and strength of bone derives from the presence of mineral salts, 
that permeate the organic matrix, formed by the osteoid mineralization, due to the secretion 
of vesicles containing alkaline phosphatase, by the osteoblasts. This cleaves the phosphate 
groups and acts as the foci for calcium and phosphate deposition. The vesicles then rupture 
and act as a centre for crystals to grow on. The mineral phase comprises approximately 
50% of bone by volume and 75% by weight. The principal constituents of bone mineral are 
calcium phosphate, mainly carbonated hydroxyapatite, amorphous calcium phosphate and 
calcium carbonate, with lesser quantities of sodium, magnesium, silicon and fluoride.  
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Figure 1.3. Schematic drawing of an osteoclast. 
1.2 Morphology and structure of bone tissue 
Fig. 1.4 illustrates the structure of bone. Whole bones are composed of two types of 
bony tissue: cortical and trabecular. 
Cortical bone, also known as compact bone, is dense and forms the surface of bones, 
contributing 80% of the weight of a human skeleton. It is extremely hard, formed of 
multiple stacked layers with few gaps. Cortical bone comprises the diaphysis of long bones 
and the thin shell that surrounds the metaphyses. 
Cortical haversian bone consists of quasi-cylindrically shaped element called osteons or 
haversian system. The individual haversian system themselves are composed of 
concentric lamellae about 3 to 7 µm thick. These thin lamellae, in turn, are constructed 
from wrapped collagen fibres impregnated at regularly spaced sites with hydroxyapatite  
and other mineral crystals about 20 to 40 nm long.    
Osteons are typically about 200 µm in diameter, the same thickness as the laminae in 
laminar bone, and about 10 to 20 mm long. The thickness is the same because bloody 
supply for the haversian system is a central lumen containing a blood vessel, and thus 
every point in the haversian system is no more than 100 µm from the bloody supply, as 
was the case with laminar bone. Haversian bone is organized to accommodate small 
arteries, arterioles, capillaries, and venues of the microcirculation system. 
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Figure 1.4. Schematic drawing of the bone structure. 
The osteons of haversian bone and the laminae of laminar bone are basically just different 
geometric configurations of the same material. In both geometric configurations no point 
in the tissue is more than 100 µm away from the bloody supply. 
Trabecular bone (also known as cancellous, or spongy) is a type of osseous tissue with a 
low density and strength but very high surface area, that fills the inner cavity of long 
bones, as a three-dimensional, interconnected network of  trabecular rods and plates. A 
network of rods produces low-density, open cells, whereas a network of plates can result in 
higher density, nearly closed cells. The external layer of cancellous bone contains red bone 
marrow where the production of blood cellular components (known as hematopoiesis) 
takes place. Cancellous bone is also where most of the arteries and veins of bone organs 
are found. 
The classification of bone tissue as cortical or trabecular is based on relative density, the 
ratio of specimen density to that of fully dense cortical bone (usually assumed to have a 
density of 1.8 g⋅cm-3). The relative density of trabecular bone varies from 0.05 to about 
0.7, corresponding to porosities that ranges from about 30 to more than 90%. The relative 
density of cortical bone ranges from about 0.7 to about 0.95. Obviously, the distinction 
between low-density cortical bone and high-density cortical bone is somewhat arbitrary. 
Bone is first deposited as woven bone, in a disorganized structure with a high proportion of 
osteocytes in young and in healing injuries. Woven bone is weaker, with a small number of 
randomly oriented collagen fibres, but forms quickly. It is replaced by lamellar bone, 
 5
General Topics 
⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ 
 
which is highly organized in concentric arranged laminae with a low proportion of 
osteocytes. Lamellar bone is stronger and filled with many collagen fibres parallel to other 
fibres in the same layer. The fibres run in opposite directions in alternating layers, much 
like plywood, assisting in the bone's ability to resist torsion forces. After a break, woven 
bone quickly forms and is gradually replaced by slow-growing lamellar bone on pre-
existing calcified hyaline cartilage through a process known as bony substitution. 
The thickness of the lamina is about 200 µm. Between each lamina and the next there is a 
net-like system of load vessels. Occasional large radial vessels through lamina connect the 
net. 
1.2.1 Hierarchical structure of bone 
The whole architecture of bone is very complex: starting from the smallest 
constituting elements to the largest scales, the bone is not only organized in an anisotropic 
manner, but the arrangement of its constituting elements is hierarchical; this means that its 
structural units are organized at increasing size levels, and this feature confers unique 
properties to the whole bone structure. 
 
 
Figure 1.5. Hierarchical structure of bone. 
In Fig. 1.5 the hierarchical structure of bone is illustrated, starting from the lowest level, 
where nanometer-sized crystals of carbonate apatite are embedded in and surround the 
fibrous protein collagen. At the second lowest level, these mineralized fibres lie bundled 
together and are attached to each other. At the next level, these fibres come together to 
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form lamellae at a width of ~2 µm. The lamellae have various patterns; a very common 
one is a secondary osteon, in which concentric lamellae form cylindrical structures, ~200 
µm in diameter, surrounding a central blood vessel. Compact bone, solid to the naked eye, 
is modified in places to form trabecular bone, which consists of many struts; with the 
spaces between the struts filled with marrow. As above stated, the struts are not just 
randomly arranged, but are related to the direction of mechanical loads on the bone. 
Mechanical and biological properties of the bone depend on the interaction taking place 
across all levels of organization. A deeper discussion on hierarchy in bone tissue and on 
the activity devoted to reproduce it by taking advantage of the hierarchic natural structure 
of woods and plants will be provided in Chapter 5. 
1.2.2 Mechanical properties of bone 
The different structures of cortical bone and trabecular bone result in different 
mechanical properties. Bone mechanical properties are highly variable according to 
species, age, anatomical site, liquid content, etc. 
Cortical bone is an anisotropic material, meaning that its mechanical properties vary 
according to the direction of load. 
Cortical bone is often considered an orthotropic material. Orthotropic materials are a class 
of anisotropic materials characterized by three different Young's moduli E1, E2, E3 
according to the direction of load, three shear moduli G12, G13, G23 and six Poisson's ratios 
ν12, ν13, ν23, ν21, ν31, ν32. 
The mechanical characterization of trabecular bone is even more difficult. The mechanical 
properties of trabecular bone as a whole are due to the mechanical characteristics of single 
trabecules and to its highly porous structure. Fig. 1.6 shows the dependence of the Young's 
modulus of trabecular bone from bone density.  
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Figure 1.6. Young's modulus of trabecular bone as a function of density of bone. 
1.2.3 Types of bone 
 Bone characterized by different functions in the body are strongly different in 
shape, so that they exhibit different structures hierarchically organized and, 
correspondingly, different mechanical properties. Several examples are shown in Fig. 1.7: 
long bones are found in our extremities (femur, tibia, ulna, radius, humerus, etc..) and 
provide stability against bending and buckling; they are characterized by a tubular shaft 
and articular surface at each end. Short bones, which include vertebrae, the head of femur, 
all of the metacarpals and phalanges in the hands, the metatarsals and phalanges in the feet, 
and the clavicle (collarbone), provide stability against compression (along the vertical axis, 
in the case of vertebra). They also have a tubular shaft and articular surfaces but smaller 
than long bones. Plate-like bones (such as the skull, the scapula, the ribs, and the sternum) 
are thin and have broad surfaces; their main function is to protect vital organs. Irregular 
bones are also found in the body; they are irregular in size and shape and are usually quite 
compact. They include the bones in the vertebral column, the carpal bones in the hands, 
tarsal bones in the feet, and the patella (kneecap). 
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Figure 1.7. Different types of bone. 
1.3 Bone remodelling 
Bone adapts and remodels in response to the stress applied. Wolff's law1 states that 
bones develop a structure most suited to resist the forces acting upon them, adapting both 
the internal architecture and the external conformation to the change in external loading 
conditions. This change follows precise mathematical laws. 
When a change in loading pattern occurs stress and strain fields in the bone change 
accordingly. Bone tissue seems to be able to detect the change in strain on a local bases 
and then adapts accordingly. The internal architecture is adapted in terms of change in 
density and in disposition of trabecules and osteons and the external conformation in terms 
of shape and dimensions. When strain is intensified new bone is formed. On a microscopic 
scale bone density is raised and on a macroscopic scale the bone external dimensions are 
incremented. When strain is lowered bone resorption takes place. On a microscopic scale 
bone density is lowered and on a macroscopic scale the bone external dimensions are 
reduced (Fig. 1.8). 
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Figure 1.8. Bone remodelling: effect of reduction (from A to B) and of intensification of strain 
(from B to A) on bone trabecules. 
When the change in strain is due to a change in direction of load on a microscopic scale the 
structure of trabecules and osteons is rearranged and on a macroscopic scale a change in 
bone shape may occur. 
Remodelling is carried out by the cellular component of bone. When resorption takes place 
osteoclasts reabsorb collagen and mineral phase (Fig. 1.9A) which are then taken into the 
circulatory system (Fig. 1.9B). During deposition osteoblasts group on the deposition 
surface and build the collagen network of bone (Fig. 1.10A). Mineralization takes place 
afterwards (Fig. 1.10B).  
 
 
Figure 1.9. Bone resorption. 
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Figure 1.10. Bone deposition. 
 Bone resorption and bone deposition processes are always active in bone. An equilibrium 
strain state exists in correspondence to which the two activities are perfectly balanced. 
When strain intensity is higher than the equilibrium strain deposition activity is more 
intense than resorption activity and net deposition occurs. When strain intensity is lower 
than the equilibrium strain deposition activity is less intense than resorption activity and 
net resorption occurs. Dynamical equilibrium between resorption and deposition is again 
achieved when the equilibrium strain state is newly established. 
The cell-biology based model of Davy and Hart expresses functional dependence of bone 
remodelling on the strain field, based on cell activity (Fig. 1.11). The load applied to the 
bone together with geometric and material properties determine the local strain. Strain is 
detected by a transducer which generates the strain remodelling potential (SRP). This 
signal is modulated by genetic, hormonal and metabolic factors, generating the 
remodelling potential which regulates the recruitment rate and the activity of osteoblasts 
and osteoclasts, stimulating bone formation and bone resorption. The balance between 
bone deposition and bone resorption determines the net bone remodelling. remodelling 
modifies bone geometric and material properties through a feedback loop. 
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Figure 1.11. Schematic diagram of the Davy and Hart model for bone remodelling. 
1.4 Need of the development of bone substitutes 
Bone disease is a serious health condition that directly impacts on the quality of life 
of sufferers, particularly among the aged. In most cases, the treatment of bone defects 
requires a bone graft, and sometimes in extensive amount2-7. 
Nowadays, more than 2 million bone grafting procedures are happening annually 
worldwide, with a turn-over of the order of billions of dollars per annum, in order to repair 
bone defects in orthopaedics, neurosurgery and dentistry8-9, which include the treatment of 
posttraumatic skeletal complications, such as delayed unions, non-unions, mal-unions10. 
Bone grafting may be also required for the healing of spinal fusions, filling defects 
following removal of bone tumours and several congenital diseases.  
A major contributor to the need for “spare parts” for the body is the progressive 
deterioration of tissue with age. Bone is especially vulnerable to fracture in older people 
because of a loss of bone density and strength with age. Fig. 1.12 summarizes the effect of 
time on bone strength and density from the age of 30 years onward.  
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Figure 1.12. Effect of age on strength and density of bone. 
The effect is especially severe in women because of hormonal changes associated with 
menopause. Bone density decreases because bone-growing cells (osteoblasts) become 
progressively less productive in making new bone and repairing micro-fractures. The lower 
density greatly deteriorates the strength of the cancellous bone, in the ends of long bones 
and in vertebrae. An unfortunate consequence is that many old people fracture their hips or 
have collapsed vertebrae and spinal problems. 
In addition, bone composition and properties can vary considerably within a population 
and are difficult to control. Thus remodelling of the implant can be very different from one 
person to another and from one implant to another. 
The replacement of a bone or a part of must be distinguished from organ grafts (e.g. 
kidney, heart). In organ grafts, the cells are generally kept alive and the reestablishment of 
blood supply restores the functions of the whole organ. In bone tissues, however, the blood 
supply cannot be efficiently restored and the tissue is condemned to die, be reabsorbed, and 
replaced. In most cases the replacement of bone fragments by foreign bone tissue leads to 
poor junction, rehabitation, and remodelling problems.  
As the average age of the population increases and the patients receiving such implants 
become younger, the above-mentioned numbers are likely to increase. For these reasons, 
the field of biomedical materials has grown rapidly over the past 40 years, offering 
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solutions to repair defects, correct deformities, replace damaged tissue and provide 
therapy, with a continuously increasing market value. This has contributed to the increase 
in the average lifetime of individuals in developed countries.  
Although current biomaterials provide an effective immediate solution for many patients, 
concerns have arisen over their short- and long-term clinical success. In the short-term 
concerns have arisen due to the low bio-reactivity with existing bone. Such properties have 
highlighted clinical implications for the time required for patient rehabilitation11. In longer-
term studies, biomaterials degrade with time and this may have adverse effects on 
interfacial apposition to the implant and its mechanical stability12-14. Moreover, it is 
reported that nearly 20% of the hip replacement surgeries performed in past years were to 
‘‘revise’’ the original implants. As a consequence, considerable research interest has 
focused on investigating mechanisms that contribute to implant-prosthesis failure and on 
developing new biomaterials with extended lifetimes. One novel design approach towards 
improved implant performance has involved the use of biomimetic approaches, whereby 
nano- and micro-scale features and/or chemistry of the implant may be designed to mimic 
those of living bone tissue. 
1.4.1 Current solutions for bone substitutes 
Since a very ancient time, diseased bone portions were substituted with parts in 
metal; in the last century ceramic bodies substituted metal more and more, owing to the 
problems related to the metal dissolution in the human body and the release of toxic debris. 
Then, the substitution of bone intended mainly to restore the structural functionality of the 
missing part, but it was not able to completely restore all its properties; the very complex 
composition and morphology of the bone tissue are responsible of its unique ability to 
continuously adapt to the ever changing mechanical solicitations, so to be simultaneously 
light, tough and elastic and able to locally regenerate after traumas of limited extension. 
Thus, with the increasing of the expectance of life and well-being, the development of 
bone substitutes able to restore the whole functionality of the original tissue was of 
increasing importance in the last decades; beyond the commercial aspects, the problem has 
a highly social relevance as the patients can regain a more active and satisfactory life and 
sooner than in the past. 
An ideal bone substitute should be biomimetic, i.e. able to perfectly mimic in vivo the 
behaviour of the natural bone. For this reason, not only biocompatibility is required, but 
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features of bioactivity, osteoinductivity, osteoconductivity and bio-resorbability are also 
strongly needed. 
Biocompatibility is the ability of a material to perform with an appropriate host  response 
in a specific application, without having any toxic or injurious effects on biological 
systems15. 
The scope of this definition is very wide and many subgroups of applications can be found 
to make more narrow definitions of biocompatibility. Anyway, for a long-term implantable 
medical device, like a bone substitute, the biocompatibility refers to the ability of the 
device to perform its intended function, with the desired degree of incorporation in the 
host, without eliciting any undesirable local or systemic effects in that host. 
Bioactivity is the ability of the implant to bond to bone tissue. The process of bone 
bonding is the result of multiple, parallel and sequential reactions at the material-tissue 
interface. These interactions are related to either physicochemical phenomena that occur in 
the presence or absence of cells, or are related to reactions affected by cellular activity. The 
events occurring at the bone-implant interface can be summarized as follows:  
(1) dissolution from the ceramic16,17; (2) precipitation from solution onto the ceramic18,20; 
(3) ion exchange and structural rearrangement at the ceramic-tissue interface16,18,19,21,22; (4) 
inter-diffusion from the surface boundary layer into the ceramic23; (5) solution-mediated 
effects on cellular activity21,24,25; (6) deposition of either the mineral phase (a), or the 
organic phase (b), without integration into the ceramic surface18,19,22; (7) deposition with 
integration into the ceramic19,21; (8) chemotaxis to the ceramic surface21; (9) cell 
attachment and proliferation24-27; (10) cell differentiation21; and (11) extracellular matrix 
formation27,28. 
Osteoinductivity is the ability of a material to induce cell differentiation oriented to the 
synthesis of a bone matrix, able to mineralize in bone tissue. 
Osteoconductivity is a passive property of the implant consisting in the ability of making 
easy the formation and diffusion of the new bone both through its chemical (presence of 
ions and substances able to enhance the cell activity for osteogenesis, the process of new 
bone development) and morphological (hierarchically organized porous structure able to 
host the growing bone tissue and the vascular system) features. 
Bioresorbability is the ability of the implant to be dissolved by the in vivo processes of 
bone remodelling and to be replaced by the new bone tissue.  
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When the characteristics of bioactivity, osteoinductivity and osteoconductivity are merged 
together, the implant is rapidly integrated into the growing bone tissue (osteointegration) 
and a direct structural and functional connection between ordered living bone and the 
implant surface is so established29. 
Several methods of reconstructing bone defects are available namely using autograft, 
allograft, demineralised bone matrix (DBM), calcium phosphate (in particular 
hydroxyapatite and tricalcium phosphate), autologous bone marrow aspirates, bone 
morphogenetic proteins, and several other related growth factors (VEGF, PDGF, etc.).  
The gold standard of bone-grafting is harvesting autologous cortical and cancellous bone 
(autograft), which provides optimal osteoinductive, osteoconductive, and osteogenic 
properties30. Iliac crest is the most frequently chosen donor site as it provides easy access 
to good quality and quantity cancellous autograft. Harvesting autologous bone from the 
iliac crest has, however, several downsides as it lengthens the overall surgical procedure 
and is usually complicated by residual pain and cosmetic disadvantages31,32. 
Furthermore, it may fail in clinical practice as most of the cellular (osteogenic) elements do 
not survive transplant33. Other limitations include elderly or paediatric patients and patients 
with malignant disease34. In addition autograft harvesting is associated with a 8.5-20% of 
complications including haematoma formation, blood loss, nerve injury, hernia formation, 
infection, arterial injury, urethral injury, fracture, pelvic instability, cosmetic defects, 
tumour transplantation, and sometimes chronic pain at the donor site31,35. Another 
disadvantage is the elevated levels of resorption during healing36. 
Allograft and xenografts, depending whether the bone portion is explanted by other 
humans or animals, are regarded as the surgeon’s second option. Its use has increased 15-
fold the past decade and accounts for about one-third of bone grafts performed in the 
United States37. The current increasing availability of allograft tissue has made it possible 
to manufacture customised types, such as dowels, strips, and chips33. Allograft bone has 
more limitations in the essential bone graft characteristics described earlier and yields more 
variable clinical results. In addition, allografts carry the risk of transferring viral diseases. 
The processing of allograft tissue lowers this risk but, that can significantly weaken the 
biologic and mechanical properties initially present in the bone tissue38,39. An overview of 
the properties of allograft and autograft bone is summarized in Table 1.I. 
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Table 1.I. General properties of different bone grafts. 
Bone graft Strength Osteoconduction Osteoinduction Osteogenesis 
Autograft     
    Cancellous --- +++ +++ +++ 
    Cortical +++ ++ ++ ++ 
Allograft     
    Cancellous     
        Frozen --- ++ + --- 
        Freeze-Dry --- ++ + --- 
    Cortical     
        Frozen +++ + --- --- 
        Freeze-Dry + + --- --- 
1.4.2 Synthetic bone substitutes 
Considerable interest has developed in creating osteoconductive matrices using 
non-biologic materials. Synthetic products have the advantage to offer controlled 
composition and properties that can be modified and tailored on the characteristics of the 
specific patient and optimized for the replacement of specific portions of bone. They can 
be easily stored, shaped, and sterilized, and do not need the heavy organization of bone 
organ banks40. 
Degradable polymers, bioactive glasses, and various metals have been studied. Polylactic 
and Polyglycolic acid polymers have been used extensively as suture materials, and 
biodegradable fracture fixation implants. These materials have the advantage of being 
assembled in various forms and can be integrated with growth factors, drugs, and other 
compounds to create multiphase delivery systems. They provide a porous architecture for 
the ingrowth of new bone and then fully degrade. 
A variety of porous metal surfaces and coatings have been used as surfaces for bone 
ingrowth intended to fix prosthetic joint replacement components to bone. These include 
sintered cobalt-chrome beads, titanium alloy fibre metals, and plasma-sprayed surfaces. 
New metallurgy techniques are creating metallic matrices of much greater porosity. 
Tantalum can be fabricated as metallic foam-like structure with interconnecting pores, 
which allows exceptionally rapid and complete ingrowth. Hydroxyapatite coating of metal 
surfaces enhances ingrowth and direct bonding of bone to porous surface41. 
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Essentially, these coatings can be used on implants with relatively simple surface geometry 
and use excessive high temperatures. This means that it is difficult to coat implants with 
complex surface geometry (e.g. porous surface) and that no biologically active agents can 
be added to the coating during the spraying process. 
1.4.3 Bioceramics 
Since half century, specially designed ceramic materials, called bioceramics, were 
adopted for the repair, reconstruction, and replacement of diseased and damaged parts of 
the body, usually the hard tissues of the musculo-skeletal system, such as bones, joints, or 
teeth6 (see Table 1.II). 
The great challenge facing the use of ceramics in the body is to replace old, deteriorating 
bone with a material that can function the remaining years of the patients’ life (> 20 years). 
This demanding requirement of survivability is under conditions of use that are especially 
harsh to ceramic materials: corrosive saline solutions at 37 °C under variable, multiaxial, 
cyclical mechanical loads.  
Table 1.II. Present uses of bioceramics. 
Application Material 
Orthopaedic load-bearing applications Al2O3 
Coatings for chemical bonding (orthopaedic, 
dental and maxillary prosthetics) 
HA, surface-active glasses and glass-ceramics 
Dental implants Al2O3, HA, surface-active glasses 
Alveolar ridge augmentations Al2O3, HA, HA-autogenous bone composite, H-
PLA composite, surface-active glasses 
Otolaryngological applications Al2O3, HA, glasses and glass-ceramics 
Artificial tendons and ligaments PLA-carbon fiber composites 
Coatings for tissue ingrowth (cardiovascular, 
orthopaedic, dental, and maxillofacial 
prosthetics) 
Al2O3 
Temporary bone space fillers Trisodium phosphate, calcium and phosphate salts 
Periodontal pocket obliteration HA, HA-PLA composites, trisodium phosphates, 
calcium and phosphate salts, glasses 
Maxillofacial reconstruction Al2O3, HA, HA-PLA composites, glasses 
Percutaneous access devices Bioactive glass-ceramics 
Orthopaedic fixation devices PLA-carbon fiber, PLA-CaP-base glass fibers 
Survivability of a bioceramic requires formation of a stable interface with living host 
tissue. The mechanism of tissue attachment is directly related to the type of tissue response 
at the implant interface (Table 1.III). No material implanted in living tissues is inert; all 
materials elicit a response from living tissue. The four types of response allow different 
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means of achieving attachment of prostheses to the musculo-skeletal system and can be 
summarized as follows: 
 
If the material is toxic, the surrounding tissue dies 
If the material is non-toxic and biologically inactive (almost inert), a fibrous tissue of 
variable thickness forms. 
If the material is non-toxic and biologically active (bioactive), an interfacial bond forms. 
If the material is non-toxic and dissolves, the surrounding tissue replaces it 
(bioresorbable). 
Table 1.III. Classification of Bioceramics on the basis of tissue attachment. 
Type of attachment Example 
• Dense, non porous, nearly inert ceramics attached 
by bone growth into surface irregularities by 
cementing the device into the tissues, or by press 
fitting into a defect (termed morphological fixation). 
• Al2O3, Alumina (single crystal and polycrystalline) 
 
• For porous inert implants bone ingrowth occurs, 
which mechanically attaches the bone to the material 
(termed biological fixation). 
• Porous polycrystalline Al2O3  
• Hydroxyapatite-coated porous metals. 
• Dense, non porous, surface-reactive ceramics, 
glasses, and glass-ceramics attach directly by 
chemical bonding with the bone (termed bioactive 
fixation). 
• Bioactive glasses 
• Bioactive glass-ceramics 
• Hydroxyapatite 
 
• Dense, non porous or porous resorbable ceramics 
are designed to be slowly replaced by bone. 
• Calcium sulfate (plaster of Paris) 
 • Tricalcium phosphate 
• Calcium phosphate salts 
 
The reactivity of the surrounding bone tissue to the implant is closely correlated with the 
rate of formation of an interfacial bond of implants with bone. The relative level of 
reactivity influences the thickness of the interfacial zone of layer between the material and 
tissue. The failure of implant materials generally originates from the biomaterial-tissue 
interface. When biomaterials are almost inert and the interface is not chemically or 
biologically bonded, there is relative movement, and progressive development of a non-
adherent fibrous capsule. Movement at the biomaterial-tissue interface eventually leads to 
deterioration in function of the implant or of the tissue at the interface or of both. The 
thickness of the non-adherent capsule varies greatly, depending upon both the material and 
the extent of the relative motion. It is crucial that inert implants are implanted with a very 
tight mechanical fit so to maintain a little value of the fibrous tissue thickness, otherwise it 
can become several hundred micrometers thick, leading to the loosening of the implant and 
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clinical failure, with fracture of the implant or of the bone adjacent to it. Moreover, the 
bone at interface with an inert material is very often structurally weak, because of disease, 
localized death of bone or stress shielding, due to the higher elastic modulus of the implant 
which prevents the bone from being loaded properly. 
Fig. 1,13 shows a comparison of the different chemical activities of different ceramic-
based biomaterials. 
 
 
Figure 1.13. Comparison of the different chemical activities of different ceramic-based 
biomaterials. 
1.5 Calcium phosphates in biologic systems 
The wide application in the last decades of calcium phosphates as biomaterials is 
mainly due to the biological properties of these materials, whose composition is very close 
to the one of bone mineral, which represents about 70% of the mass of dry bone tissue6,7,42. 
The first study dates back to the 1920, reporting an accelerated bone healing in surgically 
created defects in rabbits43. Anyway, specific interest in calcium phosphates for biomedical 
applications, and specifically in apatites, raised up in the 1960s and initial studies 
principally involved the synthesis and analysis of hydroxylapatites in an attempt to better 
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understand the physico-chemical and biological behaviour of natural apatites, which 
constitute the mineral part of human bones and teeth42,44,45. 
Following these studies, calcium phosphate-based bioceramics have been in use in 
medicine and dentistry for the last 40 years. Different phases of calcium phosphate 
ceramics are selected depending upon whether a resorbable or bioactive material is desired. 
These materials constituted a wide variety of biomaterials like coatings of metal 
orthopaedic (hip and knee joints) and dental implants (Fig. 1.14), cements, injectable 
cements, composite materials, and drug carriers (antibiotics, anticancerous drugs, growth 
factors), three-dimensional dense and porous scaffolds for bone reconstruction or 
replacement, applied especially in small bones and middle ear bones, powder granulates 
for the repair of bone defect in maxillofacial surgery, alveolar ridge augmentation, 
otolaryngology. 
     
              
Figure 1.14. Examples of bioceramic implants for different applications. 
The stable phases of calcium phosphate ceramics depend considerably upon temperature 
and the presence of water, either during processing or in the use environment. At body 
temperature, only two calcium phosphates are stable in contact with aqueous media, such 
as body fluids: at pH < 4.2, the stable phase is CaHPO4·2H2O (dicalcium phosphate, 
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brushite, DCPD), whereas, at pH > 4.2, the stable phase is Ca10(PO4)6(OH)2 
(Hydroxyapatite, HA). At higher temperatures, other phases, such as Ca3(PO4)2 (β-
tricalcium phosphate, TCP), and Ca4(PO4)2O (tetracalcium phosphate, TeCP) are present. 
The unhydrated, high temperature calcium phosphate phases interact with water, or body 
fluids, at 37 °C to form HA. Thus, the solubility of a TCP surface approaches the solubility 
of HA and decreases the pH of the solution, which further increases the solubility of TCP 
and enhances resorption. 
Other calcium phosphates have been identified with or without association with apatite; 
they include: Ca8H2(PO4)6⋅5H2O (octacalcium phosphate, OCP); Ca2P2O7 (calcium 
pyrophosphate dehydrate in mono- and triclinic forms, CPP); amorphous calcium 
phosphate, ACP. 
Apatites in normal calcified tissues of teeth and bone have been postulated to form either 
directly or indirectly by way of precursor calcium phosphates such as ACP, DCPD, OCP 
or TCP. The general occurrence and co-existence of phosphate minerals in human tissues 
are summarized in Table 1.IV. 
Table 1.IV. Phosphate minerals present in human tissues.  
Phosphate minerals Chemical formula Occurrences 
Apatite or “apatitic” calcium 
phosphates 
(Ca, NA, Z)10 (PO4, CO3, 
Y)6 (OH, X)2 
Enamel, dentine, bone 
Whitlockite, β-TCP (Ca, Mg)9(PO4)6 
Salivary stones, dental 
calculi, tubercular deposits, 
pulmonary calcifications, 
calcified cartilage  
Octacalcium phosphate Ca8H2(PO4)6⋅5H2O Dental and urinary calculi 
Brushite, DCPD, calcium 
phosphate dehydrate CaHPO4⋅2H2O 
Dental calculi, concretions 
in old bones, 
chondrocalcinosis 
Calcium pyrophosphate 
dehydrate, CPPD, mono and 
triclinic 
Ca2P2O7⋅2H2O Pseudo-gout deposits, in synovium fluid 
Amorphous calcium 
phosphate (containing Mg2 
and/or P2O74-) 
Variable composition 
Non-visceral calcifications 
associated with uremia; 
aortic valves 
1.5.1 Calcium phosphate dehydrate, Brushite (DCPD) 
The formation of DCPD in vivo is observed in dental calculi and in other 
pathological calcifications. It can forms either by direct precipitation or by dissolution of 
apatite and reprecipitation of the more stable DCPD crystals under acid conditions. The 
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presence of trace elements (e.g., F-, P2O74-, Sr2+ and Mg2+) is associated with different 
morphologies of DCPD crystals. DCPD can co-exist with other calcium phosphates, like 
OCP and apatite, depending on pH. 
1.5.2 Tricalcium phosphate (TCP) 
Tricalcium phosphate exists under two crystallographic forms: β and α-TCP. The α-
form is unstable at low temperature and is obtained by quenching the β-form heated above 
1125 °C (transition temperature). The β-form may however be stabilized by several ionic 
impurities, such as Mg2+ ions, frequently associated with Ca salts. α-tricalcium phosphate 
is more soluble and more reactive than β-TCP, and it can be rapidly hydrolyzed into apatite 
in aqueous media. Both varieties can be used in Ca-P cement preparations. 
The β-form makes an excellent resorbable biomaterial. However, it is not found in 
biological systems and it cannot be obtained by precipitation.  
Biological TCP is always partially magnesium-substituted, giving rise to whitlockite (Ca, 
Mg)9 (PO4, HPO4)6. It is not detected as constituents of normal tissue calcifications but 
their presence in several pathological tissue calcifications, in abnormally calcified cartilage 
and in human dental carious lesions has been reported46,47. 
β-TCP is more soluble than apatite and can be hydrolyzed into apatitic phases; whitlockite 
on the contrary seems less soluble and has never been shown to convert into apatite48. The 
presence of Mg in β-TCP is thus an important parameter affecting its biological properties, 
especially its ability to be resorbed. 
β-TCP can be obtained by thermal decomposition of a non-stoichiometric apatite with a 
Ca/P ratio of 1.5 or by solid state reaction at high temperatures (900 °C). The industrial 
product may sometimes be blended precipitated powders with a correct overall 
composition but grain heterogeneity. Prolonged heating at 1000 °C is generally sufficient 
to insure homogenization of the chemical composition. 
Although the presence of other trace ions (Mn2+, Fe2+, Co2+, Ni2+) also promotes the 
formation of β-TCP at the expense of apatite49, the influence of Mg2+ ion is the most 
significant, so that the Mg/Ca ratio in biological and synthetic systems is the major 
determining factor in the formation of the whitlockite phase at the expense of apatite46,50. 
However, in presence of CO32- or F- ions, the effect of Mg2+ presence is reduced and the 
formation of apatite phase is favoured. 
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In order to control the resorbability of Ca-P ceramics, mixtures of β-TCP and HA have 
been proposed51,52, showing that the ratio of β-TCP/HA in the final product is related to the 
resorption rate, in vivo. Such mixtures can be obtained either by blending pure powders, or 
more simply by heating a non-stoichiometric apatite with an adequate Ca/P ratio. 
1.5.3 Amorphous Calcium Phosphates (ACP) 
Amorphous calcium phosphates is believed to be a constituent of bone mineral53-55. 
The ACP in bone is believed to transform to apatite, thus acting as a transitory precursor of 
biological apatites just as they are supposed to be in some synthetic preparations53-56. 
Amorphous Ca-P may play an important role in the future because of their high reactivity. 
Several ways of formation exist: precipitation in highly supersaturated solutions, from 
alkaline to neutral pH, quenching of fused Ca-P compounds, and non-aqueous 
precipitations. They may exhibit very different Ca/P ratios, from 1 to 2 or more. All are 
easily hydrolyzed into apatitic compounds. Amorphous Ca-P begins, generally, to 
crystallize around 600 °C. Despite different composition, they all appear to be structurally 
related, independent of the preparation method. 
In synthetic systems, the presence of carbonate or magnesium or pyrophosphate promotes 
the formation of ACP42; the simultaneous presence of two or more of these ions are even 
more effective in promoting the formation of ACP. 
The comparative efficiency in promoting the formation of ACP parallels the efficiency in 
stabilizing the amorphous phase: 
[Mg2+ + P2O74-]>>[P2O74-]>>[Mg2+ + CO32-]>>[Mg2+]>>[CO32-]. 
Then, the stability of ACP in human pathological tissue calcifications can be attributed to 
their magnesium and/or pyrophosphate contents. 
1.6 Bioactivity of calcium phosphates 
Synthetic bioactive Ca-P materials are not in equilibrium with biological fluids. 
Thus, several reactions occur on the mineral surface7. For apatites, very first reaction is the 
hydrolysis of the surface PO43- groups into HPO42- and the uptake of carbonate and sodium 
ions. Generally the hydrolysis of surface phosphate groups is associated with a decrease of 
the calcium concentration at the surface57. These reactions correspond simply to exchanges 
between the solution and the first atomic layers of the apatite surface. The extent of these 
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reactions may vary according to the composition of the mineral and how it was produced. 
Inflammatory cells in close proximity to the material, may also create an acidic 
environment. Poorly crystalline apatites with many defects are particularly sensitive to 
these changes. 
As biological fluids are generally supersaturated with respect to apatite, the Ca-P materials 
also serve as a template for the formation of carbonate-apatite crystals. This event has been 
shown to be the major factor behind the osteoconductivity of all biomaterials and has been 
evidenced in different classes of bioactive orthopaedic implants (polymers and bioactive 
glasses). The crystals formed are very much like bone mineral crystals. They are 
carbonated apatites and exhibit non-apatitic environments. 
The precipitation of the neo-formed crystals can also be boosted by release of calcium, 
phosphate ions or rise in the pH that may locally increase the supersaturation ratio in the 
vicinity of the implant surface. This phenomenon can be favoured by hydrolysis reactions 
of the material constituents. Enlarging the surface area is another way to increase the 
amount of reactive, neo-formed crystals. 
The ability of a biomaterial to generate this layer has been considered as a measure of its 
biological activity, although such a relationship has not yet been established on a 
quantitative basis. Despite the analogy of the crystals formed with bone mineral crystals, 
the processes of formation and organization appear to be rather different. Bone mineral 
crystals are always formed in an organic collagen matrix with which they are closely 
associated. Although the layer formed on bioactive biomaterials frequently incorporates 
bone proteins, there is no organization like that of bone. It appears more like an 
uncontrolled mineralization. 
The functions of the neo-formed layer have not yet been clearly established. This layer 
creates a very reactive surface with a high specific surface area, which is able to attach 
bone specific proteins, especially osteopontin and osteocalcin58. The neo-formed layer 
appears, as a support, and the adsorption of proteins to it is necessary to accommodate 
osteoblast cell attachment and favour their multiplication. Although such proteins might 
bind directly to the HA surface, the adsorption affinity could be quite different depending 
on the apatitic substrate. Thus, synthetic apatites rich in labile non-apatitic environments 
exhibit a high surface reactivity and have a higher affinity for some proteins than 
stoichiometric HA. Depending on the apatitic substrate and the rate of formation of the 
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layer, the presence of labile non-apatitic environments and the reactivity of the neo-formed 
layer may vary. 
1.7 Apatites 
1.7.1 Hydroxyapatite: structure and chemistry 
Apatites are an industrially important group of materials with applications in 
catalysis, environmental remediation, bone replacement and ceramic membranes amongst 
others, and constitute a large class of materials with general formula59 
[M(1)2][M(2)3](XO4)3X, where: 
M represents a bivalent cation; 
XO4 represents a trivalent anion; 
Z represents a monovalent anion. 
Among all the apatites, calcium hydroxyapatite is the most relevant in biological systems, 
as it is the major component of bones and teeth; its formula is defined as: Ca5(PO4)3OH or, 
more often, Ca10(PO4)6(OH)2.  
M/X ratio commonly defines the stoichiometry of an apatite, in case of HA it corresponds 
to Ca/P = 1.667. 
In ideal HA, calcium, phosphorus and hydroxyl ion are present in the following weight 
percentage: Ca = 39.84 %; PO4 = 56.77 %; OH=3.39 %. 
The apatite prototype Ca5(PO4)3F structure was first determined by Naray-Szabo in 193060 
and was confirmed to adopt P63/m symmetry (Fig. 1.15). 
 
Figure 1.15. Crystal structure of Hydroxyapatite. 
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The 10 Ca2+ ions occupy two crystallographically different symmetry sites, 4f and 6h. Four 
Ca2+ ions (4f ) are located in columns along the three-fold axes at 1/3, 2/3, 0 and 2/3, 1/3, 0 
separated by approximately one half of the c -axis. These are commonly referred to as Ca1 
(or column Ca). Ca1 is coordinated to nine O atoms, with six shorter bonds that define an 
approximate trigonal prism and three longer bonds capping the prism faces. The Ca-O9 
polyhedra share the trigonal faces to form chains parallel to the c-axis. The remaining six 
Ca2+ ions (6h sites, referred to as Ca2 or triangular Ca) form two triangular sets at z = 1/4 
and 3/4 on the mirror planes. The Ca2 ions are seven-coordinated, with six O atoms and 
one OH- ion. The six XO4 tethraedra are PO43- groups in a 6h site. OH- anions occupy the 
special position 4e at z/c=0.202, that has multiplicity of 4. As in the hexagonal structure 
the presence of the mirror plane at 1/4 and 3/4 make hydroxyls ions in this position 
reflected too close to themselves, an occupation factor of 1 would result in an incorrect 
stoichiometry. Thus, the occupation of the site must be 0.5, and in this case the orientation 
of the OH- groups in the lattice cannot be known. A full description of OH- sites in 
stoichiometric HA can be achieved by reducing the symmetry of the crystal to the 
subgroup P21/b61. As the cell contains twice the atoms of the hexagonal one, the correct 
stoichiometry is retained and the sticking of the hydroxyls is prevented; the resulting unit 
cell parameters are a = 9.421 Å, b = 18.843 Å, c = 6.881 Å,  γ= 120.0°.(Fig. 1.16) 
 
Figure 1.16. Structure of monoclinic hydroxyapatite. 
Thus, HA can be described in terms of two interpenetrating lattices: an overall P63/m 
structure, with a local P21/b in correspondence of the hydroxyls columns. For this reason 
and for sake of simplicity, we will always refer to the hexagonal description of HA, as the 
monoclinic description is required only for explaining the statistical occupation of OH- 
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ions and is not influent on the chemico-physical properties of HA related to the biologic 
behaviour. 
1.7.2 Biological Apatites 
Although the above-described structure of synthetic HA has been used as a model 
for the apatite present in the human hard tissues for many years, many differences in 
composition and in other properties make the biological apatites different from pure 
calcium hydroxyapatite and from each other and should be more appropriately referred to 
as calcium-deficient, multi-substituted hydroxyapatite (Tab. 1.V). 
The apatite lattice is very tolerant of substitutions, vacancies and solid solutions, for 
example, X can be replaced by ½CO3 or ½O; Ca by Sr, Ba, Pb, Na or vacancies62; and PO4 
by HPO4, AsO4, VO4, SiO4 or CO3. 
Owing to this ability, biological apatites are capable of variable composition and therefore 
to be heterogeneous even within each category and even within each calcified tissue 
(enamel, dentine, bone). Non-stoichiometry (Ca/P of biological apatites ranges from 1.54 
to 1.73 compared to 1.67 for pure HA), the presence structural or surface-bound of foreign 
ions and the co-existence or pre-existence of possible precursors such as DCPD, 
octacalcium phosphate (OCP), TCP, ACP make an accurate crystallochemical analysis and 
definition a difficult, if not an impossible undertaking. 
Because of these difficulties, many studies on biological apatites have been made 
indirectly by studying apatites prepared from aqueous and non-aqueous systems. 
Notwithstanding, the chemico-physical behaviour of the synthetic apatites cannot always 
be directly extrapolated to biological apatites. 
The biological apatites are uniquely similar in that they all contain carbonate in varying 
amounts as a substitute for phosphate in the apatite structure63,64. They differ in crystallite 
sizes, shapes and other physico-chemical properties such as chemical (susceptibility to acid 
dissolution) and thermal stabilities65,66.  
Based on observations from in vitro systems63,65,67-70, some of these foreign ions affect the 
crystallinity (reflecting crystallite size and/or strain), morphology, lattice parameters of the 
biological apatites50 and as a consequence, impart stability or instability to the tissues 
involved. Some of these impurities are associated with the susceptibility or resistance of 
human tooth enamel to acid dissolution (caries) and of bone resorption processes50,71,72. 
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Table 1.V. Atomic composition of human hard tissues. 
COMPOSITION Bone (wt%) Enamel (wt%) Dentin (wt%) 
Ca2+ 34.8 36.5 35.1 
PO43- 15.2 17.7 16.9 
CO32- 7.4 3.5 5.6 
Mg2+ 0.72 0.44 1.23 
Na+ 0.9 0.5 0.6 
Si 0.05 0.14 0.01 
Cl- 0.13 0.3 0.1 
K+ 0.03 0.08 0.05 
F- 0.03 0.01 0.06 
S - 0.1 0.2 
In traces: Sr2+, Pb2+, Zn2+, Cu2+, Fe3+,… 
Total inorganic phase 70.0 97.0 70.0 
Total organic phase 23.0 1.5 20.0 
Total aqueous phase 7.0 1.5 10.0 
Biological apatite is not a stable material, as it is involved in the complex bone metabolism 
and thus subject to a continuous structural remodelling, due also to its very poor 
crystallinity degree. One important characteristics of biologic HA is for example, the 
increase of its crystallinity in the ageing and the increase of Ca/P ratio. This phenomenon 
reflects in a progressive decrease of the capacity of biologic HA to remodel itself, as the 
stability and solubility of HA strongly decreases when it approaches to the stoichiometry 
(Ca/P =1.667). 
1.7.3 Effect of carbonate 
The presence of carbonate ions in the biological apatites strongly contributes to the 
variation of Ca/P ratio. As higher its content as higher is the metabolic activity of the 
tissue: for example, enamel, which is a nearly inert tissue, contains very few carbonate, 
compared to bone and dentin, which are very active tissues. Carbonate ions are either 
adsorbed on the surface or incorporated into the HA structure, into two different 
crystallographic sites, hydroxyl (A-type carbonation) or phosphate (B-type carbonation). 
The B-type is the preferential carbonate substitution found in the human bone, in the range 
2-8 wt%, depending on the age of individual73, with the A/B type ratio in the range 0.7-0.9. 
A higher value of the A/B ratio was observed in old tissue, compared to young tissue74. It 
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has been observed by in vivo tests that the decrease of crystallinity in B-carbonated HA 
yields an increase of solubility75. B-type carbonation is related to a higher affinity of 
apatite for osteoblast cells, compared to A-type carbonation, as it does not alter the surface 
polarity of HA. This reflects in a higher cellular adhesion and an increase production of 
collagen76,77.  
1.7.4 Effect of magnesium 
Among substituting cations, magnesium is widely studied due to its biological 
relevance. It has been verified that in calcified tissues, the amount of magnesium 
associated with the apatite phase is higher (about 5% at.) at the first stages of the bone 
remodelling process and decreases with increasing calcification and with the ageing of 
individual78. The presence of magnesium increases the nucleation kinetic of HA 
contemporary retarding that of its crystallization; for this reason magnesium concentration 
is higher in the cartilage and in young bone and there is growing evidence that it may be an 
important factor in the qualitative changes of the bone matrix that determines bone 
fragility. Magnesium depletion adversely affects all stages of skeletal metabolism, causing 
cessation of bone growth, decrease of osteoblastic and osteoclastic activities and 
osteopenia. 
1.7.5 Effect of silicon 
Among the numerous trace elements present in bone mineral, silicon plays an 
essential role for normal bone and cartilage growth and development79. 
Apart from oxygen, silicon is the most abundant element in the earth’s crust. The presence 
of silicon in mammalian systems is quite variable. Silicon is present at a level of _1 ppm in 
the serum, 2–10 ppm in the liver, kidney, lung and muscle, 100 ppm in the bone and 
ligaments and 200–600 ppm in cartilage and other connective tissues80. In the examination 
of a variety of connective tissues using chemical methods, silicon was found in high levels 
of 200–550 ppm bound to extracellular matrix compounds such as hyaluronic acid, 
chondroitin sulfate, dermatan sulfate, and heparan sulfate in connective tissues such as 
cartilage and the umbilical cord80. The high concentration of silicon observed in 
extracellular matrix components implies a role for silicon as a biological cross-linking 
agent that contributes to the architecture and resilience of connective tissue80. 
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The role of silicon as an essential element for higher biological organisms (i.e. other than 
primitive diatoms, sponges and plants such as bamboo) was discovered in the 1970s 
through the deficiency studies of Carlisle81,82, Schwarz83 and Seaborne84. Carlisle 
performed an initial silicon deficiency study in which silicon was localized in active 
growth areas, such as the osteoid, of the young bone of mice and rats, and silicon levels up 
to 0.5 wt% were observed in these areas81, demonstrating the significant dependence of 
healthy skeletal development on silicon. Carlisle also reported lower levels of collagen in 
the cartilage of Si-deficient animals, with no significant difference in the level of non-
collagenous proteins82. 
In a similar study, rats raised with a low silicon diet and environment were compared with 
rats supplemented with sodium metasilicate as a fresh aqueous solution at 50 mg Si/100 g 
of diet. After, Schwartz and Milne found a 33.8% increase in the growth rate in Si-
supplemented animals, compared to the Si-deficient animals83. In the Si-deficient animals 
deformities were observed in the skull and tooth enamel and a lower water content of the 
bones coincided with a lower glycosoaminoglycan content83. On the basis of these studies, 
it was determined that silicon should be categorized as an essential trace element for 
metabolic processes associated with development of bone and connective tissues85,86. 
Silicon's primary effect in bone and cartilage appears to be on formation of the organic 
matrix. Bone and cartilage abnormalities are associated with a reduction in matrix 
components, resulting in the establishment of a requirement for silicon in collagen and 
glycosaminoglycan formation. Additional support for silicon's metabolic role in connective 
tissue is provided by the finding that silicon is a major ion of osteogenic cells, especially 
high in the metabolically active state of the cell. Further studies also indicate that silicon 
participates in the biochemistry of subcellular enzyme-containing structures. silicon also 
forms important relationships with other elements.  
A study using cDNA microarray analysis is reported, showing that the rapid release of 
soluble silicate, phosphate and calcium ions can activate specific genes controlling the cell 
cycle of osteoblasts for new bone formation and proliferation. 
Aqueous silicon in the form of orthosilicic acid (Si(OH)4) has been shown to enhance 
osteoblasts proliferation, differentiation and collagen production, and to have dose 
dependent effects on osteoclast cells under in vitro conditions, enhancing the alkaline 
phosphatase and osteocalcin activities, with an associated increase in osteogenesis87. 
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A critical step in collagen type I synthesis and its secretion into the extracellular space is 
the hydroxylation of the proline residues of the collagen chains, a reaction catalyzed by 
prolyl hydroxylase88. Indeed it has previously been reported that optimal activity of prolyl 
hydroxylase appears to depend on the presence of adequate concentrations of silicon. The 
increase in prolyl hydroxylase activity observed following the addition of soluble silicon to 
the diet of Si-deficient animals may reflect the rate of collagen biosynthesis where soluble 
silicon is generally implicated. Silicon is also known to bind to glycosaminoglycan 
macromolecules and has been shown to play a role in the formation of cross-links between 
collagen and proteoglycans80, thus resulting in the stabilization of bone matrix molecules 
and preventing their enzymatic degradation. 
On the basis of these studies it is clear that silicon plays important and significant roles in 
the bone and cartilage systems, acting on the physiological system most prominently 
during the growth and development of the skeletal system of higher organisms. Silicon also 
influences the cartilage synthesis and the integrity of the extracellular matrix, as well as the 
biomineralization process and also has dose-dependent effects on the differentiation, 
proliferation and collagen synthesis of osteoblasts, with a direct influence on the 
remodeling process and osteoclast development and resorption activities. 
The incorporation of foreign ions during the crystallization in solution has inspired 
researchers to investigate the substitution of chemical groups found naturally in enamel or 
bone. Application of this knowledge can then be used to adjust properties such as 
solubility, mechanical behaviour and bone bonding ability. Chemical elements not found in 
bone can be substituted for different effects. For example, addition of silver has been used 
for imparting antimicrobial properties89. 
1.8 Methods for synthesis of HA 
Many patents, publications and reviews describe the formation of 
hydroxyapatite90,91. Several mechanisms of formation have been explored including 
precipitation, conversion of other calcium salts, solid state reactions, and sol-gel 
preparation4. Nevertheless, some variability may appear depending on the synthesis 
method. Precipitation methods are the most widely used since they can produce large 
amount of HA with good reproducibility. 
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Precipitation from solution is the most common synthesis route and involves simultaneous 
addition of a calcium salt and a phosphate compound to water, or drop-wise addition of the 
phosphate into an aqueous solution of the calcium salt. Examples of calcium salts include 
calcium nitrate, calcium hydroxide, calcium chloride, or calcium acetate. The salts are 
reacted with a hydrogen phosphate or the phosphate ions are introduced in solution from 
di-ammonium hydrogen phosphate or orthophosphoric acid. 
The mostly employed reactions involve (i) the neutralization of calcium hydroxide by 
orthophosphoric acid92,93, and (ii) the reaction of calcium nitrate with di-ammonium 
hydrogen phosphate. The precipitation reaction is conducted with pure reactants at a pH 
greater than 9, with a controlled reactant addition rate, under stirred conditions and a 
temperature between 25 and 90 °C. 
In reactions where ammonium is part of the precursor, dilute ammonium hydroxide is 
added continuously to restore the pH after a decrease caused by removal of a hydroxide 
from the solution to precipitate HAP. The slow incorporation of calcium into the apatitic 
structure must be accompanied by stirring and aging after the reaction. The Ca/P molar 
ratio of 1.67 is attained in a few hours after the completion of the reaction at 90°C94. Post 
reaction maturation is an important step for ensuring the production of stoichiometric 
hydroxylapatite95. During maturation, the crystal shape is modified and slender crystals 
become more "blocky" as the Ca/P molar ratio approaches 1.67 94. After maturation, the 
precipitate is washed several times in double distilled water; high water purity is essential 
at all times because the apatite lattice readily incorporates foreign elements into the 
structure. The precipitate is finally dried, sieved and in case, calcined. 
In the present work, the neutralization method will be employed, to avoid the employment 
of ammonia ions which could be retained in the HA powder; the neutralization method has 
the advantage to be carried out in a basic environment  (pH ~ 9-12), so that the only stable 
phase can be hydroxyapatite. The calcium hydroxide suspension is kept under stirring, 
upon neutralization by the dripping acid solution; as in the previous methodology, the 
precipitate is washed, and after dried, sieved and in case, calcined. 
Crystallinity, a term used to describe the crystal perfection and/or crystallite size, can vary 
depending upon the synthesis conditions. A high crystallinity is typically desired where an 
apatite is subjected to elevated processing temperatures for consolidation into dense forms. 
However, low crystallinity can impart a higher resorbability in applications such as 
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composites and cements. Synthesis at 90°C produces a purer apatite with a higher degree 
of crystallinity, than at room temperature. Crystals can be plate-like, acicular or blocky and 
exhibit a surface area of 30-120 m2/g94,96. Crystal size in the c-axis direction can be as 
small as 50 nm when produced at 25 °C to as large as 700 nm at 90 °C. These crystallites 
agglomerate into clusters upon drying.  
Another method for the preparation of apatite biomaterials is the conversion of a calcium 
compound in phosphate solution4. Calcium hydroxide and calcium carbonate are most 
often used. These heterogeneous reactions are generally more difficult to control than the 
simple precipitation, because they involve a dissolution/ reprecipitation phenomenon. The 
characteristics of the starting material (specific surface area, particle size, porosity) have to 
be carefully verified to obtain reproducible results. These preparations do however offer 
some advantages into porous Ca-P ceramics. In addition , the reactants are abundant and 
inexpensive. The reaction may, in some conditions, be performed at low temperature and 
do not produce any by-products that have to be disposed of.  
Several high temperature solid-solid reactions may lead to hydroxyapatite. These reactions 
are not generally used to produce large amounts of apatites but they are involved in the 
direct production of ceramic pieces (reactive sintering). 
High-temperature synthesis was the first method of apatite production reported and 
involved passing phosphorus tri-chloride vapour over red-hot lime. This process involved 
the reaction of a gaseous and solid phase. Diffusion between two solid calcium phosphates 
also produces hydroxyapatite, at temperatures in excess of 1000 °C, however, this method 
does not produce homogeneous apatites and leads to an increase in grain size through 
growth and reduction in surface area; two aspects that may be important in the further 
processing and application of calcium phosphates. Other synthesis reactions include 
hydrothermal techniques, hydrolysis of other calcium phosphates97 and sol-gel methods98. 
Hydrothermal synthesis is the second most common method and, in comparison to the wet 
chemical method, is able to produce well-crystallized, compositionally homogeneous 
apatite99. A high crystallinity, carbonate-substituted hydroxyapatite is produced by this 
method. Calcium phosphates that have been hydrolysed to hydroxyapatite include 
octacalcium phosphate100, tricalcium phosphate101, and brushite97,102. 
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1.9 Non-stoichiometric and substituted HA 
As pH values decrease, a calcium deficient HA is more likely to be formed103,104. 
During aqueous precipitation, other species may be substituted in the structure or adsorbed 
onto the surface. 
Non-stoichiometric apatites are quite easy to synthesize, as they can be obtained by any 
precipitation method over a wide range of pH, temperature and concentration. Their 
composition and crystal characteristics are however more difficult to control. The most 
interesting of these apatites are HPO42- and CO32-containing apatites which are close to 
bone mineral. Although bone mineral has a variable composition, diverse apatites 
mimicking the evolution of bone mineral in young and old animals can be prepared. These 
apatites also show similar crystal shape and dimensions and their composition can be 
represented by a chemical formula analogous to that of bone mineral. 
Addition of more than one substitute element group can lead to a combination of an 
expansion and contraction of the unit cell69. For example, carbonate causes a decrease in 
the a-axis105 that could be counteracted by an increase from an acid phosphate group106. 
This reaction sequence is complicated by the ability of carbonate to substitute phosphate or 
hydroxide, the former being the more common96.  
The addition of many of these chemical groups decreases the growth rate at low 
concentrations. Full substitution of fluoride for the hydroxyl ion removes lattice distortion, 
produces a more stable apatite and, thus, is able to drive precipitation to completion more 
easily107. Carbonate replaces phosphate in reactions containing fluoride and at high pH96. 
All ionic sites of the apatite structure accept substitutes42. It is generally the size of the 
ionic substitute that determines its incorporation in a given lattice. For Ca-P apatites, the 
monovalent anionic site substitution of OH- by F-, Cl-, Br- are known but I- is not. These 
sites may also be occupied by carbonate ions, as in enamel and bone. The trivalent anionic 
phosphate sites may be occupied by bivalent or tetravalent ions like carbonate, HPO42-, or 
silicate SiO44- and many other trivalent ions such as vanadate or arsenate. These sites 
cannot accept vacancies, probably because the trivalent anions are quite large and 
vacancies would destabilize the lattice7. 
Cationic sites can also be occupied by other divalent cations like Pb2+, Mg2+, Zn2+, Cu2+, 
Mn2+, and by monovalent ions such as Na+ and K+ or trivalent ions like La3+. The cationic 
site can also accept vacancies: up to maximum of 2 sites out of the 10 existing in 
 35
General Topics 
⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ 
 
stoichiometric apatites. This property of the apatite structure allows the adaptation of its 
physical and chemical properties to many different calcified tissues, such as enamel, bone, 
dentine, and fish scales. However, in the preparation of pure HA, this property is a 
drawback because many ions from the solution can be incorporated, including toxic ions, 
or mineral ions with a positive biological activity. Thus the preparation of pure apatite has 
to take these properties into account. 
The pH is an important factor in the precipitation of apatites as it determines the HPO42- 
content of the final product. Stoichiometric apatites are generally obtained at alkaline pH 
and in boiling solutions. Anyway, stoichiometric hydroxyapatite does not form 
spontaneously in solution; their formation in highly supersaturated solutions is preceded by 
the precipitation of an amorphous phase possessing a Ca/P ratio much lower than that of 
apatite. This first precipitate then transforms into an apatite phase whose Ca/P ratio tends 
progressively towards that of HA.  
Surface properties also play a role in the preparation of apatites. Generally, precipitated 
apatites have a very high specific surface area (between 50 and 90 m2/g) that may adsorb 
many ions or constituents. In fact, adsorbed ions may eventually be incorporated into the 
lattice during growth or maturation of the crystals. Surface constituents generally slow 
down the maturation process and the evolution towards stoichiometry. The surface CO32- 
and HPO42- ions play a special role as they may alter the global stoichiometry of the solid. 
Precipitation has been performed in various conditions. The preparation of HA seems to be 
better achieved in Ca-rich solutions than in phosphate-rich solutions. 
Following, the effect of the most relevant ionic substitutes on the chemico-physical 
properties of synthetic HA are described in more detail. 
Carbonate (CO32-) 
A key target of biomaterials research is the preparation of a synthetic carbonate 
containing hydroxyapatite (CHA) bone-substitute ceramic, that mimics the chemical 
composition of the natural hard tissue. The carbonate group can substitute both the 
hydroxyl and the phosphate ions, giving rise to the A-type and B-type carbonation 
respectively, so that a CHA substituted in both sites can be described as 
Ca10−x/2[(PO4)6−x(CO3)x][(OH)2−2y(CO3)y]. The charge unbalance occurring when (CO3)2− 
ions replace (PO4)3− (B-type CHA) groups is primarily compensated by vacancies in Ca1 
sites107. The exact position of the carbonate ions in the lattice of the HA has been 
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elucidated only recently107,108. By using full Rietveld refinement of the crystal structure of 
the synthetic calcium-deficient carbonated apatite two orientations of CO3 triangles, 
sharing one of their edges, were found. They occupy randomly the adjacent faces of a PO4 
tetrahedron that are parallel to the c axis. (Fig. 1.17). 
 
Figure 1.17. View of the two possible arrangement of CO3 moieties around the PO4 
tetrahedron. 
In synthetic non-aqueous (1000 °C) systems, the mode of carbonate incorporation is CO3 
for OH (type A substitution)109; in aqueous systems CO3 for PO4 (type B substitution); in 
biological apatites, predominantly CO3 for PO4 42. The extent of carbonate incorporation is 
influenced by the presence of other ions such as Na+, K+, which favour greater 
incorporation of carbonate, and Sr2+, which limits the extent of incorporation. 
Type B carbonate apatites are obtained when apatites are prepared either by direct 
precipitation or hydrolysis of ACP, DCPD, DCP or OCP in carbonate-containing solutions. 
The amount of carbonate incorporated in the apatite is dependent on the CO3 concentration 
of the solution, but the maximum incorporation of CO3 in the apatite is limited to about 22 
wt% CO3, or 3 mol of CO3. At higher CO3 concentrations in solution the calcite form of 
calcium carbonate occurred when precipitations were made at 25 °C and 37 °C; the 
aragonite form became the preferred phase when precipitation were made at 95-100 °C.  
Type B carbonate apatites can be also prepared by conventional synthesis of HA, when 
carbonate ions are present in the reaction  vessel109. 
Carbonate substitution in type B carbonate apatites causes the following effects: a) 
decrease in a axis and increase in c-axis dimensions compared to CO3-free apatites; b) 
decrease in crystal size as shown by the broadening of the diffraction peaks in the XRD 
patterns and in TEM; c) increase in crystal strain as shown by the loss of resolution of the 
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PO4 absorption bands in the IR spectra; d) change in crystal morphology; e) greater 
solubility. As carbonation in B site increases the biomimetism of the synthetic apatite, it is 
advisable to orient the synthesis techniques for the incorporation of suitable amounts of 
carbonate ions, substituting the phosphate76,77. 
Examination of the CO3-apatites before and after exposure to acid buffer showed that the 
apatite after exposure had less carbonate suggesting the dissolution of CO3-rich apatite and 
reprecipitation of CO3-poor apatite. Support for the second alternative was provided by the 
initial decreases in crystallinity and subsequent increase in crystallinity with time. 
The higher solubility of CO3-containing apatite compared to the CO3-free apatite could 
have been predicted on the basis of the carbonate effect on decreasing the crystal size and 
therefore increasing the surface area as well as its effect on increasing the crystal strain. In 
addition, the Ca-CO3 bond is weaker than the Ca-PO4 bond, thus making a CO3-containing 
synthetic and biological apatite more susceptible to acid dissolution than CO3-free apatite. 
Magnesium (Mg2+) 
As Mg2+ is smaller than Ca2+ (0.86 Å vs. 1.14 Å), the incorporation of magnesium 
affect the crystal structure of HA and the substitution cannot occur over the full 
concentration range. Progressive increase of the amount of incorporated magnesium, in 
fact, slightly reduces the cell parameters of the crystal and the average crystal radius; 
above a concentration limit of ~ 0.15 Mg2+/Ca2+ the apatite structure likely collapses and 
the formation of other phases (typically TCP or amorphous calcium magnesium 
phosphates), that act as segregating phases for this ion, is observed42. The incorporation of 
Mg in synthetic apatites is very limited (maximum of about 4 wt% Mg) unless carbonate or 
fluoride ions are simultaneously incorporated with Mg. The amount of Mg incorporated in 
the apatite is proportional to the Mg concentration in the solution. The incorporation of Mg 
increased by the simultaneous incorporation of F- or CO32-. The limited incorporation of 
Mg is also observed in apatites prepared at high temperatures (above 900 °C) by solid state 
reaction. 
The presence of Mg in the apatite causes the following effects on its properties: a) decrease 
in a-axis dimension; b) decrease in crystallinity as shown in XRD patterns and IR spectra; 
c) increase in HPO42- incorporation as shown by the higher β-TCP/HA ratio in sintered 
Mg-containing HA and d) increase in extent of dissolution. 
 38 
                                                                                                                                   Chapter 1 
⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ 
 
As for B-carbonation, the incorporation of magnesium in synthetic HA is of great interest 
for the  design of biomimetic  bone substitutes110,111. 
Silicon (SiO44+) 
The simplest model of incorporation of silicon in the HA structure (Si-HA) is the 
substitution of SiO44- for PO43- functional groups112.  
Anyway, to avoid a large cost in energy, local charge neutrality is mandated, and this 
requires some other defect to be associated with the PO43- to compensate for the charge 
deficit. There are many possible mechanisms for charge compensation and which 
predominates depends on the thermodynamic conditions during the preparation of the 
materials. Mechanisms that have been considered include O vacancies and excess Ca, 
which can each compensate for two Si substitutions. For Si-HA, OH vacancies can also 
provide compensation113-117. Which of the mechanisms dominates depends on the 
availability of water during the manufacture, and it appears that there is not likely a unique 
Si-HA material but different types depending on the details of the preparation 
conditions118-122.  
Further evidence of the importance of silicon on bone formation was found in bioactive 
silicate containing glass ceramics. As the ionic bond lengths of a P-O bond with tetrahedral 
coordination (0.157 nm) are comparable to a similarly coordinated Si-O bond (0.166 
nm)123, the X-ray diffraction patterns of Si-HA and stoichiometric HA appear to be 
identical, anyway refinement of the diffraction data revealed some small structural 
differences between the two materials. The silicon substitutes the phosphorous in the HA 
lattice, resulting in a small decrease in the a axis and an increase in the c axis of the unit 
cell. This substitution also caused a decrease in the number of hydroxyl (OH) groups in the 
unit cell, which was expected from the proposed substitution. The incorporation of silicon 
in the HA lattice resulted in an increase in the distortion of the PO4 tetrahedra, indicated by 
an increase in the distortion index124. 
Acid phosphate (HPO42-) 
The non-stoichiometry of biological apatites, especially of human enamel apatite, 
has been partially attributed to the presence of HPO42- ions, either surface-bound, lattice 
bound (partially substituting for PO43-), or as constituent of OCP interlayered with apatite. 
In biological and in synthetic apatites from aqueous systems, the original presence of 
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HPO42- is deduced from the formation of pyrophosphate upon ignition at temperatures 300 
to 500 °C or formation of β-TCP upon ignition at 700 °C to 950 °C. 
The incorporation of HPO4-for-PO4 in apatite causes an expansion in the a-axis and slight 
contraction in the c-axis dimensions. The effect of HPO42- incorporation on the properties 
of apatite has not been directly investigated but can be predicted to cause instability 
causing the apatite to be more susceptible to acid-dissolution. 
The amount of HPO42- and CO32- in the bone mineral may vary considerably, however the 
sum of divalent ions is quite constant in most bone tissues. The amount of vacancies in 
cationic sites and in monovalent anionic sites is always very high and close to the 
maximum attainable for an apatitic structure. 
Pyrophosphate (P2O7) 
The presence of pyrophosphate in solutions from which apatite forms cause 
suppression of crystal growth, favouring the formation of ACP. The involvement of P2O74- 
with the apatite structure, i.e., whether it is lattice- or surface-bound has not been 
determined. Its presence as a crystal surface poison has been implied. 
Strontium (Sr2+) 
Sr2+ substitutes for calcium in synthetic apatites causing an expansion in both a- 
and c- axis dimensions. In bone and tooth minerals, strontium is found as one of the minor 
constituents; its incorporation in bone mineral was correlated with changes in the a-axis 
dimensions of the bone apatite. In the bone mineral, the presence of strontium was 
associated with lower solubility, while in enamel, reports on the strontium effect have so 
far been contradictory. 
Lattice H2O 
Pyrolysis below 200 °C of enamel apatites and apatites prepared from aqueous 
systems causes loss of weight without any significant change in their lattice parameters; 
pyrolysis at temperatures between 300 and 400 °C causes a contraction in the a-axis 
dimensions concomitant with weight loss. This latter effect has been explained as being 
due to either loss of “lattice H2O”, or loss of H2O from reactions between HPO42- groups or 
reactions between HPO42- and CO32-. Either H2O-for-OH or HPO4-for PO4 substitution in 
the apatite structure will cause an expansion in the lattice parameters and the loss of H2O 
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(from “lattice H2O or as a reaction product of HPO42-) will cause the observed reduction in 
the a-axis resulting from the reordering of the apatite lattice after pyrolysis. 
Multiple substitutions in the apatite structure 
The simultaneous or concerted substitutions of different ions in biological apatites 
cause additive or conflicting effects on the physico-chemical properties of the apatite. Such 
properties include: lattice parameters, crystallinity (expressing crystallite size and / or 
strain), chemical and thermal stabilities. In some case, the incorporation of one impurity 
can suppress the incorporation of another, especially when competing for the same 
crystallographic site. The effect of multiple substitutions contribute stability or instability 
to the apatite which is translated in terms of susceptibility to acid dissolution of the teeth 
and bone mineral. For example, the presence of CO32- causes instability, F- stability, and 
simultaneously, the stabilizing effect of F- becomes much more important than the opposite 
effect of CO32-. 
1.10 Thermal behaviour of apatites 
Apatites are generally sintered in air at 1100-1300 °C6, following compaction of the 
powder into a desired shape. Sintering is frequently associated with growth of crystals and 
a change of their shape.  
The phases formed at high temperature depend on temperature and on the partial pressure 
of water (pH2O) in the sintering atmosphere. When water is present, HA can be formed and 
is a stable phase up to 1360 °C.. When there is no water, TeCP and TCP are the stable 
phases. The temperature range of HA stability increases with pH2O, as does the rate of 
phase transition of TCP or TeCP to HA. 
Two ranges of decomposition of apatites and Ca-P compounds can be distinguished7: a 
low-temperature irreversible decomposition (150-1000 °C) and a high-temperature 
reversible decomposition (above 1000 °C). 
The first reaction occurring in Ca-P materials is the condensation of hydrogen-phosphate 
ion HPO42-. The reaction begins at temperatures as low as 150-300 °C in non 
stoichiometric HA and other HPO42- containing compounds: 
2HPO42- --> P2O74- + H2O 
The P2O7 ions are believed to remain in the apatite lattice, in a very distorted form. 
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Carbonate ions also begin to decompose at low temperature (100-300 °C) especially in 
HPO42- containing apatites, probably because of proton transfer and bicarbonate ion 
decomposition: 
2HPO42- + 2CO32- Æ 2PO43- + H2O + 2CO2 
At higher temperatures (500-1000 °C)  carbonate ions begin to decompose by themselves: 
CO32- Æ CO2 + O2- 
The O2- ion, formed in the apatite structure, is generally rapidly hydrolyzed into OH-. 
However, when apatites are rich in carbonate ions calcium oxide also forms a separate 
phase. 
At about 700 °C pyrophosphate ions react with OH- ions to restore PO43- ions: 
P2O74- + 2OH Æ 2PO43- + H2O 
All these reactions are irreversible. At around 800 °C massive restructuring of the non-
stoichiometric apatite generally occurs depending essentially on the Ca/P ratio of the initial 
product. When the atomic ratio Ca/P is between 1.5 and 1.667 β-TCP and stoichiometric 
hydroxyapatite are formed. When the atomic Ca/P ratio is higher than 1.667 then CaO and 
stoichiometric HA are detected. It is only for a ratio equal to 1.667 that stoichiometric HA 
is observed a single phase.  
This decomposition reaction can represent a very sensitive way to determine the 
stoichiometry of apatites. However the role of impurities in this decomposition is not clear, 
especially that of Mg2+, which is the major impurity in Ca-P compounds. 
A final reaction may occur at about 850 °C, the decomposition of OH-: 
2OH- Æ H2O + O2- 
This reaction depends, of course, on the water partial pressure and is completely reversible. 
The oxyapatite eventually formed: 
Ca10(PO4)6O, which has been proposed as a potential biomaterial. This compound, very 
unstable, is however not known in a pure form and only exists as an oxyhydroxyapatite 
Ca10(PO4)6OHxO1-x/2 
At temperatures higher than 1200 °C apatites may begin to decompose in a reversible 
manner into TCP and tetracalcium phosphate (TeCP). This is attributed to the oxyapatite 
formed: 
Ca10(PO4)6O Æ2Ca3(PO4)2 + Ca4(PO4)2O 
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At higher temperatures (above 1600 °C) a liquid phase forms and CaO is the only solid 
phase to subsist. Slow cooling in presence of water allows these high temperature phases to 
react again and restore stoichiometric HA. 
1.11 Characterization of apatite biomaterials 
The characterization of Ca-P biomaterials covers several aspects7. In addition to the 
traditional physical-chemical and mechanical characterization, implantable materials have 
to prove their innocuousness and, if possible, their bioactivity. As in many 
multidisciplinary domains, chemical and physical properties relevant for the use of the 
biomaterial must also be identified. 
Three levels of characterization may be distinguished: a) chemical; b) 
morphological and c) structural. 
The chemical composition of biomaterials can be determined by phase analysis and 
classical chemical analysis. Phase analysis is commonly performed by X-ray diffraction, 
representing a fast and powerful tool to assess the type of crystalline compounds formed 
during apatite synthesis. Calcium phosphates exhibit very similar scattering powers (~0.5 
compared to α-Al2O3) so that their presence can be easily detected, even in amount ~ 1%; 
the detection of CaO can even be more sensitive, as its scattering power is 1.3. XRD 
allows a good identification of well crystallized phases and in some cases may distinguish 
between different apatite phases, for example in case of strontium-substituted HA, where 
the higher atomic weight of the substituting atom (Sr for Ca) determines a marked shift of 
the X-ray diffraction peaks. However the technique is not sensitive enough to identify solid 
solutions like oxy-hydroxyapatite and in the case of poorly crystalline compounds peak 
broadening prevents also any precise identification of apatite phases. In addition, it is often 
difficult to discriminate between closely related structures like octacalcium phosphate and 
HA. The variation in the cell parameters, when due to multiple substitutions, cannot give 
information on the presence and type of atom substitutions in anionic and cationic site, so 
that deeper investigations are needed: infra-red and Raman spectroscopies are usually 
applied to check the occurrence of carbonation in A or B site, but an accurate 
determination of the amount of HPO42- ions especially in presence of carbonate is not 
possible. 
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The classical chemical analysis is finally applied to determine the overall content in atoms 
in the apatite sample, namely calcium, phosphorus and the substitutes employed for the 
augmentation of the apatite biomimetism (magnesium, silicon, strontium, fluoride, etc..); 
anyway no information are provided whether the element is incorporated in the apatite 
structure or attached to the crystal surface, so that more sophisticated spectroscopic 
investigations are needed. In fact, the location of the substitute ion greatly influences the 
chemical properties of apatite in terms of solubility and reactivity with the physiological 
environment, when present into the cell structure; thus, the substitute itself is released 
according to the increased solubility of apatite. When attached on the surface, conversely, 
its release in solution is probably faster and independent on the solubility of HA; anyway 
the ion release can be mediated by amorphous regions which in low crystallinity HA 
powders surround the more ordered HA crystals125. In this case the kinetic of release 
depends on the structure, composition and thickness of the amorphous layer. The 
determination of ion release in substituted apatites is fundamental, as their type and 
availability strongly influence the activity of osteoblast cells and, in consequence, of the 
whole process of bone remodelling. 
The presence of crystalline and amorphous phases in biological-like HA makes extremely 
hard its chemical-physical characterization, so that a number of supplementary 
investigations can be routinely employed for this purpose. 
Thermo-gravimetric investigations are employed to determine the thermal behaviour of 
HA powders, as also described in Section 3.10; thus, it can be estimated the amount of 
water differently bound to HA, both physically (in the lower temperature region) and 
chemically (up to 400 °C), the condensation of eventual hydrogen-phosphates and of 
carbonate. In the region of high temperatures (T > 1000 °C) the weight loss due to OH- 
evaporation is detected and can provide information on the OH- content, more quantitative 
and complementary with respect to infrared spectroscopy. 
Thermo-analytical investigations provide information on the structural changing occurring 
in HA during heating, due to the variation of latent heat; commonly, the transformation in 
β-TCP at high temperature can be detected by an exothermic peak, but the rearrangement 
of the complex structure of a substituted HA (crystallization of the amorphous fraction, 
carbonate decomposition, grain growth, secondary phase formation at low temperature) 
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usually yields only continuous variations of latent heat, so that the assignment of a critical 
temperature for these phenomena is much harder. 
The characterization of powder morphology and size is important for further treatment of 
the apatite powder in preparing three dimensional bodies as bone scaffolds. Ceramic 
aqueous suspensions are needed for this purpose, which are used for preparation of 
templates through impregnation by polymeric preforms, freeze-drying techniques and 
foaming methods. Low crystalline HA is nanosized and exhibit a high surface charge 
which provokes powder agglomeration and precipitation when suspended in water. A full 
investigation of powder size and morphology and its surface charge is thus essential for 
obtaining the optimal conditions to suspend the HA powders, on the basis of their 
composition. Since the presence of atomic substitutes provokes changing in powder 
solubility and reactivity, different rheological behaviour are expected and a careful 
assessment of the powder properties should be performed for each typology of HA. 
Solubility tests represent a relatively easy and powerful tool for investigating the behaviour 
of multi-substituted HA in physiological environment; in fact, when tests are carried out in 
simulated body fluid (SBF) at 37 °C, the amount and kinetic of the different ion release 
during a certain lapse of time is representative of the apatite bioactivity, in terms of 
substances provided to cells in the neighbours of the synthetic implant. This information is 
indicative of the potential success of the biomaterial, in terms of bone regeneration and 
scaffold resorption; anyway, the response of cells to the presence of an implant also 
depend on other features than the chemical ones. First of all, the implant morphology must 
be adequate for osteoconduction, otherwise the bone formation would occur on the implant 
surface only; second, the resorption process by osteoclasts must be commensurate to the 
kinetic of osteoblasts activity, otherwise the scaffold would dissolve prior the complete 
restoration of the original bone portion; third, in bone remodelling the cell response is 
stimulated by the biomechanical loads, so that in case of load-bearing implants, the 
mechanical strain exhibited by the implant and the surrounding bone must be similar, 
otherwise the stress mismatch can have negative influence on the implant adhesion and on 
the quality of the newly formed bone. 
This last aspect is mainly related to the employment of consolidated 3D scaffolds; in this 
case the full characterization of the starting HA powder is useful to determine the best 
conditions for sintering, but a further series of investigations will be needed on the final 
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ceramic body as its surface properties will be completely different from those of the 
starting material. Moreover, other properties become fundamental for its success as bone 
implant, namely the pore size distribution, pore interconnection, solubility, capability of 
forming an interlayer of carbonated HA when soaked in SBF, which is an important index 
of bioactivity and finally mechanical strength. The bioactivity assessment is especially 
important for non-bioresorbable materials, as the surface will establish a permanent contact 
with living tissues. 
Most of the investigated techniques here mentioned will be more extensively illustrated in 
the next Chapter. 
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CHAPTER 2 
 
ANALYTICAL TECHNIQUES 
2.1 X Ray Diffraction (XRD) 
X-ray diffraction is a non-destructive analytical technique which reveals information 
about the crystallographic structure, crystallite size, and preferred orientation in 
polycrystalline or powdered solid samples. This technique is based on observing the 
scattered intensity of an x-ray beam hitting a sample as a function of incident and scattered 
angle, polarization, and wavelength or energy. 
Powder diffraction is commonly used to identify unknown substances, by comparing 
diffraction data against a database of Powder Diffraction Files (PDF) maintained by the 
International Centre for Diffraction Data (ICDD). It may also be used to characterize 
heterogeneous solid mixtures to determine relative abundance of crystalline compounds 
and, when coupled with lattice refinement techniques, such as Rietveld refinement, can 
provide structural information on unknown materials. Powder diffraction is also a common 
method for determining strains in crystalline materials. 
The great advantages of the technique are: 
 
• simplicity of sample preparation 
• rapidity of measurement 
• the ability to analyze mixed phases 
 
When X-rays hit an atom, they make the electronic cloud move as does any 
electromagnetic wave. The movement of these charges re-radiates waves with the same 
frequency (blurred slightly due to a variety of effects); this phenomenon is known as the 
Rayleigh scattering (or elastic scattering). The scattered waves can themselves be scattered 
but this secondary scattering is assumed to be negligible. A similar process occurs upon 
scattering neutron waves from the nuclei or by a coherent spin interaction with an unpaired 
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electron. These re-emitted wave fields interfere with each other either constructively or 
destructively (overlapping waves either add together to produce stronger peaks or subtract 
from each other to some degree), producing a diffraction pattern on a detector or film (Fig. 
2.1).  
 
Figure 2.1. Constructive and destructive interference in Rayleigh scattering 
of X rays. 
The resulting wave interference pattern is the basis of diffraction analysis. X-ray 
wavelength is comparable with inter-atomic distances (~150 pm) and thus is an excellent 
probe for this length scale. 
The interference is constructive when the phase shift is a multiple to 2π; this condition can 
be expressed by Bragg's law: 
nλ = 2d ⋅sin θ, 
where: 
• n is an integer determined by the order of diffraction, 
• λ is the wavelength of x-rays, 
• d is the spacing between the planes in the atomic lattice, 
• θ is the angle between the incident ray and the scattering planes 
Powder diffraction data are usually presented as a diffractogram in which the diffracted 
intensity I is shown as function either of the scattering angle 2θ.  
The most widespread use of powder diffraction is in the identification and characterisation 
of crystalline solids, each of which produces a distinctive diffraction pattern. Both the 
positions (corresponding to lattice spacings) and the relative intensity of the lines are 
indicative of a particular phase and material, providing a "fingerprint" for comparison. A 
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multi-phase mixture will show more than one pattern superposed, allowing for 
determination of relative concentration. 
Crystal structure 
The crystal structure of a material or the arrangement of atoms in a crystal can be 
described in terms of its unit cell. The unit cell is a tiny box containing  the spatial 
arrangement of atoms. The units cells stacked in three-dimensional space describes the 
bulk arrangement of atoms of the crystal. The unit cell is given by its lattice parameters, 
the length of the cell edges and the angles between them, while the positions of the atoms 
inside the unit cell are described by the set of atomic positions (xi,yi,zi) measured from a 
lattice point. The symmetry properties of the crystal are embodied in its space group. 
Crystal structure and symmetry play a role in determining many of its properties, such as 
cleavage, electronic band structure, and optical properties.  
Although there are an infinite number of ways to specify a unit cell, for each crystal 
structure there is a conventional unit cell, which is chosen to display the full symmetry of 
the crystal. However, the conventional unit cell is not always the smallest possible choice. 
A primitive unit cell of a particular crystal structure is the smallest possible volume one 
can construct with the arrangement of atoms in the crystal such that, when stacked, 
completely fills the space. This primitive unit cell does not always display all the 
symmetries inherent in the crystal. In a unit cell each atom has an identical environment 
when stacked in 3 dimensional space. In a primitive cell, each atom may not have the same 
environment. The crystal structure consists of the same group of atoms, the basis, 
positioned around each and every lattice point. This group of atoms therefore repeats 
indefinitely in three dimensions according to the arrangement of one of the 14 Bravais 
lattices (Fig. 2.2). 
The possible lattice centrings are: 
• P: Primitive centring, lattice points on the cell corners only; 
• I: Body centred, one additional lattice point at the center of the cell; 
• F: Face centred, one additional lattice point at centre of each of the faces of the cell; 
• A, C: Centred on a single face, one additional lattice point at the centre of one of the cell 
faces 
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Figure 2.2. The 14 possible Bravais lattices. 
There are only seven possible crystal systems that atoms can pack together to produce an 
infinite 3D space lattice in such a way that each lattice point has an identical environment 
to that around every other lattice point. The simplest and most symmetric, the cubic (or 
isometric) system, has the symmetry of a cube. The other six systems, in order of 
decreasing symmetry, are hexagonal, tetragonal, rhombohedral (also known as trigonal), 
orthorhombic, monoclinic and triclinic. 
When the crystal systems are combined with the various possible lattice centrings, we 
arrive at the Bravais lattices. They describe the geometric arrangement of the lattice points, 
and thereby the translational symmetry of the crystal. In three dimensions, there are 14 
unique Bravais lattices which are distinct from one another in the translational symmetry 
they contain.  
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Miller indices 
Miller indices are an useful tool to describe the lattice plans, specifying their 
orientation with respect to the three axis of the unit cell. 
To calculate the Miller indices of a plane one has to determine the reciprocal of its 
intersections with the three axes in terms of fractions or multiples of the unit cells edges; 
these numbers are indicated in brackets, e.g. (hkl), which indicates an infinite number of 
equidistant parallel planes, so that the following expression is satisfied: 
h(x/a) + k(y/b) + l(z/c) = n 
where n indicates the plane position with respect to the origin. 
In Fig. 2.3 some examples of the use of Miller indices is illustrated. 
 
 
Figure 2.3. Some examples of Miller planes. 
Crystallinity 
In contrast to a crystalline pattern consisting of a series of sharp peaks, amorphous 
materials (liquids, glasses etc.) produce a broad background signal. Many polymers, 
organic molecules or inorganic glasses usually exhibit this kind of pattern, but often also 
inorganic nanostructured crystalline phases can contain also an amorphous fraction. XRD 
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can be used to determine the degree of crystallinity by comparing the integrated intensity 
of the background pattern to that of the sharp peaks. 
Size and Strain Broadening 
There are many factors that determine the width B of a diffraction peak. These 
include: 
1. instrumental factors 
2. the presence of defects to the perfect lattice 
3. differences in strain in different grains 
4. the size of the crystallites 
 
In powdered samples, the strain can often be neglected, so that a simple formula can be 
applied to obtain the average size of the diffracting coherent domains, the Scherrer 
formula: 
ϑ
λ
cosB
KD =  
where, 
D is the crystallite average size 
K is a form factor, usually taken as 0.9 
λ is the wavelength of the incident radiation  
B is the peak width corrected for the instrumental broadening 
θ is the diffraction angle 
Diffractometers 
Diffractometers can be operated both in transmission and in reflection 
configurations. The reflection one is more common. The powder sample is filled in a small 
disc-like container and its surface carefully flattened. The disc is put on one axis of the 
diffractometer and tilted by an angle θ while a detector (scintillation counter) rotates 
around it on an arm at twice this angle. This configuration is known under the name Bragg-
Brentano (Fig. 2.4) 
The model of diffractometer employed was a Miniflex (Rigaku, Tokyo, Japan), 
equipped with a Cu anode, whose characteristic Kα1 wavelength is 0.154056 nm.  
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Figure 2.4. Diffractometer adopting the Bragg-Brentano geometry. 
2.2 Fourier-Transform Infrared Spectroscopy (FTIR) 
Infrared spectroscopy (IR spectroscopy) is the subset of spectroscopy that deals 
with the infrared region of the electromagnetic spectrum.  
The infrared portion of the electromagnetic spectrum is divided into three regions; the 
near-, mid- and far- infrared, named for their relation to the visible spectrum. The far-
infrared, approximately 400-10 cm-1 (1000–30 μm), lying adjacent to the microwave 
region, has low energy and may be used for rotational spectroscopy. The mid-infrared, 
approximately 4000-400 cm-1 (30–1.4 μm) may be used to study the fundamental 
vibrations and associated rotational-vibrational structure. The higher energy near-IR, 
approximately 14000-4000 cm-1 (1.4–0.8 μm) can excite overtone or harmonic vibrations.  
Infrared spectroscopy exploits the fact that molecules have specific frequencies at which 
they rotate or vibrate corresponding to discrete energy levels (Fig. 2.5). These resonant 
frequencies are determined by the shape of the molecular potential energy surfaces the 
masses of the atoms and, by the coupling of vibrational and electronic interactions in the 
molecule. 
Thus, the resonant frequencies can be in a first approach related to the strength of the bond, 
and the mass of the atoms at either end of it. Thus, the frequency of the vibrations can be 
associated with a particular bond type and can be used for the characterization of very 
complex mixtures. 
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Figure 2.5. Possible vibrations detected by infrared spectroscopy. 
The infrared spectra of a sample is collected by passing a beam of infrared light through 
the sample. Examination of the transmitted light reveals how much energy was absorbed at 
each wavelength (see Fig. 2.6).  
This can be done with a monochromatic beam, which changes in wavelength over time, or 
by using a Fourier transform instrument to measure all wavelengths at once. From this, a 
transmittance or absorbance spectrum can be produced, showing at which IR wavelengths 
the sample absorbs. Analysis of these absorption characteristics reveals details about the 
molecular structure of the sample. 
 
Figure 2.6. Scheme of equipment for infrared spectroscopy 
The method employed for sample preparation is to grind a quantity of the sample with 
potassium bromide finely (to remove scattering effects from large crystals), which is used 
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also as a reference. This powder mixture is then crushed in a mechanical die press to form 
a translucent pellet through which the beam of the spectrometer can pass. 
A reference is used for two reasons: 
• This prevents fluctuations in the output of the source affecting the data; 
• This allows the effects of the solvent to be cancelled out (the reference is usually pure 
solvent). 
The equipment employed in the present work was a Thermo Nicolet-Avatar 320 FT-IR. 
2.3 Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-
AES) 
ICP-AES, also referred to as Inductively Coupled Plasma Optical Emission 
Spectrometry (ICP-OES), is a type of emission spectroscopy that uses a plasma (e.g. 
inductively coupled plasma) to produce excited atoms that emit electromagnetic radiation 
at a wavelength characteristic of a particular element. The intensity of the radiation is 
proportional to the concentration of the element, which is obtained through a previous 
calibration obtained with opportune standard solutions. 
An inductively coupled plasma (ICP) for spectrometry is sustained in a torch that consists 
of three concentric tubes, usually made of quartz. The end of this torch is placed inside an 
induction coil supplied with a radio-frequency electric current. A flow of argon gas is 
introduced between the two outermost tubes of the torch and an electrical spark is applied 
for a short time to introduce free electrons into the gas stream. These electrons interact 
with the radio-frequency magnetic field of the induction coil and are accelerated first in 
one direction, then the other, as the field changes at high frequency. The accelerated 
electrons collide with argon atoms, and sometimes a collision causes an argon atom to part 
with one of its electrons. The released electron is in turn accelerated by the rapidly-
changing magnetic field. The process continues until the rate of release of new electrons in 
collisions is balanced by the rate of recombination of electrons with argon ions (atoms that 
have lost an electron). This produces a ‘fireball’ that consists mostly of argon atoms with a 
rather small fraction of free electrons and argon ions.  
The samples to be analyzed are firstly solubilized and then introduced into the hot region 
through an atomizer. The temperature of the plasma is very high, of the order of 10.000 K, 
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so that the atomization of the sample is nearly complete, improving the accuracy of the 
analysis. Moreover, the carrier gas is inert (usually argon), so preventing the formation of 
oxides. 
As a droplet of atomized sample enters the central channel of the ICP, it evaporates and 
any solids that were dissolved in the liquid vaporize and then break down into atoms. At 
the temperatures prevailing in the plasma a significant proportion of the atoms of many 
chemical elements are ionized, each atom losing its most loosely-bound electron to form a 
singly charged ion. 
 
The equipment employed in the present work was a Liberty 200, Varian, Clayton South, 
Australia. 
2.4 Scanning Electron Microscopy (SEM) 
The scanning electron microscope (SEM) is a type of electron microscope that 
creates various images by focusing a high energy beam of electrons onto the surface of a 
sample and detecting signals from the interaction of the incident electrons with the 
sample's surface. The type of signals gathered in a SEM vary and can include secondary 
electrons, characteristic x-rays, and back scattered electrons (Fig. 2.7). In a SEM, these 
signals come not only from the primary beam impinging upon the sample, but from other 
interactions within the sample near the surface.  
 
Figure 2.7. Signals produced by the interaction of the electron beam with the sample. 
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The SEM is capable of producing high-resolution images of a sample surface in its primary 
use mode, secondary electron imaging. Due to the manner in which this image is created, 
SEM images have great depth of field yielding a characteristic three-dimensional 
appearance useful for understanding the surface structure of a sample. This great depth of 
field and the wide range of magnifications are the most familiar imaging mode for 
specimens in the SEM. Characteristic x-rays are emitted when the primary beam causes the 
ejection of inner shell electrons from the sample and are used to tell the elemental 
composition of the sample. The back-scattered electrons emitted from the sample may be 
used alone to form an image or in conjunction with the characteristic x-rays as atomic 
number contrast clues to the elemental composition of the sample. 
In a typical SEM, thermo-ionic electrons are emitted from a tungsten cathode and are 
accelerated towards an anode (Fig. 2.8). 
 
 
Figure 2.8. Scheme of a Scanning Electron Microscope. 
Tungsten is used because it has the highest melting point and lowest vapour pressure of all 
metals, thereby allowing it to be heated for electron emission. The electron beam, which 
typically has an energy ranging from a few hundred eV to 100 keV, is focused by one or 
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two condenser lenses into a beam with a very fine focal spot sized 0.4 nm to 5 nm. The 
beam passes through pairs of scanning coils or pairs of deflector plates in the electron 
optical column, typically in the objective lens, which deflect the beam horizontally and 
vertically so that it scans in a raster fashion over a rectangular area of the sample surface. 
When the primary electron beam interacts with the sample, the electrons lose energy by 
repeated scattering and absorption within a teardrop-shaped volume of the specimen 
known as the interaction volume, which extends from less than 100 nm to around 5 µm 
into the surface. The size of the interaction volume depends on the electrons' landing 
energy, the atomic number of the specimen and the specimen's density. The energy 
exchange between the electron beam and the sample results in the emission of electrons 
and electromagnetic radiation, which can be detected to produce an image, as described 
below. 
Detection of secondary electrons 
The most common imaging mode monitors low energy (<50 eV) secondary 
electrons. Due to their low energy, these electrons originate within a few nanometers from 
the surface. The electrons are detected by a scintillator-photomultiplier device and the 
resulting signal is rendered into a two-dimensional intensity distribution that can be viewed 
and saved as a digital image. This process relies on a raster-scanned primary beam. The 
brightness of the signal depends on the number of secondary electrons reaching the 
detector. If the beam enters the sample perpendicular to the surface, then the activated 
region is uniform about the axis of the beam and a certain number of electrons "escape" 
from within the sample. As the angle of incidence increases, the "escape" distance of one 
side of the beam will decrease, and more secondary electrons will be emitted. Thus steep 
surfaces and edges tend to be brighter than flat surfaces, which results in images with a 
well-defined, three-dimensional appearance. Using this technique, resolutions less than 100 
nm are possible. 
Resolution of the SEM 
The spatial resolution of the SEM depends on the size of the electron spot, which in 
turn depends on both the wavelength of the electrons and the magnetic electron-optical 
system which produces the scanning beam. The resolution is also limited by the size of the 
interaction volume, or the extent to which the material interacts with the electron beam. 
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The spot size and the interaction volume both might be large compared to the distances 
between atoms, so the resolution of the SEM is not high enough to image individual atoms, 
as is possible in the shorter wavelength (i.e. higher energy) transmission electron 
microscope (TEM). The SEM has compensating advantages, though, including the ability 
to image a comparatively large area of the specimen; the ability to image bulk materials 
(not just thin films or foils); and the variety of analytical modes available for measuring the 
composition and nature of the specimen. 
The equipment employed in the present work was a Stereoscan 360, Leica, Cambridge, 
UK. 
Energy dispersive X-ray spectroscopy (EDS) 
EDS (or EDX) is an analytical technique, coupled with the SEM equipment, used 
predominantly for the elemental analysis or chemical characterization of a specimen. Being 
a type of spectroscopy, it relies on the investigation of a sample through interactions 
between electromagnetic radiation and matter, analyzing X-rays emitted by the matter in 
this particular case. Its characterization capabilities are due in large part to the fundamental 
principle that each element of the periodic table has a unique atomic structure allowing x-
rays that are characteristic of an element's atomic structure to be uniquely distinguished 
from each other. 
To stimulate the emission of characteristic x-rays from a specimen, an high energy beam of 
charged particles such as electrons or protons, or a beam of x-rays, is focused into the 
sample to be characterized. At rest, an atom within the sample contains ground state (or 
unexcited) electrons situated in discrete energy levels or electron shells bound to the 
nucleus. The incident beam may excite an electron in an inner shell (Fig. 2.9), prompting 
its ejection and resulting in the formation of an electron hole within the atom’s electronic 
structure. An electron from an outer, higher-energy shell then fills the hole, and the 
difference in energy between the higher-energy shell and the lower energy shell is released 
in the form of an X-ray. The x-ray released by the electron is then detected and analyzed 
by the energy dispersive spectrometer. These x-rays are characteristic of the difference in 
energy between the two shells, and of the atomic structure of the element form which they 
were emitted. 
 67
Analytical Techniques 
⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ 
 
A detector is used to convert X-ray energy into voltage signals; this information is sent to a 
pulse processor, which measures the signals and passes them onto an analyzer for data 
display and analysis. 
The equipment employed in the present work was an INCA 300, Oxford Instruments, UK 
 
Figure 2.9. Interaction of the electron beam with the electronic cloud. 
2.5 Thermogravimetric and Thermoanalytical analyses (TG-DTA) 
Thermogravimetric Analysis or TGA is a type of testing that is performed on 
samples to determine changes in weight in relation to change in temperature. Such analysis 
relies on a high degree of precision in three measurements: weight, temperature, and 
temperature change. As many weight loss curves look similar, the weight loss curve may 
require transformation before results may be interpreted. A derivative weight loss curve 
can be used to tell the point at which weight loss is most apparent.  
The analyzer usually consists of a high-precision balance with a pan loaded with the 
sample. The sample is placed in a small electrically heated oven with a thermocouple to 
accurately measure the temperature. The atmosphere may be purged with an inert gas to 
prevent oxidation or other undesired reactions. A computer is used to control the 
instrument. 
Analysis is carried out by raising the temperature gradually and plotting weight against 
temperature. After the data is obtained, curve smoothing and other operations may be done 
such as to find the exact points of inflection. 
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Differential thermal analysis (or DTA) is a thermoanalytic technique. In DTA, 
the material under study and an inert reference (Al2O3 in our case) are heated (or cooled) 
under identical conditions, while recording any temperature difference between sample and 
reference. This differential temperature is then plotted against time, or against temperature 
(DTA curve or thermogram). Changes in the sample, either exothermic or endothermic, 
can be detected relative to the inert reference. Thus, a DTA curve provides data on the 
transformations that have occurred, such as phase transitions, glass transitions, 
crystallization, melting and sublimation. The area under a DTA peak can be to the enthalpy 
change and it is not affected by the heat capacity of the sample. 
A DTA apparatus consist of a sample holder comprising thermocouples, sample containers 
and a ceramic or metallic block; a furnace; a temperature programmer; and a recording 
system. The key feature is the existence of two thermocouples connected to a voltmeter. 
One thermocouple is placed in the inert reference material, while the other is placed in a 
sample of the material under study. As the temperature is increased, there will be a brief 
deflection of the voltmeter if the sample is undergoing a phase transition. This occurs 
because the input of heat will raise the temperature of the inert substance, but be 
incorporated as latent heat in the material changing phase.  
 
The equipment employed in the present work was a Netzsch Gerätebau Jupiter STA 
(Simultaneous Thermal Analysis) 449C, Selb, Germany. 
2.6 Powder Analysis 
2.6.1 Specific surface area 
Specific surface area is a material property of solids which measures the total 
surface area per unit of mass, solid or bulk volume, or cross-sectional area. 
It is a derived scientific value that can be used to determine the type and properties of a 
material (e.g. soil). It is defined either by surface area divided by mass (with units of 
m²/kg), or surface area divided by the volume (units of m²/m³ or m-1) 
The SSA can be measured by adsorption using the BET isotherm. This has the advantage 
of measuring the surface of fine structures and deep texture on the particles. 
BET theory is a well-known rule for the physical adsorption of gas molecules on a solid 
surface, that is basis for an important analysis technique for the measurement of the 
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specific surface area of a material. In 1938, Stephen Brunauer, Paul Hugh Emmett, and 
Edward Teller published an article about the BET theory in a journal for the first time; 
“BET” consists of the first initials of their family names. 
The concept of the theory is an extension of the Langmuir theory, which is a theory for 
monolayer molecular adsorption, to multilayer adsorption with the following hypotheses: 
(a) gas molecules physically adsorb on a solid in layers infinitely; (b) there is no 
interaction between each adsorption layer; and (c) the Langmuir theory can be applied to 
each layer. The resulting BET equation is expressed by (1): 
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P and P0 are the equilibrium and the saturation pressure of adsorbates at the temperature of 
adsorption, v is the adsorbed gas quantity (for example, in volume units), and vm is the 
monolayer adsorbed gas quantity. c is the BET constant, which is expressed by (2): 
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E1 is the heat of adsorption for the first layer, and EL is that for the second and higher 
layers and is equal to the heat of liquefaction. 
Equation (1) is an adsorption isotherm and can be plotted as a straight line with 1 / v[(P0 / 
P) − 1] on the y-axis and φ = P / P0 on the x-axis according to experimental results. This 
plot is called a BET plot. The linear relationship of this equation is maintained only in the 
range of 0.05 < P / P0 < 0.35. The value of the slope A and the y-intercept I of the line are 
used to calculate the monolayer adsorbed gas quantity vm and the BET constant c. The 
following equations can be used: 
IA
vm +=
1            3), 
I
Ac += 1            4). 
The BET method is widely used in surface science for the calculation of surface areas of 
solids by physical adsorption of gas molecules. A total surface area Stotal and a specific 
surface area S are evaluated by the following equations: 
V
NsvS mtotalBET =,           5), 
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a
SS totalBET =            6), 
where N is Avogadro’ s number, s is the adsorption cross section, V is the molar volume of 
adsorbent gas and a is the molar weight of adsorbed species.  
The equipment adopted in the present work was a Sorpty 1750, Carlo Erba, Milano, Italy 
2.6.2. Electro-acoustic spectroscopy 
 When an object is immersed in a liquid, a surface electrical charge layer forms, 
which creates an electrostatic field that then affects the ions in the bulk of the liquid. This 
electrostatic field, in combination with the thermal motion of the ions, creates a counter 
charge, and thus screens the electric surface charge. The net electric charge in this 
screening diffuse layer is equal in magnitude to the net surface charge, but has the opposite 
polarity. As a result the complete structure is electrically neutral. Some of the counter-ions 
might specifically adsorb near the surface and build an inner sub-layer, or so-called Stern 
layer. The outer part of the screening layer is usually called the diffuse layer (Fig. 2.10). 
 
 
Figure 2.10. Schematic of double layer in a liquid at contact with a solid. 
The diffuse layer, or at least part of it, can move under the influence of a tangential stress. 
There is a conventionally introduced slipping plane that separates mobile fluid from fluid 
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that remains attached to the surface. Electric potential at this plane is called electrokinetic 
potential or ζ-potential.  
The electric potential on the external boundary of the Stern layer versus the bulk 
electrolyte is referred to as Stern potential. Electric potential difference between the fluid 
bulk and the surface is called the electric surface potential. The characteristic thickness of 
the DL is Debye length κ-1. It is reciprocally proportional to the square root of the ion 
concentration C. In aqueous solution it is on scale of a few nanometers and the thickness 
decreases with the concentration of the electrolyte. 
Electroacoustic spectroscopy is based on the analysis of the ultrasound waves (ESA) 
generated by the interaction of externally applied electric fields with charged colloidal 
particles in liquid medium (Fig. 2.10). The amplitude of ESA depends on the electric 
charge of the particle, the particle concentration and the amplitude of the electric field; its 
amplitude is measured through electrodes or transducers transforming the mechanical 
pressure of the acoustic wave in an electric signal. 
The instrument (Acoustosizer, Colloidal Dynamics, Sydney, Australia) is provided with 
three probes of temperature, pH and electrical conductivity (Fig. 2.11); ζ potential is 
obtained by automatic titration of the suspension towards acidic and basic values, which 
also allows to evaluate the size distribution of the particles vs. pH. 
 
Figure 2.11. Equipment for electro-acoustic spectroscopy. 
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CHAPTER 3 
 
DEVELOPMENT OF MULTI-
SUBSTITUTED HYDROXYAPATITE 
3.1 Synthesis of multi-substituted HA powders 
The synthesis of multi-substituted HA powders1 was  carried out by employing 
calcium hydroxide (Ca(OH)2, 95% pure) and orthophosphoric acid (H3PO4, 85% pure), 
with the addition of sodium hydrogen-carbonate (NaHCO3), magnesium chloride 
hexahydrate (MgCl2·6H2O, 99.5% pure) and silicon tetra-acetate ((CH3COO)4Si, 98% 
pure), as sources of carbonate, magnesium and silicon respectively, in aqueous solution; all 
reactants were provided by Sigma-Aldrich (S. Louis, MO, USA).  
The amount of reactants was set up in order to keep the calcium : phosphorus ratio equal to 
1.667, so that a competition between Ca2+, PO43- and the substituting ions (CO32-, Mg2+ and 
SiO44-) could be established. 
Among the doping elements which can be introduced into the HA structure, magnesium is 
isoelectronic with calcium and it does not provoke any unbalance of charge in the related 
crystallographic site; (CO3)2- ions substituting (PO4)3- yield a sub-stoichiometry in the 
calcium site, in order to re-establish the charge neutrality; finally, (SiO4)4- ions substituting 
(PO4)3- yield the loss of OH- ions2. Thus, the approximated general formula for such a 
multi-substituted HA can be written as follows: 
Ca10-z-x/2Mgz(PO4)6-x-y(CO3)x(SiO4)y(OH)2-y                      (1), 
supposing that no carbonation in A site occurred. 
Silicon-substituted hydroxyapatite has been successfully synthesized by using silicon tetra-
acetate2,3 or tetraethyl-orthosilicate4 as a silicon source. The co-substitution of silicon and 
magnesium in the HA lattice was also performed by Kim et al.5, showing that HA structure 
can retain both ions in the amount of 2 wt% on the whole. 
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The extent of substitution in the HA structure will be onwards indicated as X with the 
symbol of the substituting ion at the subscript, so that XMg, XC and XSi indicate the molar 
ratios Mg : Ca, CO3 : PO4, SiO4 : PO4 respectively. 
Silicon-substituted HA powders (Si-HA) were synthesized with an initial XSi of 0.05 (Si-
HA-1), 0.10 (Si-HA-2) and 0.20 (Si-HA-3). Si-HA-1 was prepared by dispersing 20 grams 
of Ca(OH)2 in 700 ml of distilled H2O, after the suspension was poured in a glass flask and 
kept in continuous stirring (Fig. 3.1) at ambient temperature (about 25 °C). 
The silicate-containing suspension was prepared by dispersing a suitable amount of 
(CH3COO)4Si (see Table 3.I) in 200 ml of distilled H2O; after, it was added to the Ca(OH)2 
suspension in continuous stirring.  
 
Figure 3.1. Equipment for the synthesis of HA powder. 
The phosphate solution was prepared by adding 17.74 g of H3PO4 to 400 ml of H2O and 
dripped into the suspension containing calcium and silicon. During synthesis, a white 
precipitate formed; after the dripping of the phosphate solution was completed, the 
precipitate was left to ripen and decant in the mother liquor for 24 hours, then the 
supernatant was eliminated and the cake-like product was washed three times in 1 litre of 
distilled water and centrifuged. The product was dried at low temperature (40 °C), in a 
ventilated oven in order to preserve the surface state and hydrophilicity of the powder6, 
crushed in an agate mortar and sieved under 150 μm. 
For the synthesis of silicon substituted carbonated HA (Si-CHA) a reaction vessel 
equipped with two separated dropwise dispensers, for the phosphate and carbonate-
containing solution, was employed. The ion content in the reaction vessel was set up to 
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have Ca / P = 1.667, as in the synthesis of Si-HA. Powders characterized by different 
initial carbonate content (XC) were prepared, while the initial content of silicon was 0.01 or 
0.05. 
For the synthesis of silicon-magnesium substituted HA powder (Si-MHA), a solution of 
magnesium chloride hexahydrate was prepared and mixed with the calcium hydroxide 
suspension at ambient temperature in the reaction vessel. Fixed amounts of silicon (XSi = 
0.05) and magnesium (XMg = 0.15) were selected.  
Table 3.I. Amount of reagents employed in the synthesis of multi-substituted HA powders. 
 Ca(OH)2 H3PO4 NaHCO3 (CH3COO)4Si MgCl2·6H2O XSi XMg XC 
Si-HA-1 20 17.74 --- 2.07 --- 0.05 --- --- 
Si-HA-2 20 17.74 --- 4.15 --- 0.10 --- --- 
Si-HA-3 20 17.74 --- 8.30 --- 0.20 --- --- 
Si-CHA-1 20 17.74 8.66 2.07 --- 0.05 --- 0.67 
Si-CHA-2 20 17.74 1.94 2.07 --- 0.05 --- 0.15 
Si-CHA-3 20 17.74 4.26 2.07 --- 0.05 --- 0.33 
Si-MHA 20 17.74 --- 2.07 7.86 0.05 0.15 --- 
Si-MCHA-1 20 17.74 8.66 2.07 7.86 0.05 0.15 0.67 
Si-MCHA-2 20 17.74 1.94 2.07 7.86 0.05 0.15 0.15 
The synthesis of silicon-magnesium substituted carbonated hydroxyapatite (Si-MCHA) 
was performed with fixed amounts of silicon (XSi = 0.05) and magnesium (XMg = 0.15), 
while carbonate content (XC) was 0.67 (Si-MCHA-1) and 0.15 (Si-MCHA-2). 
Hydroxyapatite simultaneously substituted with strontium, silicon, magnesium and 
carbonate in biological–like amounts was synthesized by modifying the procedure above 
described, employing strontium nitrate (Sr(NO3)2) as a source of strontium7. The synthesis 
of one powder was performed (Sr-Si-MCHA), with XSi = 0.05, XMg = 0.15, XC = 0.15 and 
XSr (molar ratio Sr : Ca) set at the value of 0.20. 
The employment of strontium in biomaterials has been already reported8-12 and is of strong 
interest, as it is expected to increase the implant osteointegration, due to the reduction of 
bone resorption by osteoclasts and the stimulation of bone formation by osteoblasts13-15. 
Strontium is abundant in natural apatite minerals, but it is present only at ppm levels in the 
bone tissue, so that in higher amounts strontium can have significantly beneficial effects on 
bone balance in osteopenic animals15; this can also lead to an efficient effect in the 
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treatment of osteoporosis15,16. In Fig. 3.2 it is shown the effect of osteoporosis on bone 
trabeculae. 
 
Figure 3.2. Effect of osteporosis on the bone trabeculae (right). 
In the present synthesis, a high amount of strontium was tentatively introduced in the HA 
structure to test the capability of accepting strontium as substitute of calcium, in 
competition with other elements like magnesium and in presence of anionic substitutes, 
like carbonate and silicate.  
Stoichiometric HA (HAL), B-carbonated HA (CHA), magnesium-substituted HA (MHA) 
and HA substituted by both carbonate and magnesium (MCHA), were prepared as 
references to evaluate the discrepancies in physical-chemical behaviour of multi-
substituted HA due to the different atomic substitutions. 
The synthesis of these powders was carried out as above described: The Ca/P ratio was set 
to 1.667 in all powders, with XC = 0.15 in CHA and MCHA, and XMg = 0.15 in MHA and 
MCHA. 
3.2 Characterization of multi-substituted hydroxyapatites 
The as-prepared HA powders were characterized by several analytical techniques 
(see also Chapter.2). X-ray diffraction was employed to evaluate the powder crystallinity 
and the occurrence and amount of secondary phases. All the spectra were collected with a 
scan step of 0.04 degrees, with 1s counting time.  
The specific surface area (s.s.a.) of the HA powders was evaluated by the Brunauer-
Emmett-Teller method. The powder density was measured by helium picnometer 
(Micromeritics 1305, USA). The particle size distribution was evaluated by electro-
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acoustical spectroscopy. Electro-acoustical spectroscopy was also employed for the 
determination of ζ potential and electrical conductivity of the different HA powders as a 
function of pH: HNO3 (1M) and KOH (1M) solutions were used to adjust the pH towards 
acidic and basic values respectively. 
Fourier Transform Infrared Spectroscopy was used to check the occurrence of the typical 
functional groups present in calcium phosphate phases (phosphate, hydroxyl, water 
(adsorbed and structural), carbonate); in particular FTIR spectroscopy allowed to assess 
whether carbonation occurred in phosphate (B) and/or hydroxyl (A) position in the HA 
powders. All the samples were prepared by carefully mixing 1 mg of HA powder with 100 
mg of potassium bromide by pestle and mortar; the obtained pellet was put in a ventilated 
oven at 130 °C for 2 hours, prior the spectrum acquisition, in order to eliminate the water 
adsorbed on the powder surface6; prior analysis, anyway, the pellet was briefly exposed to 
air atmosphere. Following this procedure, the water detected by FTIR analysis is more 
strictly related to the structural water characterizing the specific HA powder, as the 
contribution of the water adsorbed by potassium bromide is completely eliminated and the 
H2O adsorbed by the HA surface is strongly reduced. All the FTIR spectra were obtained 
by averaging 32 scans collected in the wavelength range 400-4000 cm-1, with a spectral  
resolution of 4 cm-1. 
The thermal behaviour of the powders was analyzed by thermo-gravimetric (TG) and 
thermo-differential (DTA) analysis: samples of about 10 mg of powder were weighed and 
put in an alumina crucible of about 180 mg in weight, positioned on one plate of the 
thermo-balance; an empty alumina crucible of similar weight was also present as a 
reference. The temperature was raised from ambient temperature up to 1350-1400 °C with 
a heating rate of 10 °C/min. In the evaluation of the TG curves a reference spectrum was 
subtracted, yielded by the empty crucible, to account for the buoyancy effects. The extent 
of the powders carbonation was evaluated by the weight loss in the range 500-1100 °C, 
due to the decomposition of carbonate groups with evaporation of carbon dioxide, and the 
corresponding stoichiometric coefficient of CO3 anion was estimated considering that the 
highest possible degree of substitution of carbonate ions in the phosphate site (B-
carbonation) is ~ 50 mol%, corresponding to ~ 21 wt% CO3 loss17.  
The chemical composition of the powders was evaluated by inductively coupled plasma-
optical emission spectrometry and energy dispersion spectroscopy applied to scanning 
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electron microscopy system, also employed for the investigation of the powder 
morphology. The samples for ICP analysis were prepared by dissolving 50 mg of powder, 
previously dehydrated in ventilated oven at 100 °C for 1 hour, in 10 ml of nitric acid 
solution (37 wt%); the sample solution was obtained by diluting with deionised water up to 
250 ml in volume. A reference solution was prepared by mixing standard solutions 
containing the investigated atoms at the expected concentrations. An equally diluted 
solution of nitric acid was also analyzed and the corresponding spectrum subtracted by the 
experimental one. 
EDS analysis was performed by uniaxially compacting the HA powder in a steel die; after, 
the so-obtained pellet was cold isostatically compacted under a higher pressure (200-300 
MPa) to obtain a dense body, which is successively coated with a graphite layer prior to 
analysis. 
An estimation of the chemical composition of the multi-substituted HA powders was 
performed, starting from the amount of carbonate present in B site (x stoichiometric 
coefficient), as evaluated from TG analysis; following, the molar ratio silicon : phosphorus 
found by ICP analysis allowed to evaluate the silicate stoichiometric coefficient (y):  
yx
y
P
Si
−−= 6             (2), 
and consequently, the phosphorus, namely the quantity 6-x-y, calcium and magnesium 
content, obtained by the Ca/P and Mg/Ca molar ratios obtained by ICP analysis. The 
general equations expressing the chemical compositions of the obtained apatite phases, 
evaluated by the above-mentioned procedure, can thus be obtained. 
Solubility tests were performed on the HA powders, granulated in the range 400-600 µm 
and immersed in simulated body fluid (SBF, Hanks’ balanced salt solution H6648, Sigma 
Aldrich) thermo-stated at 37 °C. Granulated HA powders were obtained by spreading the 
loose HA powder on a paper sheet and humidifying with atomized deionised water; this 
procedure has to be repeated several times, alternating with a gentle mixing of the 
aggregate. Finally, the soft agglomerate was sieved by mechanical vibration through a 600 
μm and 400 μm sieves: the fraction of granulate retained between these two sizes were 
collected and dried in a ventilated oven at 70 °C, prior its use. 
Three grams of granulated powders were put in a beaker with 100 ml of SBF; pure SBF 
was continuously added by a peristaltic pump with a flow rate of 0.270 ml/min, while the 
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same amount was simultaneously drawn by the beaker containing the granulated powder, 
and stored (Fig. 3.3). This liquid medium, containing the products of granules dissolution, 
was taken away each 24 hours and analysed by ICP. 
The duration of all the solubility tests was seven days. For each investigated HA powder 
the cumulative curves release of the different ions release (calcium, magnesium and 
silicon), calculated on relative weight over the whole HA (according to its formula, 
calculated as above explained), were built and the behaviour of the different multi-
substituted HA powders were so compared. 
 
 
Figure 3.3. Equipment for solubility tests on multi-substituted HA granulates. 
3.2.1 Phase analysis by XRD 
 Figs. 3.4-3.6 show the XRD spectra of the as obtained powders: the only crystalline 
phase detected is hydroxyapatite, on the basis of the ICDD card n° 09-0432, and no other 
calcium phosphate or silicate was found. 
The XRD spectra of all the HA powders are typical of a low-crystalline phase; this is in 
agreement with the low temperature employed in the synthesis. The powder crystallinity 
can be directly estimated by the XRD spectrum following the procedure described in Landi 
et al.18  
In Fig. 3.4 the comparison between the XRD spectra of HAL and Si-HA with different 
silicon content (see also Tab. I) is shown. The powder crystallinity strongly decreased in 
powder with higher silicon content: in fact, the peaks sharpness in XRD spectra of Si-HA 
powders is lower and the peaks less resolved. Thus one can infer that the presence of 
silicon hampered the crystallization of HA phase and this can be due to the substitution of 
phosphate ions by silicate, and the simultaneous loss of stoichiometry for the elimination 
of OH- ions2.  
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Figure 3.4. Comparison between XRD spectra of stoichiometric HA (HAL) and Si-HA with 
different content of silicon. 
In Fig. 3.5 the comparison between the XRD spectra of carbonated-hydroxyapatite (CHA) 
and silicon substituted CHA (Si-CHA) with different carbonate content is shown: a loss of 
crystallinity from CHA to Si-CHA is evident. The XRD spectra of Si-CHA-2 and Si.CHA-
3 are comparable; conversely, the XRD spectrum of Si-CHA-1 is typical of an amorphous 
phase, with one peak corresponding to the inter-reticular distance of d = 0.303 nm, by 
applying the Bragg law (see Chapter 2), attributed to calcium carbonate (ICDD n° 05-
0586).  
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Figure 3.5. Comparison between XRD spectra of CHA and Si-CHA with different carbonate 
content. 
For Si-CHA-1 an initial value of XC = 0.67 was employed, to obtain highly carbonated 
apatite phase; it is known that the carbonation in B position reduces the stability and 
crystallinity of hydroxyapatite19, as vacancies in the calcium site form in order to re-
equilibrate the charge neutrality. Anyway, a silicon-free crystalline carbonated 
hydroxyapatite has been prepared using an initial XC = 0.67 and no formation of calcium 
carbonate was detected. Thus, the formation of the ACP phase and calcium carbonate in 
Si-CHA-1 was probably due to the simultaneous substitution of silicon and carbonate in 
the phosphate site of the hydroxyapatite lattice; as the progressive reduction of the 
crystallinity leads to a nearly-amorphous phase, there must exist a limit of amount of 
foreign ions which can substitute phosphate without disrupting the crystal structure of HA; 
this limit depends on the type and amount of the foreign ions and in Si-CHA-1 it has been 
overcome. As the starting carbonate content was reduced in Si-CHA-2 and Si-CHA-3 
samples, being constant the initial XSi, the crystallization of the apatite phase took place 
and a fraction of the carbonate ions introduced in the reaction vessel was incorporated in 
its structure (see also Fig. 3.12). 
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Fig. 3.6 shows the comparison between the XRD spectra of magnesium-substituted HA 
(MHA) and MHA containing also carbonate and silicon (MCHA and Si-MCHA). The loss 
of crystallinity is rather less evident than in Si-CHA and Si-HA; the same behaviour can be 
observed by comparing the spectra of MCHA and Si-MCHA-2. As well as in Si-CHA-1, 
the simultaneous presence of different substituting ions yielded the formation of an ACP 
phase in Si-MCHA-1, synthesized with an initial XC = 0.67 20, and the crystallization of 
CaCO3, owing to the carbonate present in the reaction ambient. In this case, anyway, the 
amount of carbonate formed was rather higher than in Si-CHA-1, as deduced by the higher 
intensity of the XRD peak of CaCO3, compared with the profile of the amorphous phase. 
Considering that the initial amounts of silicon and carbonate were the same in the two 
powders, it is evident that the increase of the CaCO3 content in Si-MCHA-1 is a 
consequence of the decreased limit of foreign ions which can be present in the reaction 
ambient without disrupting the crystal structure of HA, due to the simultaneous presence of 
magnesium also, which is known to reduce the crystallization process of HA17,21-23. 
 
Figure 3.6. Comparison between the XRD spectra of multi-substituted HA powders 
containing magnesium, silicon and carbonate. 
The pyrolysis of ACP at ~700 °C can yield the crystallization of the amorphous phase20,24; 
on this basis, a thermo-analytical spectrum was acquired to assess the actual temperature of 
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crystallization and, finally, small batches of Si-CHA-1 and Si-MCHA-1 were treated at 
700 °C for 1 hour in a conventional furnace. Fig. 3.7 shows the XRD spectra of the 
powders after the thermal treatment: in Si-CHA-1, the main crystalline phase was HA, but 
CaCO3 (ICDD card n° 05-0586) and CaO (ICDD card n° 037-1497), already present in the 
as-obtained powder, were also detected; in Si-MCHA-1 instead, a large formation of β-
TCP occurred (ICDD card n° 09-0169), with only a few HA and residual calcite. 
On the basis of LeGeros et al.20, it is reasonable that the contemporary presence of 
carbonate and magnesium promoted the formation of ACP in Si-MCHA-1, and the higher 
sharpness of the DSC curve, compared to Si-CHA-1, is more similar to the exothermic 
peak found when thermally treating ACP on purpose synthesized24. It is as well confirmed 
that ACP formed in presence of magnesium exhibits the tendency to resist hydrolysis to 
apatite: in fact, a large amount of β-TCP formed with only a small amount of HA, although 
the starting Ca/P ratio was typical of a stoichiometric HA. In fact, the formation of CaCO3 
contribute to deplete the calcium reservoir for the formation of HA, so that the reduced 
Ca/P ratio favoured the formation of β-TCP. 
 
Figure 3.7. Crystallization of amorphous Si-CHA-1 (a) and Si-MCHA-1 (b) after treatment at  
700 °C. 
3.2.2 Chemical analysis by ICP 
 Table 3.II shows the results of the chemical analysis of the multi-substituted HA 
powders examined in this work: at the left side, the starting and the actual degree of atomic 
substitution in terms of molar ratios are compared; at the right side the related Ca/P molar 
ratios are reported. XSi, XC and XMg respectively indicate the molar ratios Si/P, CO3/PO4 
and Mg/Ca.  
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In Table 3.III the weight fractions of each element on the whole HA phase are listed, 
evaluated on the basis of the chemical and thermo-gravimetric analyses. 
Table 3.II. Chemical analysis of the multi-substituted HA powders. 
Sample 
Starting 
XSi 
Actual 
XSi 
Starting 
XC 
Actual 
XC 
Starting 
XMg 
Actual 
XMg 
Ca/P 
HAL --- --- --- 0.070 --- --- 1.66 
Si-HA-1 0.050 0.040 --- 0.065 --- --- 1.75 
Si-HA-2 0.100 0.081 --- 0.066 --- --- 1.73 
Si-HA-3 0.200 0.163 --- 0.069 --- --- 1.78 
CHA --- --- 0.150 0.147 --- --- 1.90 
Si-CHA-1 0.050 undetected 0.670 --- --- --- --- 
Si-CHA-2 0.050 0.026 0.150 0.112 --- --- 1.72 
Si-CHA-3 0.050 0.006 0.330 0.111 --- --- 1.79 
MHA --- --- --- 0.054 0.150 0.053 1.61 
Si-MHA 0.050 0.045 --- 0.069 0.150 0.040 1.73 
MCHA --- --- 0.150 0.150 0.150 0.045 1.82 
Si-MCHA-1 0.050 undetected 0.670 --- 0.150 0.135 --- 
Si-MCHA-2 0.050 0.028 0.150 0.135 0.150 0.046 1.81 
The chemical analysis performed on the as-obtained HA powders confirms the presence of 
the doping atoms, namely silicon and magnesium; while the use of sodium hydrogen-
carbonate allowed the entering of carbonate ions in the apatite structure: sodium was not 
detected in the powders, therefore it was eliminated during washing procedures. 
Table 3.II shows that in Si-HA powders the silicon concentration approached the starting 
nominal Si values in term of XSi: the efficiency of silicon substitution, i.e. the ratio 
between the actual and the initial XSi was about 80%. In Si-MHA powder the substitution 
efficiency was even higher, while in Si-CHA samples it was related to XC and more 
precisely it decreased by raising XC, keeping XSi constant. 
A value of XC=0.15 (Si-CHA-2) yielded a carbonate substitution of 75% of the initial 
amount, and simultaneously, ~50% of the silicon introduced; conversely, starting from 
XC=0.33 (Si-CHA-3), the silicon present in the powder decreased up to ∼10% of the initial 
amount and, correspondingly, the carbonate substitution was limited to ~35%. Finally, 
when XC=0.67 (Si-CHA-1), as already described above, the crystalline apatite phase 
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structure collapsed: the silicon was completely eliminated during powder washing and no 
more detectable by ICP analysis. 
Table 3.III. Weight fraction of the various elements in the multi-substituted HA powders 
wt% of the elements on the apatite phase 
Sample 
Ca P Si CO3 Mg 
HAL 38.7 18.0 --- 2.75 --- 
Si-HA-1 39.3 17.4 0.63 2.5 --- 
Si-HA-2 38.3 17.1 1.26 2.4 --- 
Si-HA-3 37.6 16.3 2.41 2.35 --- 
CHA 40.8 16.6 --- 5.4 --- 
Si-CHA-2 38.5 17.3 0.41 4.1 --- 
Si-CHA-3 39.8 17.2 0.09 4.2 --- 
MHA 37.8 18.1 --- 2.1 1.24 
Si-MHA 38.6 17.2 0.70 2.6 0.96 
MCHA 39.3 16.7 --- 5.5 1.04 
Si-MCHA-2 38.9 16.6 0.42 4.9 1.08 
The behaviour exhibited by the Si-CHA samples revealed that a competition arose between 
the silicon and carbonate ion to occupy the phosphate site. The substitution efficiency of 
silicate to enter into the phosphate site even in non-artificially carbonated samples resulted 
<100%; this can be due to the presence of the above-mentioned spontaneous carbonation. 
It is interesting the stabilizing effect of magnesium towards the other foreign ions: in 
presence of magnesium higher amounts of silicon (comparing Si-MHA with Si-HA-1) and 
carbonate (comparing Si-MCHA-2 with Si-CHA-2) were retained in the HA structure. 
Conversely, in presence of silicate and/or carbonate, a lower amount of magnesium could 
enter in the HA structure (compare Si-MHA with MHA and MHA with Si-MHA and Si-
MCHA-2); in this case, carbonate seemed more influent than silicon in allowing the 
incorporation of magnesium. In Si-MCHA-1, containing ACP phase, a very high amount 
of magnesium was found; as CaCO3 does not contain any magnesium, one can infer that 
almost all the magnesium introduced was incorporated in the ACP phase, as also described 
above. 
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3.2.3 Thermal analysis 
 Fig. 3.8 shows the thermo-gravimetric (TG) spectra of the multi-substituted HA 
powders. All powders show a similar behaviour: the carbonated HA powders (CHA and 
Si-CHA-2) exhibit a higher weight loss in the region 500-1100 °C, where the 
decomposition of carbonate takes place. All the powders without carbonate added, 
however, experience a weight loss of ~2,5 wt% (see Table 3.III), confirming the 
spontaneous carbonation revealed by FTIR analysis (see later, Fig. 3.12).  
The strong weight loss occurring in Si-CHA-1 and Si-MCHA-1 in the region 500-1100 °C 
is evident (Fig. 3.9); however, most of the CO3 decomposition occurred in the restricted 
region 650-750 °C. In fact, these powders are composed by an ACP phase and crystalline 
CaCO3 in different amounts; a TG-DTA spectrum of pure CaCO3 was acquired, revealing 
that CO2 is exhaled in the restricted range 650-800 °C (Fig.3.10). 
The DSC spectra exhibit inflections around ∼700 °C, in particular in Si-CHA-1 the 
inflections are at ∼620-630 °C and at ∼715 °C, while in Si-MCHA-1, they were more net-
shaped and at ∼670 and 705 °C. On the basis of a previous study24, the first inflection was 
attributed to the crystallization of ACP, while the second one, corresponding to the net 
weight loss occurring in both powders, was attributed to the decomposition of CaCO3 and 
the evaporation of CO2, on the basis of a TG-DSC of pure CaCO3 acquired in the same 
range of temperature (Fig. 3.11). 
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Figure 3.8. Thermogravimetric analysis of multi-substituted HA powders.  
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Figure 3.9. TG-DTA curves of Si-CHA-1 and Si-MCHA-1 powders. 
 
 
Figure 3.10. TG-DSC of pure CaCO3 powder. 
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Figure 3.11. Comparison between TG spectra of Si-CHA-1 and CaCO3. 
It is interesting also to note the weight loss in the low temperature range between 100 and 
400 °C (Tab. 3.IV); here, most of the adsorbed water is already eliminated, thus the weight 
loss is supposed to be due to the evaporation of the water more structurally bonded to the 
HA structure25. Again, Si-CHA-1 and, even more, Si-MCHA-1 exhibit a much higher 
weight loss in this temperature range, so that this phenomenon can be related to the 
incorporation of a higher amount of water in the ACP structure, released during the firing 
up to 400 °C. 
Table 3.IV. Percent weight loss in the range 100-400 °C. 
 HAL Si-HA-1 Si-HA-2 Si-HA-3 
wt% 8.33 5.66 5.62 6.17 
     
 CHA CHA_Si_1 CHA_Si_2 CHA_Si_3 
wt% 5.27 10.57 7.23 6.15 
     
 MHA Si-MHA Si-MCHA-1 Si-MCHA-2 
wt% 5.18 6.21 14.62 6.75 
3.2.4 Chemical analysis by FTIR 
 The IR spectra of the investigated HA powders (Fig. 3.12) show the typical 
absorption bands related to the modes of phosphate (ν2 bending, ~470 cm-1; ν4 bending, 
∼565 cm-1; ν1 sym stretch, ~960 cm-1; ν3 asym stretch, ~1035 cm-1), hydroxyl (stretch, 
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∼3570 cm-1), water (bending, ∼1635 cm-1; sym+asym stretch, ∼3410 cm-1) and carbonate in 
B position (ν3 bending, ∼875 cm-1; ν3 stretching, 1417, 1455 cm-1).  
 
 
Figure 3.12. FTIR spectra of multi-substituted HA powders. 
The NaHCO3 as a reactant resulted efficient in yielding a high degree of carbonation of the 
apatite phase in B position. The typical bands related to B carbonation are also exhibited 
by HA powders obtained in absence of added carbonate, due to impurities present in the 
reactant calcium hydroxide, or to carbon dioxide present in the atmosphere and dissolved 
into the mother solution during powder synthesis.  
A careful inspection of the IR spectra shows that a very small amount of carbonation in the 
hydroxyl site (A-carbonation) is present in all the investigated powders (see the shoulder at 
~1540 cm-1, which together with the signal at 1455 cm-1 corresponds to ν3 stretching); 
notwithstanding, these powders can rightly be considered mainly B-carbonated. The 
carbonation in A site and the silicon substitution in the phosphate position provoke a 
reduction in hydroxyl content2, as can be noted in Fig. 3.12 as the OH stretching band 
(~3570 cm-1) is reduced in multi-substituted HA powders compared to the reference HA. 
The same effect is put in evidence in Fig. 3.13, where the IR spectrum of HAL is compared 
with those of Si-HA powders characterized by an increasing silicon content (see also Table 
I). 
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Figure 3.13. Effect of silicon on hydroxyl bands in Si-HA powders. 
Fig. 3.12 also puts in evidence the different intensities of the FTIR adsorption bands of 
water at ~3410 cm-1. It is observed that the IR bands of water exhibited by the HA powders 
containing magnesium are much more intense than in Mg-free HA powders.  
Another interesting features can be noted by inspecting the FTIR curves of Si-CHA-1 and 
Si-MCHA-1 (Fig. 3.14): the adsorption band related to the stretching of water molecule at 
~3410 cm-1, especially for Si-MCHA-1, is much more broaden and intense, compared to 
the other multi-substituted HA. The band is also doubled, while for the other HA powders 
it appeared more like one single band. As TG analysis showed an increased weight loss in 
the 130-400 °C range, in HA powders containing ACP phase, it is confirmed that the 
amount of structurally bound water is increased in the presence of ACP; the double band 
appearing in the related FTIR spectra can reveal the presence of water molecules 
differently bound, with chemical bonds of different energies. The sample containing 
magnesium again exhibited a higher water content; these findings confirm the higher 
strength with which Mg-HA surface binds water molecules and consequently coordinates a 
higher number of water layers, compared to magnesium-free HA25. As concerns the 
silicon-substituted HA powders, there is no evidence of an analogous effect of silicon on 
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their surface properties, anyway further investigations are needed for extensively 
discussing this point. 
 
 
Figure 3.14. Water adsorption bands in Si-CHA-1 and Si-MCHA -1 powders. 
Finally, two additional IR bands are also visible in the IR spectra of Si-substituted HA 
powders, situated in the range 490-505 and 890-895 cm-1, respectively. Fig. 3.13 shows 
that the peaks intensities increase by raising the silicon content, thus their occurrence 
should be ascribed to modifications of the apatite structure induced by the presence of 
silicon. It is hard to assign such bands without further analysis, we can suggest however 
the existence of a bond between silicon and some impurities present in the reactants, like 
chloride and fluoride; such bonds give rise to strong peaks in the spectral regions where 
our additional peaks are located, as obtained by a computer simulation through the 
software IR Mentor Pro 6.5, by Bio-Rad Laboratories, Sadtler Division. 
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3.2.5 Powder analysis 
 The typical morphology of multi-substituted HA powders is reported in Fig. 3.15. 
The primary particles are well visible, they appear as elongated grains of about 30x70 nm 
and form a small agglomerate of ~300 nm in size. 
 
 
Figure 3.15. Typical morphology of a silicon-substituted HA. 
Table…reports the results of particle size analysis in terms of specific surface area, 
obtained by BET (see Section 2.6.1) and powder density measurement, obtained by helium 
picnometry. Both measurements were carried out after a thermal treatment to eliminate the 
adsorbed water: for BET the heating was carried out in vacuum up to 200 °C, while for 
density measurement, the powder was previously treated at 130 °C for 1 hour in a 
ventilated oven. 
An estimation of the particle size can be obtained, if we suppose that all the particles have 
the same sphericity, that is highly reasonable, by the following expression: 
SSA
d ⋅= ρ
6   (3). 
Table 3.V shows that the incorporation of ionic substitutes raised the specific surface area, 
contemporary decreasing the density of the powder. The mild heating did not eliminate all 
the water present in the powder, but only the one physically adsorbed on the powder 
surface, so the density value can be affected by the presence of lattice H2O, differently 
formed between the HA crystalline domains. 
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Silicon-carbonated apatites exhibit the highest value of s.s.a. and, correspondingly, the 
smallest particle size; anyway the average particle size of the different HA powders 
resulted ~30 nm, irrespective of the chemical composition (Table 3.V), thus no conclusions 
can be derived on the effect of atomic substitutes on particle size and morphology. 
Anyway, the here detected particle size is in close agreement with the SEM investigations 
and the results found by Bertinetti6, on the basis of TEM observations on HA powders 
characterized by different crystallinity. 
Table 3.V. Particle characteristics in multi-substituted HA. 
Material Specific surface area 
(m2/g) 
Powder density 
(g/cm3) 
Estimated particle 
size (nm) 
HAL 70.43 3.068 27.8 
Si-HA-1 75.03 2.804 28.5 
Si-HA-2 83.73 2.700 26.5 
Si-HA-3 80.91 2.748 27.0 
CHA 83.11 2.856 25.3 
Si-CHA-2 182.86 2.573 12.7 
Si-CHA-3 214.64 1.940 14.4 
MCHA 89.54 2.789 24.0 
Si-MHA 84.73 2.718 26.0 
Si-MCHA-2 78.54 2.645 28.9 
As-synthesized HA powders are typically very sensitive to moisture, thus they tend to 
easily form agglomerates (Fig. 3.16) as larger as the particle size is decreased, owing to the 
increase of the surface charge18. 
 
Figure 3.16. Self-agglomeration of HA powders. 
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A control of the degree of agglomeration of HA powders is crucial: in fact, highly stable 
powder suspensions in water are often needed to produce green dense or porous bodies to 
be subsequently sintered in three-dimensional devices, destined to be implanted. An excess 
of agglomeration soon provokes powder decantation and no stable suspensions can be 
obtained. 
Electroacoustical spectroscopy is a powerful tool to investigate the state of powder 
surfaces (see Section 2.6.2); in the present work, the electrical conductivity and the particle 
size distributions of multi-substituted HA powders in aqueous solutions were evaluated. 
Particle size distributions are described both in terms of differential (Fig. 3.17a) and 
cumulative fractions (Fig. 3.17b). The solutions containing the HA powders were analyzed 
after ultrasonic treatment. 
In Fig. 3.17a, displaying the occurrence of a certain particle size in each HA powder, it can 
be seen that, except Si-CHA, all powders containing silicon are characterized by a particle 
size distribution described by a continuously decreasing curve. Conversely, the remaining 
powders exhibit agglomerates statistically distributed around a typical mean value; for all 
powders this value is below 300 nm, in particular HA is centred around 150 nm, Si-CHA at 
200 nm, while CHA and MCHA have agglomerate centred at ~40 nm. On the basis of the 
previous data on effective particle size (Tab. 3.V), it can be deduced that powders seem to 
have undergone different extents of agglomeration. There is no clear relationship between 
the specific surface areas and the degree of agglomeration occurred in HA powders; 
anyway silicon-substituted HA showed a reduced tendency towards aggregation, as a large 
number of particles in their original size is still present. 
In Fig. 3.17b the cumulative size distribution allows a better evaluation of the degree of 
agglomeration: HA, and even more Si-CHA confirmed to be highly agglomerated, with 
few particles below 100-150 nm. Among the remaining powders, silicon-containing HA 
confirmed their very reduced agglomeration: 80% of powder was below 30 nm, so 
virtually not agglomerated, and 90% was below 70 nm, which is the size of a group of 3-4 
primary particles. 
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Figure 3.17. Particle size distribution of multi-substituted HA powders.: a) differential; b) 
cumulative. 
Conductivity measurements were performed to evaluate the behaviour of powder under an 
applied electric field in liquid medium. pH was continuously varied during the analysis, 
towards both acidic and basic conditions. 
It is of particular interest the region around neutral pH, as it is more similar to the 
physiologic conditions; towards acidic environment, at pH < 5, HA tends to dissolve and 
brushite (CaHPO4⋅2H2O) is the most stable phase; in consequence of the HA dissolution, 
the increase of ions present in solution determined the enhancement of the conductivity. 
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Fig. 3.18 shows that all the investigated powders displayed similar conductivities. The 
powder containing the highest amount and type of substitutes, Si-MCHA-2, exhibited the 
highest conductivity values in the pH region 5 – 8, as also highlighted in the detail; this 
behaviour suggests an increased instability and solubility of this powder, especially at 
lower pH values. At physiological pH 7.4, anyway, this behaviour can reflect in a higher 
reactivity in vivo, i.e. higher resorption and release of biologically active ions which can 
yield a faster and more effective new bone formation with improved amount and quality of 
the new bone. 
 
Figure 3.18. Electrical conductivity of multi-substituted HA powders. 
In the detail, it is more evident the similar behaviour of multi-substituted HA powders in 
the region of neutral pH; the general increase of the conductivity in the region of acidic pH 
is reduced in the case of stoichiometric HA, which confirmed to be the most stable HA 
powder. 
The characterization of the surface state of HA powders included also the determination of 
ζ potential.  
The determination of the ζ potential is determinant in the set up of the optimal conditions 
to prepare powder aqueous suspensions, particularly the determination of iso-electric point, 
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corresponding to the point of zero charge, where no potential exists between particles and 
flocculation occurs. 
 
Figure 3.19. ζ-potential vs. pH of multi-substituted HA powders. 
All HA powders exhibit a very small ζ potential in the neutral region (pH=7.4), becoming 
close to zero around pH ~8 (Fig. 3.19). The tendency to agglomeration is very high and 
decreases towards basic pH values, when ζ potential assumes negative values. The only 
exception is Si-MCHA-2, the powder with the highest doping, whose ζ potential never 
goes to zero. Towards acidic pH values, ζ potential slightly increases and becomes very 
high at pH< 4.5, in correspondence of the dissolution of HA in brushite. Commonly, 
specific deflocculating agents are employed for decreasing the ζ potential up to -30 ÷ -40 
mV, so to have well dispersed powder suspensions, characterized by a high solid : liquid 
ratio. In this stage, electroacoustic spectroscopy is one of the most powerful tool for the 
setting up of the optimal conditions. 
3.2.6 Solubility tests 
 Si-HA-1, Si-CHA-2, Si-MHA and Si-MCHA-2 powders, containing silicon in 
biological-like amounts (see Tab. II), were selected for solubility tests and compared with 
the corresponding silicon-free HA samples: HAL, CHA, MHA and MCHA. 
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The amount of ions released by the selected granulated HA powders (granules size range: 
0.4-0.6 mm, see Fig. 3.20) in SBF bath thermo-stated at 37 °C during seven days, are 
shown in Figs. 3.21-3.23: the plots display the ion dissolution with respect to the starting 
ion content. 
In Fig. 3.21 the calcium release is shown: HAL exhibits a limited calcium dissolution 
which saturates after less than 100 hours, accordingly with the very low solubility product 
of stoichiometric hydroxyapatite. MHA exhibits a slightly increased calcium release in the 
long term. Among the remaining powders, the release data address to a continuous powder 
dissolution characterized by an approximately linear trend. The HA powders containing 
silicon exhibit a more abundant calcium release with respect to the silicon free HA 
powders (Si-HA-1 vs. HAL; Si-CHA-2 vs. CHA and Si-MHA vs. MHA).  
 
Figure 3.20. Typical morphology of a granulated HA. 
The HA powders containing carbonate (CHA, Si-CHA and Si-MCHA-2) released a larger 
relative amount of calcium ions and the rate of release is more than doubled, compared to 
the carbonate-free HA (Si-HA and Si-MHA, see Tab. III). Finally, in MCHA, the presence 
of magnesium limits the release of calcium, compared with the other carbonate containing 
HA, but it is much higher than the carbonate-free HA.  
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Figure 3.21. Cumulative release of calcium by multi-substituted HA powders. 
The cumulative release of magnesium also followed a linear trend (Fig. 3.22), with a 
similar release rate (Tab. 3.VI); in this case, it is interesting to note that the magnesium-
substituted apatite containing also silicon (Si-MHA) exhibited a strongly reduced 
magnesium release, even compared with the silicon-free powder (MHA). This feature 
suggests that in absence of carbonate, which strongly increases the solubility of the HA 
structure, the presence of silicon stabilized magnesium in the HA structure.  
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Figure 3.22. Cumulative release of magnesium by multi-substituted HA powders. 
The same behaviour can be observed in Fig. 3.23, displaying the silicon release in multi-
substituted HA powders: as expected, carbonate-containing HA powders exhibited the 
highest silicon release; moreover, with or without carbonate, the presence of magnesium 
stabilized silicon into the HA structure. 
The mutual limitation of ion solubility involving silicon and magnesium suggests the 
formation of complexes containing these two ions, more strongly bound to the HA crystal 
structure or to its amorphous surface. 
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Figure 3.23. Cumulative release of silicon by multi-substituted HA powders. 
Fig. 3.21 reports that in HAL, the release of calcium was observed up to 96h (a) time range, 
see Table 3.VI) after immersion in SBF, while in the single and multi-substituted powders 
it prolonged continuously over the whole investigated period, with different release rates, 
on the basis of the curve slopes. In HAL the early exhaustion of the calcium release 
confirms the low solubility product of stoichiometric hydroxyapatite, 
The determination of the ion release kinetic in physiological-like environment is important 
for predicting the in vitro and in vivo behaviour of the biomaterial. In most cases, it was 
possible to interpolate the values of ion release with a straight line, so indicating the 
existence of a single mechanism of ion release in equilibrium with the SBF solution, kept 
continuously renewed. 
The fit with a straight line was more efficient in case of calcium and magnesium release; 
calcium dissolved only in very small amounts, substituted HA exhibited up to 4 times the 
calcium dissolution than stoichiometric HA (Fig. 3.21); magnesium is released up to 25 % 
in a week (Fig. 3.22), in this case it was interesting the stabilizing effect of silicon, in 
absence of carbonate, but no significant enhancement of magnesium dissolution was 
found, although the release of Si-MCHA-2 was likely to be increasing for times longer 
than a week (Fig. 3.22). 
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The incongruent dissolution of calcium and magnesium in multi-substituted HA, compared 
to their composition, suggests that magnesium could be more likely present in the 
amorphous part of the HA particles, rather than replacing Ca; it is reasonable in fact that 
the amorphous layer surrounding the apatite grains dissolved within the first period of 
immersion in SBF leaving a more stable and less soluble core. Concerning HAL, it can be 
supposed that the whole amorphous layer is dissolved within the first 100 hours; in 
substituted HA, characterized by a decreased crystallinity (see Figs. 3.4-3.6), the 
amorphous shell can be thicker and contain part of the substitute ions, yielding a more 
intense and prolonged release in SBF.  
Alternatively, since magnesium has a higher affinity with water than calcium25, its 
tendency to migrate outside the cationic site of HA can be enhanced in aqueous 
environment, so that atomic vacancies could be created in the HA structure. The increase 
of vacancies in the HA crystal structure could favour its phase decomposition above 1000 
°C in β-TCP containing magnesium. 
Silicon also was released in a much higher extent, compared to calcium and magnesium 
(see Figs. 3.21-3.23); as found for Mg-substituted HA6, it is possible that part of silicon is 
situated in the amorphous layer, anyway deeper investigations are needed to confirm this 
assertion. 
The release curves of silicon are not linear in the whole investigated time range, so 
indicating two different mechanism of release; they were considered in two different lapses 
of time: a) range 0-96 h and b) range 96-168 h; in this way, two approximate straight lines 
for the two time ranges were obtained.  
Table 3.VI shows the solubility data in terms of release rate, measured by the slope of the 
straight line interpolating the experimental data; the accuracy of the interpolation is high, 
as the coefficient of correlation R2 is very close to 1. 
As expected, HA powders containing carbonate exhibit the highest release rates, it is also 
evident that the presence of other substitutes (magnesium, silicon) partially stabilized the 
release of calcium. Among the non-carbonated HA powders, a higher calcium release is 
detected in presence of silicon, rather than magnesium. 
The release of magnesium is not enhanced in presence of silicon, comparing MHA and Si-
MHA. Conversely, in presence of carbonate, the stabilizing effect of silicon towards 
magnesium is more evident; this is in agreement with the results found by the plots of ion 
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release, where the stabilization of magnesium by silicon in term of ion amount was 
evident. 
The release rate of silicon is very high, compared to calcium and magnesium also, 
especially in the first stage (t<96 h). The highest rates of silicon release were detected in 
carbonated HA (Si-CHA-2 and Si-MCHA-2); again the mutual stabilization of magnesium 
and silicon was confirmed, as the release rate of Si-MHA is the lowest.  
In the second stage, after four days, there is a strong decrease of silicon release rate; in this 
case, the highest effect was in Si-MCHA-2, while Si-CHA-2 exhibited again the highest 
value, although reduced at one third. 
Even though there is still a lack of information about the surface and crystal states of multi-
substituted HA powders, it is reasonable to guess that their different release kinetics are 
related both to the intrinsic solubility of HA, presenting several ion substitutes in its cell, 
and the characteristics of the amorphous shell around the crystallized apatite, in terms of 
thickness and composition, which can mediate the ion release from itself and the HA 
crystal. 
Table 3.VI.  Release kinetic data of multi-substituted HA powders in SBF at 37 °C. 
(a) and (b) indicate the first and second branch of the release curves of silicon, respectively. 
Ca release Mg release Si release 
Sample Release rate 
(wt%·h-1) · 10-3 
R2 
Release rate 
(wt%·h-1) · 10-3 
R2 
Release rate 
(wt%·h-1) · 10-3 
R2 
CHA 1.8 0.97 --- --- --- --- 
MHA 0.6 0.99 69 0.97 --- --- 
MCHA 1.3 0.97 92 0.97 --- --- 
Si-HA-1 0.8 0.98 --- --- 238(a)         52(b) 0.97 
Si-CHA-2 1.4 0.98 --- --- 469(a)       153(b) 0.97 
Si-MHA 0.8 0.99 68 0.98 192(a)         44(b) 0.97 
Si-MCHA-2 1.5 0.99 82 0.95 301(a)         24(b) 0.95 
The solubility behaviour of the multi-substituted HA powders is such that it is predictable 
that ion release can occur over a long period of time; this is an important finding in the 
viewpoint of in vivo application, as these materials, at physiological conditions, are able to 
continuously supply elements which are essential for osteoblast activity and new bone 
tissue formation and development. The simultaneous presence of many of such elements 
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can further enhance the cell activity; in vitro and in vivo investigations will be performed 
to corroborate this hypothesis.  
3.3 Thermal stability of multi-substituted HA powders 
 HA powder can be used as-synthesized, in form of granulate, which can be 
implanted in vivo as a bone filler, and according to its bioactivity and bioresorbability, it 
can yield the development of new bone tissue. Many applications of bone healing need 
instead three-dimensional bodies, to be implanted in vivo as porous scaffolds, able to 
induce the proliferation of osteoblasts, with growing and osteointegration of new bone 
tissue. The general procedure to achieve consolidated ceramics is the pre-forming of a 
green body, subsequently consolidated through a thermal treatment of sintering. Since 
substituted HA phases usually exhibit a reduced stability to both chemical and thermal 
treatments, preliminary tests were carried out by sintering the multi-substituted HA at 
different temperatures between 1000 and 1400 °C and analyzed by XRD to assess phase 
decomposition, in comparison with stoichiometric HA. 
In Si-HA powders an increasing fraction of α-TCP formed (ICDD card n° 29-0359), with 
the increase of the initial silicon content; at high silicon content, the decomposition starts 
already at 1000 °C (Fig. 3.24).  
On the basis of Sayer et al.26, the presence of silicon induces the formation of α-TCP at 
lower temperatures, compared with stoichiometric HA; moreover silicon partially 
substitutes phosphorus in the α-TCP structure; in the samples investigated in this work this 
tendency is confirmed, and the amount of α-TCP formed increased with higher contents of 
silicon. 
Fig. 3.25 displays the increasing reactivity of Si-HA powders during thermal treatments; 
starting by the low temperature, the latent heat is well higher in Si-HA-3, a small inflection 
is visible at ~700 °C, in the region in which ACP usually crystallizes. Thus, it can be 
hypothesized that a certain amount of amorphous phase is present in silicon-substituted 
apatites, increasing with the silicon content. Above 1000 °C, the difference between the 
three curves is much more evident, due to the different extent of HA decomposition (Fig. 
3.24).  
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Figure 3.24. Effect of silicon on the formation of α-TCP after sintering. 
 
 
Figure 3.25. DSC curves of Si-HA powders. 
The presence of carbonate stabilized the HA structure during the thermal treatments, even 
in presence of silicon (Tab. 3.VII). It was detected the formation of a limited amount of β-
TCP, CaO and CaCO3: in the initially amorphous powder (Si-CHA-1), the crystallization 
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of HA took place at ~700 °C; at higher temperatures, the residual CaCO3 started to 
decompose, giving rise to a residual amount of CaO. The powders with less initial 
carbonate showed a high stability, with some residual calcium oxide and traces of β-TCP. 
Table 3.VII. Phase  transformation in Si-CHA powders during sintering. 
 β-TCP CaO CaCO3 Remarks 
CHA     
1000 °C  <1   
1250 °C  1.5   
1400 °C 4 1.5   
     
Si-CHA-1    Amorphous 
700 °C  2.5 5  
1000 °C  3.5 1.5  
1250 °C  5   
1400 °C  5   
     
Si-CHA-2     
1000 °C     
1250 °C 1.7 1.8   
     
Si-CHA-3     
1000 °C     
1250 °C 1.7 4.0 0.4  
Similar differences in the DSC curves are observed also in Si-CHA powders. The initially 
amorphous calcium phosphate (Si-CHA-1) crystallized at around 700 °C, as revealed by 
the inflection in DSC curve (Fig. 3.26). Such inflection is not visible in the other Si-CHA 
powders, but a wide endothermic phenomenon, extending up to 1000-1100 °C, and 
probably related to the decomposition of carbonate. The different behaviour revealed by 
the DSC curves cannot be related to the carbonate content as it is nearly the same in both 
powders; the most remarkable difference in the chemical composition of the two powders 
is their content in silicon (0.09 vs. 0.41 wt%), so that a variation in the kinetic of carbonate 
decomposition related to the presence of silicon could be hypothesized. 
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Figure 3.26. DSC curves of Si-CHA powders. 
The presence of magnesium influenced the formation of secondary phases (Tab. 3.VIII). α-
TCP formed only in small amounts at 1400 °C in Si-MCHA-2; instead, a large amount of 
β-TCP formed, induced by the presence of magnesium in Si-MHA17. In Si-MCHA-1, 
constituted by ACP and CaCO3, a large amount of TCP formed already at 700 °C (see also 
above), strongly decreasing at the highest temperatures, when HA content simultaneously 
increased up to 96 % after sintering at 1400 °C. Few calcium oxide (< 3 vol%) was also 
detected. In Si-MCHA-2, the overall amount of secondary phase is very limited, so that the 
mutual stabilization of HA structure by the doping ions is evident. 
The presence of silicon influences the reactivity of MHA powders, especially above 1000 
°C (Fig. 3.27), where the formation of high amounts of β-TCP, probably containing the 
magnesium originally present in the HA structure, took place. DSC analysis confirms the 
higher thermal stability compared with MHA (Fig. 3.28); Si-MCHA-1 shows the inflection 
at ~700 °C, in correspondence with the crystallization of ACP. This powder, in comparison 
with Si-MCHA-2, exhibited very different behaviour during heating, on the basis of XRD 
analysis, but their DSC curves are very similar, suggesting that part of phenomena of β-
TCP crystallization observed in Si-MCHA-1, took place during cooling. 
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Table 3-VIII. Phase  transformation in Si-MHA powders during sintering. 
 β-TCP α-TCP CaO CaCO3 Remarks 
MHA      
1000 °C 22     
1250 °C 22     
1400 °C 18 14    
      
Si-MHA      
1000 °C 6     
1250 °C 29     
1400 °C 26     
      
MCHA      
1000 °C   0.5-1   
1250 °C   0.5-1   
1400 °C   0.5-1   
      
Si-MCHA-1     Amorphous 
700 °C 74   7  
1000 °C 44   2  
1250 °C 11  3   
1400 °C 3  1   
      
Si-MCHA-2      
1000 °C      
1250 °C 9     
1400 °C 5.5 2.5    
 
 
Figure 3.27. Effect of silicon on MHA powder. 
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Figure 3.28. Effect of silicon on MCHA powder. 
3.4 HA powder substituted with strontium, carbonate, silicon and 
magnesium 
 Chemical-physical characterization was performed by XRD, FTIR and ICP to 
assess the phase composition and purity after synthesis and the extent of phase 
decomposition after sintering at different temperatures. 
The presence of four different ionic substitutes in anionic and cationic sites provoked the 
formation of ACP phase, as also occurred in other multi-substituted HA powders, 
characterized by an excess of carbonate (XC=0.67, see above, Figs. 3.5, 3.6).  
In these HA powders the excess of carbonate, coupled with the simultaneous presence of 
several ionic substitutes, was responsible of the lack of HA formation, yielding instead the 
formation of crystalline calcium carbonate also; in fact, the same typology of powders, 
successively synthesized with a reduced amount of carbonate (XC=0.15), allowed the 
crystallization of HA, although its crystallinity was very low (see above, Figs. 3.5, 3.6). 
In the present synthesis instead, ACP phase formed even in presence of reduced carbonate 
(Fig. 3.29) and neither CaCO3 nor other crystalline phases were present. A number of 
mineral apatite phases containing a high number of foreign ions, including strontium, exist 
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in nature in a crystalline form; in this case, anyway, the high number of anionic substitutes, 
which strongly destabilize the apatite structure, coupled with three different atomic species 
in cationic sites, precluded the crystallization of HA. 
  
Figure 3.29. XRD spectrum of Sr-Si-MCHA powder. 
The thermal analysis of the Sr-Si-MCHA powder confirmed the occurrence of the 
inflection at ∼ 700 °C (Fig. 3.30), which should indicate the temperature of ACP 
crystallization, in agreement with the results described above. 
For this reason, thermal treatments were performed on the as-prepared powder, at 700 °C 
or 1 hour, to investigate the phase formed after crystallization of ACP, and at 1000, 1250 
and 1400 °C, to investigate the sintering behaviour at similar conditions as the above 
investigated powders. 
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Figure 3.30. Thermal behaviour of Sr-Si-MCHA powder. 
After firing at 700 °C, HA phase crystallized and no calcium carbonate (Fig. 3.31), nor 
other calcium phosphates or compound of magnesium and/or strontium were found. 
  
Figure 3.31. XRD spectrum of Sr-Si-MCHA fired at 700 °C. 
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β-TCP was detected after sintering at 1000 °C (~ 30%), slightly increasing up to 1400 °C 
(Fig. 3.32). 
 
 
Figure 3.32. Formation of β-TCP in Sr-Si-MCHA powder. 
The absence of any secondary phases in the as-crystallized HA, containing also silicon, 
carbonate, magnesium and strontium suggests that the composition of initial ACP must be 
the one of the apatite formed after firing at 700 °C; at this temperature only few of the 
carbonate present in the apatite is lost. For this reason the determination of the approximate 
composition of the powder by chemical analysis was justified, as performed with the other 
substituted HA. 
Tables 3.IX and 3.X report the results of ICP analysis in comparison with powder with 
similar initial composition, so to evaluate the influence of strontium on the entering of the 
other substitutes. 
The presence of strontium strongly limited the entering of silicon in HA structure, 
compared with any other HA powder here investigated; similarly, carbonate uptake was 
reduced, so that the general tendency of an increased carbonate uptake, in presence of 
cationic substitutes (see also Tab. 3.II) was not confirmed, in this case the presence of 
multiple cationic substitutions reduces the effect in the carbonate uptake, in comparison 
with single ion exchange. 
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Compared with Si-MHA and Si-MCHA, the presence of strontium enabled the uptake of a 
higher amount of magnesium, even compared to powder containing only magnesium, 
counterbalancing the negative effects of the anionic substitutes, silicate and carbonate. 
Strontium itself is limited in entering into the HA structure, comparing with HA containing 
only strontium as substitute11,12, only 40% of the introduced strontium was retained. 
Table 3.IX. Chemical composition of Sr-Si-MCHA powder. 
Sample Starting XSi Actual XSi Starting XC Actual XC 
Sr-Si-MCHA 0.050 0.014 0.150 0.100 
Si-MCHA-2 0.050 0.028 0.150 0.135 
Si-CHA-2 0.050 0.026 0.150 0.112 
Si-MHA 0.050 0.045 --- --- 
Si-HA-1 0.050 0.040 --- --- 
     
Sample Starting XMg Actual XMg Starting XSr Actual XSr 
Sr-Si-MCHA 0.150 0.090 0.20 0.08 
Si-MCHA-2 0.150 0.046 --- --- 
Si-MHA 0.150 0.040 --- --- 
Table 3.X. Weight fraction of the various elements in Sr-Si-MCHA powder.  
wt% of the elements on the apatite phase 
Sample 
Ca P Si CO3 Mg Sr 
Sr-Si-MCHA 35.9 15.9 0.20 3.70 2.03 6.6 
Si-MCHA-2 38.9 16.6 0.42 4.9 1.08 --- 
3.5 In vitro tests 
3.5.1 Proliferation tests on Si-HA characterized by different silicon content  
The evaluation of the effect of silicon on the cell proliferation in vitro using normal 
human osteoblasts as cellular model, was performed in collaboration with University of 
Parma, Department of Experimental Medicine, Histology Section.  
The SiHA has been studied in the form of as-synthesised powders to choose the most 
critical conditions for the test (highest specific surface area of the material, thus highest 
reactivity conditions and ion release). The effect on the cells proliferation of different level 
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of silicon in Si-HA powders has been explored; in particular powders containing a 
biological amount (SibHA, like Si-HA-1) and the half value of the biological amount 
(Sib/2HA) have been considered. The effect of the modification of the surface hydration 
consequent to the sintering process has also been investigated. Preliminary results showed 
that the as-synthesised HA powder substituted with the higher amount of Si and the 
sintered Si-HA were both toxic: the viability test (MTT) showed value lower than 20% 
compared to the control (100%) after 7 days. Cells observed at SEM showed high levels of 
sufferance. This is apparently in contrast to the results obtained by Botelho et al.27, but in 
that study HA substituted with biological amount of Si in the form of dense pellet was 
analysed; thus, the reactivity and the biomaterial-cell interactive surface was highly lower 
and the test conditions less critical than in our case. Sib/2HA showed a viability of about 
75% , indicating a reduction of the proliferation compared to the control. However this was 
not due to toxicity but to involvement of cells in production activities. The ALP (alkaline 
phosphatase) test indicative of  the osteoblast activity in the bone formation and 
regeneration, gave lower value compared to the control but high proteins levels, 
proportional to the number of cells have been detected. Thus the lower proliferation value 
can be related to the positive effect of Sib/2-HA on the proteins of the matrix. Further 
investigation are in progress to assess what is the protein specifically involved (collagen?) 
and if new apatite nuclei will be synthesized by cells. 
3.5.2 Cytotoxicity of multi-substituted HA powders 
HA powders characterized by different simultaneous biomimetic substitution, i.e. 
carbonate, magnesium and silicon, can rightly be considered as very interesting and 
promising biomaterials for resorbable bone substitutes. Once assessed the biomimetic 
chemistry of the synthetic apatites, a subsequent step is the investigation of the cellular 
response, when in contact with surface of HA powder. Granulates of MHA and MCHA 
have been previously tested in vitro and in vivo and their improved performance compared 
to stoichiometric HA28,29, induced by Mg and even more by co-substitution of Mg and 
CO3, well assessed. 
Si-MCHA-2 was selected as optimum material to be investigated by means of cytotoxicity 
test. The test was performed on the as-obtained material, after granulation between 400 and 
600 μm, in similar way as in solubility tests; the reason for this choice is that granulated 
powder is currently employed as a bone filler, characterized by a high specific surface, i.e. 
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reactivity, thus the present test is a natural prologue to the in vivo experiments on animals. 
The tests were performed by the certified company BioLab SpA1. 
4 g of granulate was soaked into 20 ml of a culture medium, containing NCTC L929 
fibroblast cells, in order to have a weight / volume ratio of 0.2 g/ml. The sample was 
incubated for 72 hours at 37 ±1 °C. After centrifugation, 2 ml of the extract were put in 
contact with the cultivated cells for 48 hours at 37±1 °C, in CO2-containing air. After 24 
and 48 hours, the cultivated cells were examined by optical microscopy to assess the cell 
activity.  
After 24 and 48 hours of incubation, a low cellular activity was detected, corresponding to 
less than 20% of cells not presenting intracytoplasmatic granulations. In consequence of 
this, the investigated powder can be considered as slightly cytotoxic. 
The results of cytotoxicity tests show that the granulate is bio-tolerated, as the cell 
reactivity was weak; the powder under investigation was characterized by optimal amount 
of magnesium, carbonate and silicon, and the results of this test suggests that the overall 
amount of released doping ions can be in excess compared to the needs of the cell culture. 
Anyway the behaviour of the biomaterial can be very different after in vivo implantation 
and the granulate can express good bioactivity and bone regeneration. This assumption has 
been verified in other cases, i.e. a material giving cell iperstimulation in vitro corresponded 
to very good behaviour in vivo; this is reasonable, as in vitro systems are static while the in 
vivo environment is dynamic, experiencing continuous flow and renewal of fluids. 
Thus, further investigation shall be devoted to in vivo implantation of multi-substituted 
HA-based granulates for assessing the increased bioactivity and bio-resorbability. 
3.6 Conclusions 
Multi-substituted hydroxyapatite powders exhibiting very different chemical 
composition were successfully synthesized. The synthesis technique here employed was 
not difficult, not expensive and allowed to produce large amounts of powder; the 
substituting ions were introduced as soluble salts, while counter-ions eliminated (Cl-, Na+, 
NO3-, etc…) during powder washing and not incorporated in the HA structure. 
In almost all cases, HA formed as the only crystalline phase, and the substituting ions were 
detected in biologic amounts or more abundant, so that the contemporary presence of many 
                                                 
1 BioLab SpA, Via B. Buozzi, 2 20090 Vimodrone, Milano, Italy 
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foreign ions in the range of biomimetic composition is achievable. The comparison 
between the introduced and the actually found substituting ions in the different HA 
powders revealed their competition in occupying the same crystallographic site of calcium 
and phosphorus. The actual presence of the foreign ions in the HA structure was also 
demonstrated by their different solubility behaviour: carbonate confirmed to be the most 
important ion for the increase of HA dissolution in SBF; silicon and magnesium were 
continuously released over a long period of time, so that their presence in the extracellular 
matrix can provide enhancement of the new bone formation and adhesion. Silicon and 
magnesium showed to mutually stabilize in the HA structure; the reason for this behaviour 
is still not investigated, but it can be supposed that complexes containing these two ions 
can form as amorphous moieties on the HA surface. The influence of the different ions on 
the kinetic of their release in physiological environment is as well an important 
phenomenon to investigate, as the kinetic of ion release can influence the cellular response 
in vivo; a careful study of the surface state of HA powders is thus needed, for this purpose. 
Finally, cytotoxicity tests, carried out in vitro on silicon-magnesium-carbonated HA, 
demonstrated that these materials are feasible for the development of bone fillers or 
materials for drug dispensers, even though a careful set-up of the overall phase 
composition of the powder can be needed, in order to avoid an excess of ions in contact 
with the extracellular matrix, with respect to the cell needs. 
Three-dimensional ceramic bodies are needed to substitute whole portions of bone, 
including the ones subject to mechanical loads; for this reason, the thermal behaviour of 
multi-substituted HA powder was investigated, evidencing some limitations to the 
employment of these materials in high temperature treatments. Nevertheless, the 
stabilization of the HA structure, due to the mutual effect of different doping ions, opens 
the way to a possible achievement of sintered HA, characterized by the presence of 
different substituting ions in its structure. 
In alternative, it is possible in principle to obtain consolidated bodies made with substituted 
HA by solid state reaction at high temperature between stoichiometric HA and a ceramic 
phase containing biomimetic ions. The development of such composite materials will be 
possible if no secondary calcium phosphates will form during the sintering of the mixture, 
altering the phase composition and bioactive properties in an unpredictable manner. The 
resulting material should exhibit good biomimetic properties, to ensure a proper activation 
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of the bone remodelling processes, so that the secondary phase added to HA should also 
exhibit bioactive properties. 
Thus, following the development of biomimetic HA powders to be used as-prepared in 
bone filling surgery, the future research in this field will be mainly addressed in the 
obtainment of sintered HA, characterized by an adequate level of doping and a minimal 
formation of secondary phases. 
In the next Chapter the development of bioactive composites made by HA and calcium 
silicates will be discussed, taking advantage of the bioactive properties of calcium silicates 
and their higher mechanical strength compared with HA, so to be promising for the 
development of load-bearing bioactive / bioresorbable bone implants. 
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CHAPTER 4 
 
DEVELOPMENT OF REINFORCED  
HA-BASED BIOMATERIALS 
4.1 Need of reinforced bone substitutes 
In Chapter 3, it has been shown that multi-substituted HA powders exhibit a 
reduced structural stability, leading to a higher extent of ion dissolution in SBF and phase 
decomposition during thermal treatments. Although these features are positive for the 
biomimetic behaviour of the multi-substituted HA, their employment to produce 
consolidated 3D bone scaffolds is more difficult, due to secondary phase formation. 
The development of a porous bone scaffold exhibiting a high degree of biomimetism is 
nowadays strongly required for the replacement of diseased portions of bone. Biomimetism 
should be exhibited through different perspectives, i.e. biochemical, morpho-structural and 
mechanical. 
Chemically, a bone scaffold must be bioactive, so to stimulate the remodelling processes at 
the interface with the physiological environment, and bioreabsorbable, so that during the 
osteoblasts activity of new bone formation, the scaffold should be progressively reabsorbed 
by the osteoclasts and completely integrated into the newly grown bone. 
Moreover, a scaffold must be also osteoconductive and cells have to proliferate inside the 
pores and habit the whole scaffold volume; this feature is mainly controlled by the 
morphological architecture of the scaffold, which is to be designed in an accurate way, to 
ensure its full habitation by cells. 
The morphological features also influence the mechanical performances of the scaffold, 
when subject to the biomechanical loads; in fact, bone structure is hierarchically organized 
(see Fig. 1.5) and this feature allows to distribute the mechanical stresses along a huge 
number of small trabeculae, which can be more easily replaced after their breaking. The 
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mechanical behaviour of a scaffold is thus very dependent on its morphology, but also on 
the intrinsic mechanical resistance of the material, constituting the scaffold itself. 
This concept is of importance, especially in case of development of dense materials, for 
which a high number of clinical applications is addressed (endomedullar nails for long 
bones). 
Dense HA is characterized by a fracture toughness slightly below the lower limit of 
cortical bone (see Table 4.I); Conversely, Young modulus is typically higher1 and the 
flexural strength is limited to ∼80 MPa2-6, unless the samples are well polished before 
mechanical testing7-9, so not useful for load-bearing applications, involving long bones like 
femur. 
Table 4.I. Main mechanical properties of HA compared to cortical bone. 
 
Fracture 
toughness 
(MPa·m½) 
Bending 
strength (MPa) 
Young 
modulus 
(GPa) 
Compressive 
strength (MPa) 
Cortical bone 2-12 50-150 7-25 100-230 
HA ∼ 1.0 ≤ 100 80-110 500-1000 
Many attempts have been performed to develop composite materials for applications as 
bone scaffolds, characterized by improved mechanical behaviour; ceramic composites for 
bone scaffolds were obtained in a series of different compositions, e.g. bioglasses1,10, HA + 
ZrO211-13, HA + Al2O3 and other highly resistant ceramics14-17. 
The problems arising when developing such materials mainly concern phase 
decomposition, due to the chemical interactions between HA and the reinforcing phases at 
high temperatures; in these cases, HA largely decomposes in β- and α-TCP and, although 
in many cases the presence of zirconia raises the mechanical resistance of the composite, 
secondary phases form and alters the degree of bioactivity and bioreabsorbability of HA, as 
they are characterized by a higher solubility behaviour; moreover, the formation of α-TCP 
yields a volume increase in the ceramic body, compared with HA, and it can induce micro-
cracks in the final scaffold. 
The ceramic materials exhibiting high mechanical strength usually sinter at higher 
temperatures compared to HA, thus to achieve a complete sintering of the material, 
temperature must be raised well above 1200-1300 °C, usually up to 1500 °C. At these 
temperatures the extent of HA decomposition is huge, with formation of phases stable at 
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high temperatures like α-TCP and tetracalcium phosphate (TeCP), and in some cases an 
incongruent melting of HA can be observed. 
Another inconvenient arising with ceramic composites is that in most of the cases the 
higher thermal stability of the reinforcing phases is also coupled with a higher chemical 
stability, so that the reinforcement behaves as a bioinert body, which in some cases can 
also be bioactive, as it can induce the formation of a HA layer on its surface18-20, but it can 
not be reabsorbed by osteoclasts neither in the long term. 
The main limitations to the development of an ideal 3D bone scaffold are so due to the 
difficulty to obtain a material exhibiting bioactivity, bioreabsorbability and mechanical 
resistance in the meantime. 
HA is considered the election material for bone scaffolds, but the incorporation of 
biomimetic foreign ions in its structure is needed, although it determines a higher 
instability, and the mechanical performances have to be increased by the presence of a 
reinforcing phase, which should be bioactive at least. 
4.2 Calcium silicates as biomaterials 
Calcium silicates were studied as biomaterials for hard tissue repair and 
replacement since the early 1970s, when Hench and co-workers discovered Bioglass®21. 
Various types of silicate glasses and glass-ceramics such as bioactive glasses22-25, and 
wollastonite-based glass-ceramics26-30, have been investigated; the results showed that 
biomaterials containing CaO–SiO2 appeared to have excellent bioactivity and were found 
to bond to living bone and soft tissue, through the development of a biologic HA layer on 
their surface. Another study illustrates the analogies between the hydration behaviour of 
calcium silicates and calcium phosphates31, when forming the calcium silicate hydrated 
(xCaO⋅SiO2⋅nH2O,  0.833<x<z1.7) and HA phase respectively. The analogies in the 
hydration behaviour are significant, as the very early modifications of the implant surface, 
when in vivo it is in contact with the physiological environment, are determinant for the 
development of the HA layer, and the adhesion of proteins and other growing factors. 
Recent studies showed that some calcium silicate ceramics such as wollastonite and 
pseudowollastonite32-39 also have excellent bioactivity and are potential candidates of new 
biomaterials for hard tissue repair. Furthermore, Lamy40 and Liu41 have shown that 
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dicalcium silicate (Ca2SiO4) as plasma sprayed coating on titanium alloys substrates 
exhibited very good bioactivity.  
Further studies have shown that pure CaSiO3 powders and 3D ceramics were highly 
bioactive and induced formation of a hydroxyapatite layer on their surface after soaking in 
simulated body fluid (SBF)32,39,42,43 or in human saliva33.  
Tricalcium silicate Ca3SiO5, the main raw material used to elaborate paste in Portland 
cement (the most common in house building), was found to possess ability of HA 
formation and consolidation with spontaneous development of strength (spontaneous 
consolidation) towards water, so that it might be used as a self-setting bioactive cement44.  
Amorphous calcium silicates were also investigated, showing an increased solubility 
compared to crystalline calcium silicates45. 
All these materials were investigated for their intrinsic mechanical properties also46-48; 
Long48 obtained samples by using a high-speed sintering technique, characterized by high 
density and a bending strength of nearly 300 MPa. Table 4.II shows a comparison between 
the main mechanical features of some investigated calcium silicates, HA and cortical bone. 
Table 4.II. Mechanical properties of different bioactive calcium silicates in comparison with 
cortical bone. 
Material KIC (MPa m½) E (GPa) σb (MPa) 
Ca3SiO5 44 ∼2 ∼40 ∼100 
Ca2SiO4 47 ∼2 ∼40 ∼200 
CaSiO3 48 ∼2 ∼40-50 ∼300 
Ca7MgSi4O16 49 ∼1.6 ∼40-50 ~150 
CaMgSi2O6 50 3.5 170 ∼300 
Cortical bone51 ∼ 2 - 12 7-30 50-150 
All these materials exhibit different levels of mechanical strength and similar values of 
fracture toughness; among them, calcium disilicate (Ca2SiO4) was finally selected as a 
reinforcing phase for composites with HA. 
Silico-carnotite, a silico-phosphate phase of composition similar to that of HA 
(Ca5(PO4)2SiO4) was also selected as a potential material to be mixed with stoichiometric 
HA. In fact, as multi-substituted HAs are not optimal for sintering in standard conditions, 
stoichiometric HA must be used for this purpose; anyway, stoichiometric HA has a limited 
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bioactivity in vivo, but the overall biomimetism of the composite could be improved, even 
after sintering, by the presence of a phase exhibiting similar composition as HA and 
containing some of ions considered influent in the new bone formation and remodelling 
processes (Mg, Si, CO3). 
Thus, the employment of bioactive calcium silicates in composite with HA has two 
different potential advantages: 1) the possible increase of the mechanical performance of 
HA-based implants; 2) the increase of the biomimetism of stoichiometric HA by doping its 
structure during sintering. 
4.3 Development of composites HA / silico-carnotite (Ca5(PO4)2SiO4) 
4.3.1 Powder synthesis and preparation of mixtures 
The crystal structure of silico-carnotite is well known and the related ICDD file 
also contains the procedure for synthesising the pure phase (ICDD card n° 40-393). 
Thus, following the synthesis procedure there indicated, 300 g of Ca(NO3)2 ⋅ 4H2O were 
put in a beaker with 300 ml of deionized H2O, after 15.11 g of amorphous silica were 
added, under continuous stirring. A solution was prepared by dissolving 58.01 g of 
ortophosphoric acid (in aqueous solution 85 %) in 150 ml of deionized water and dripped 
into the calcium-silicate suspension (all reactants were provided by Sigma-Aldrich (S. 
Louis, MO, USA). 
The suspension was kept under stirring and the temperature was raised to 95 °C, until, after 
few hours, water completely evaporated and a gel formed. The gel was calcined at 700 °C 
for 2 hours, obtaining a fine precursor powder; the precursor powder was finally treated at 
1600 °C for 30 minutes, followed by a step at 1420 °C for 9 hours and finally quenched in 
air; the quenching of samples was achieved by using a expressly devoted elevator furnace. 
As silico-carnotite is a material devoted to improve the mechanical strength of HA-based 
bioactive composites, the sintering behaviour of silico-carnotite was investigated by 
thermal treatments in the range 900-1400 °C for 1 hour in air. 
After, mixtures of stoichiometric HA and silico-carnotite in different proportions (5-50 
wt%) were prepared, by using polyethylene jars filled with the powders, in water and using 
zirconia grinding media. The mixing was prolonged for 24 hours and after water was 
eliminated by centrifugation and the final powder was dried at 80 °C in a ventilated oven 
and sieved under 150 μm. 
 125
Chapter 4. Development of Reinforced HA-based Biomaterials 
⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ 
 
The powder mixtures were pressed in pellets and sintered at 1250 °C for 1 hour, following 
the typical sintering cycle employed for HA; the resulting samples were analyzed by XRD 
and the microstructure examined by SEM-EDS. For this purpose, the sintered pellets were 
cut and polished up to a grain size of 0.25 μm; after a chemical etching of HCl 1M for 5 
seconds was applied to selectively attack the grains boundaries and make them visible 
under SEM observation.  
4.3.2 Characterization 
Fig. 4.1 shows the XRD spectrum of the powder precursor of silico-carnotite phase, 
obtained after calcinations of the gel at 700 °C. The crystalline phases present in the 
powder were identified as mainly HA and a calcium silicate identified as Ca5(SiO4)2(OH)2 
(mineral name: Reinhardbraunsite, ICDD n° 29-0380); a small amount of calcium oxide 
(ICDD n° 37-1497) was also detected. 
 
Figure 4.1. XRD spectrum of the calcined gel, precursor of silico-carnotite phase. 
After the thermal treatment at high temperature and rapid quenching, the obtained powder 
is nearly pure silico-carnotite (Fig. 4.2), with some impurities identified as Ca3Si3O8(OH)2, 
a mineral known as Rosenhahnite (ICDD n° 29-0378). 
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Figure 4.2. XRD spectrum of the calcined gel after the thermal treatment of transformation 
in silico-carnotite phase. 
The phase composition of the powder after firing in the range 900-1400 °C was obtained 
by XRD analysis and showed in Fig. 4.3. The semiquantitative analysis of the amount of 
the phases formed during the thermal cycles was evaluated on the basis of the intensity of 
XRD peaks, normalized on the basis of the scattering power of each phase. It was found 
that silico-carnotite is stable in air only up to 900 °C; at 1000 °C about 30 % of TCP 
formed, which increased up to ∼60% at 1200 °C, and also HA phase formed. At 1400 °C, 
silico-carnotite completely disappeared and β-CaSiO3 (wollastonite) formed. 
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Figure 4.3. Decomposition of silico-carnotite after firing at different temperatures. 
Thus, although silico-carnotite was synthesized by thermal treatment at a very high 
temperature, reaching 1600 °C, further heating, even at only 1000 °C, provoked phase 
decomposition in a large extent. This behaviour can be explained, as the synthesis of silico-
carnotite phase occurred after rapid quenching in air from 1420 °C; thus, it is reasonable to 
conclude that the slow cooling of the silico-carnotite sample in air allowed the 
recrystallization of secondary phases, like HA and TCP. 
Fig. 4.4 shows the phase composition of mixtures HA / silico-carnotite after sintering at 
1250 °C for 1 hour, obtained by XRD analysis. In concentration up to 10%, only HA phase 
was recognized and very small amount of β-TCP formed. In higher concentrations β-TCP 
increased and silico-carnotite started to form; in concentrations of 50 % the peaks of silico-
carnotite were well visible and also α-TCP formed, so that HA became a minor phase. 
The absence of the characteristic XRD peaks of silico-carnotite drives to the conclusion 
that a reaction between the two phases can have occurred, as following: 
) , 22(242641024441026410 )()()()()()()()1( xxx OHSiOPOCaSiOPOxCaOHPOCax −−→+−
giving rise to a silicon-substituted HA. 
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Figure 4.4. XRD spectra of mixtures HA-silicocarnotite after sintering at 1250 °C. 
In this case, the maximum amount of silico-carnotite able to dissolve into the HA matrix 
corresponds to a x value of ≈ 0.2. 
The formation of β-TCP after sintering can be induced by the presence of silico-carnotite; 
this finding is confirmed by the increase of β-TCP by raising the content in silico-carnotite. 
The analysis by SEM confirmed this assumption. Fig. 4.5 show the SEM micrographs of 
the polished and etched surfaces: EDS analysis was performed on a high number of grains, 
revealing the overall presence of silicon with similar concentrations, in particular in the 
sample containing 10% of silico-carnotite the amount of silicon is 0.46 wt% (0.39 at%). 
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Figure 4.5. Microstructure of HA pure and doped with different amounts of silico-carnotite: 
a) 5%; b) 10%, c) 20%; d) 50%. 
4.3.3 Cytotoxicity tests 
As shown in the previous section, the mixture HA / silico-carnotite (20 wt%), 
sintered at 1250 °C for 1 hour yielded a material made by HA characterized by the 
presence of silicon in physiological amounts, and no residual silico-carnotite was detected. 
This material, exhibiting improved biomimetic behaviour, is promising for application as a 
bone substitute and thus, a toxicological test was performed to assess its biocompatibility / 
cytotoxicity. The cytotoxicity test was performed on the sintered material, dusted below 
150 μm: 1 g of powder was soaked into 5 ml of a culture medium, containing NCTC L929 
fibroblast cells, in order to have a weight / volume ratio of 0.2 g/ml. The sample was 
incubated for 72 hours at 37 ± 1 °C. After centrifugation, 2 ml of the extract were put in 
contact with the cultivated cells for 48 hours at 37 ± 1 °C, in CO2-containing air. After 24 
and 48 hours, the cultivated cells were examined by optical microscopy to assess the cell 
activity. The tests were performed by the company BioLab SpA*. 
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After 24 and 48 hours, no cellular reactivity was detected; in particular, some small intra-
cytoplasmatic granulations were observed and no cellular lysis occurred. In consequence of 
the substantially absence of cellular reactivity, the powder under investigation can be 
considered as not cytotoxic. 
4.4 Development of composites HA / β, γ-Ca2SiO4 
4.4.1 Structure and phase stability in calcium disilicate system 
Dicalcium silicate (Ca2SiO4) can exist in five polymorphic forms under ambient 
conditions52. Fig. 4.6 shows the transformation temperatures and the related volume 
changes; the most notable feature in this scheme is the transition βÆγ, occurring during 
cooling from high temperatures. Thus, following a thermal treatment, a three-dimensional 
ceramic body made by γ-Ca2SiO4 would undergo to a complete cracking during cooling, 
due to the huge volume cell variation (∼12 %); this feature may hamper the development 
of composite materials including γ-Ca2SiO4 phase.  
 
Figure 4.6. Polymorphic transformations of Ca2SiO4 53. 
Anyway, previous studies show that some physical-chemical effects can stabilize the 
monoclinic β-polymorph after cooling53; these phenomena include particle size effect and 
matrix effect. In the first case, a reduced particle size, less than a critical value, would 
stabilize γ-polymorph after cooling from high temperatures; the second case is related to 
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the presence of a matrix which stabilizes γ-phase, due to the physical constrain exerted by 
the matrix itself, which hamper the volume expansion occurring in the βÆγ 
transformation. The critical size of the γ-Ca2SiO4 for the retaining of β-polymorph after 
cooling is disputed: Chan53 reported a value of ∼ 10 μm, while Hong54 found a critical 
value of <∼2 μm. 
4.4.2 Synthesis of β and γ-Ca2SiO4 
The synthesis of Ca2SiO4 phases was performed as following: β-Ca2SiO4 was 
synthesized by mixing 100 g of Ca(OH)2 and 38.5 g of amorphous silica in 400 ml of 
deionized H2O; the temperature was raised at 95 °C under vigorous stirring for 6 hours. 
After the process, the water was eliminated by centrifuging and the powder was dried at 80 
°C in a ventilated oven; then put in a platinum crucible and fired at 1500 °C for 2 hours, 
prior quenching in air. 
XRD analysis (Fig. 4.7) confirmed that pure β-Ca2SiO4 phase was obtained (ICDD card n° 
49-1673). 
 
Figure 4.7. XRD spectrum of as-synthesized β-Ca2SiO4. 
γ-Ca2SiO4 was synthesized by following the procedure described in Gou et al.55, so 
employing microcrystalline quartz as a silicon source. In detail, 100 g of Ca(OH)2 were put 
in 1 litre of deionized H2O and stirred while temperature increased up to 95 °C; then, 
quartz was introduced in the reaction flask and stirred for 4 hours; finally, centrifugation, 
drying and sintering at 1450 °C for 2 hours with slow cooling in air. XRD analysis 
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confirmed that pure γ-Ca2SiO4 phase was obtained (Fig. 4.8), exhibiting some 
crystallographic orientations (ICDD card n° 49-1672). 
 
 
Figure 4.8. XRD spectrum of as-synthesized γ-Ca2SiO4. 
4.4.3 Preliminary sintering tests 
In view of the densification of composite ceramics with HA, preliminary sintering 
tests were carried out in air, in the range 1200-1500 °C. HA powder was mixed with γ-
Ca2SiO4 in proportion 80:20 in weight and small pellets were formed by uniaxial pressing 
of the powder mixture; the dwell time at the final temperature was set at 30 minutes, with 
the purpose of investigating the reactivity of HA at high temperatures when mixed with  γ-
Ca2SiO4. Finally, samples spontaneously cooled into the furnace. 
The resulting samples were investigated by XRD (Fig. 4.9): after sintering at 1200 °C, the 
crystalline phases detected were HA, silico-carnotite and β-Ca2SiO4. It is remarkable that 
no TCP, nor TeCP formed after sintering at so high temperatures; the XRD peaks 
belonging to HA are narrow up to 1300 °C and start to broaden at higher temperatures, this 
indicates a lose in HA crystallinity, due to the increasing instability of the HA structure 
above 1400 °C. 
Silico-carnotite started to form at 1300 °C, while γ-Ca2SiO4 completely disappeared 
already at 1200 °C; the main evidence of the disappearance of γ-Ca2SiO4 is in the absence 
of the strong reflection at d=3.013 nm, corresponding to a diffraction angle of 29.624 
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degrees in 2θ. There are some evidence of formation of β-Ca2SiO4, which can be due to 
phenomena of phase stabilization occurred during cooling, as stated above. 
Anyway, silico-carnotite formed in increasing amount as higher the sintering temperature, 
and after sintering above 1200 °C, calcium disilicate is no more detected by XRD.  
 
Figure 4.9. Phase composition of mixture HA-γ-Ca2SiO4 after sintering in air at different 
temperatures. 
4.5 Development of dense ceramic composites by Fast Hot Pressing 
(FHP) 
The sintering of ceramic composites HA-calcium silicates proved to be feasible 
even at temperatures high as 1500 °C: HA phase did not decompose in undesired 
secondary phases like TCP and although a phase transformation of the calcium silicate 
actually occurs above 1300 °C, the newly formed silico-phosphate (silico-carnotite) is 
interesting for its similarity to HA in composition; moreover, it proved to be not cytotoxic, 
after reaction with HA, and also showed the capability to dissolve in solution with HA, 
giving a silicon-substituted HA phase. 
Alternative procedures to obtain dense ceramic bodies were attempted by employing a 
sintering technique characterized by high heating rates and short dwell times. This 
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technique consisted in the employment of a furnace where heating was produced by a high 
frequency current induced in a coil (see Fig. 4.10). The coil surrounds a graphite matrix, 
which consists in a hollow cylinder filled with the ceramic powder, at the two sides two 
graphite punches can exert a pressure up to 30 MPa (Fast Hot Pressing, FHP). The raise of 
the temperature was controlled by varying the electric field at the basis of the currents 
induced in the graphite matrix, which provoked the heating of the sample; the sample 
temperature was monitored by a pyrometer, and the punches were connected to a 
transducer so that the shrinkage of the sample during heating could be recorded. 
 
Figure 4.10. Scheme of the equipment for FHP. 
The adoption of an applied pressure and the short dwell times can contribute to a higher 
extent of sample densification and a reduction of grain growth occurring at high 
temperatures; both these features can contribute to raise the final mechanical resistance. 
Thus, a series of experiments were performed both with pure stoichiometric HA powder 
and a powder mixture HA-γ-Ca2SiO4, to investigate whether the presence of a reinforcing 
phase can actually raise the mechanical strength of the final ceramic body.  
4.5.1 Sample preparation 
The FHP experiments were carried out by filling the graphite matrix (see the 
scheme in Fig. 4.11) with ceramic powders in different amounts (25-60 g); the chamber 
was closed, evacuated by rotary pump (base pressure ≈ 1 Pa) and temperature was raised at 
different heating rates (between 30 and 100 °C/min) and applying different applied 
pressure (1-30 MPa), up to final temperatures ranging between 1250 and 1500 °C. The 
recording of the sample shrinkage allowed to in situ assess the progress of the densification 
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process, so the dwell times at the final sintering temperature were set up accordingly, 
generally in the range of few minutes. 
 
Figure 4.11. Sample preparation for FHP experiments. 
After cooling, the sintered piece was extracted and cut by a low-speed saw. 
XRD analysis was performed on the surface of the sectioned sample, Archimede’ s method 
was also employed for measuring the sample density. The density was referred to the 
theoretical density of HA which can be calculated by the volume cell and the weight of the 
atoms therein present, which is ≈3.16 g⋅cm-3. SEM observations were performed on the 
internal surfaces of the samples after polishing at 0.25 μm and chemical etching to put in 
evidence the grain boundaries. 
4.5.2 Sample characterization 
HA powder was treated by FHP at temperatures up to 1500 °C; the XRD analysis 
of the obtained samples put in evidence a very important result: even after sintering at 
1500 °C, HA phase was found as the only crystalline phase and no other calcium 
phosphates were present (Fig. 4.12). The crystallinity of the sample strongly decreased at 
temperatures higher than 1300 °C, as evident by the peak broadening and the reduction of 
the intensity; it is possible that the high speed of the sintering process and the vacuum have 
retarded the decomposition of HA, and this proves that FHP process was suitable to 
produce HA bodies sintered at 1500 °C without phase decomposition. 
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Figure 4.12. XRD spectra of stoichiometric HA heat treated by FHP. 
Experiments performed with different amounts of powder (30-60 g), heating rates, applied 
pressure and final temperatures (Table 4.III) gave rise to similar results, in terms of HA 
stability, thus all the investigated samples did not exhibit any phase decomposition, 
according to Fig. 4.12. 
Table 4.III. Comparison between different FHP treatments performed on HA powder. 
Experiment Applied pressure 
(MPa) 
Thermal cycle Heating rate  
(°C·min-1) 
Density 
(g·cm-3) 
F1 30 1500 °C x 1’ 100 2.60 
F2 10 1500 °C x 1’ 50 2.69 
F3 5 1500 °C x 3’ 50 2.96 
     
F4 1.5 1500 °C x 12’ 100 2.95 
F5 1.5 1500 °C x 12’ 50 2.83 
F6 1.5 1500 °C x 1’ 30 2.93 
     
F7 30 1400 °C x 1’ 100 2.78 
F8 1.5 1400 °C x 15’ 100 2.92 
F9 1.5 1400 °C x 18’ 50 2.98 
F10 1.5 1400 °C x 18’ 30 2.94 
     
F11 1.5 1300 °C x 46’  100 2.79 
F12 1.5 1300 °C x 40’ 50 2.76 
F13 1.5 1300 °C x 40’ 30 2.70   
F14 1.5 1200 °C x 50’ 50 2.43 
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The experiments carried out at 1500 °C (F1-F6) under different applied pressures show 
that a higher density is achieved as the applied pressure decreased. Moreover, an extended 
delamination occurred in the macro-structure of the sintered bodies under high pressure 
applied, also confirmed by SEM investigations (Fig. 4.13), so that a minimal pressure is 
recommended to achieve homogeneous sintered HA bodies. A pressure of ~1.5 MPa was 
finally selected, as it allowed to obtain structurally homogeneous products and the 
shrinkage behaviour could be recorded so to stop the heating when the densification was 
completed. 
 
Figure 4.13. Delamination occurring during FHP of HA under excessive applied pressure. 
The investigation of the final density values in comparison with the heating rates (Tab. 
4.III) reveals that a higher density can be achieved through a slower heating of the sample; 
in this condition, the heat gradient inside the HA powder is less pronounced and the 
microstructure of the final body is more uniform. In fact, in the sintering process, as the 
temperature is raised, HA particles start to coalesce and subsequently grow, filling the 
voids and leading to a volume reduction of the sample. After the densification is complete, 
the large HA grains start to grow at the expenses of the smallest ones; this process is 
accelerated at higher temperatures and prolonged permanence, leading to a decrease of the 
mechanical strength. In Fig. 4.14 the microstructure of different areas of the same sample 
is showed, exhibiting a different grain size, due to an excessive heating rate (100 °C/min). 
The external part exhibited a much higher grain size compared to the internal part, due to 
the heat flux from the graphite matrix inwardly, leading to a strong anisotropy in the 
heating of the whole body: the low thermal conductivity of the ceramic did not allow an 
uniform heating of the powder in a short time and thus, the employment of too high 
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heating rates and short dwell times revealed not adequate for the sintering of a high mass 
of powder.  
 
Figure 4.14. Different grain growth in external (a) and internal part (b) of a HA sample 
heated at 1500 °C (100 °C/min). 
Moreover, the same effect was obtained, by increasing the amount of powder employed in 
the experiment, so increasing the sample mass with a reduced heating rate; a similar 
anisotropy was detected, confirming that a careful control of the heat flow inside the 
sample is strongly required to achieve homogeneous materials. 
The best results in term of sample homogeneity and density were achieved by limiting the 
heating rate at ≈30 °C/min and the mass of HA powder to about 25-30 g; these parameters 
were applied in a series of experiments devoted to obtain dense HA and composite samples 
for the test of their mechanical properties. 
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4.6 Mechanical characterization of HA and composite ceramics  
4.6.1 Sample preparation and mechanical testing 
The main purposes for obtaining ceramic composites is the improvement of the 
mechanical behaviour of the bioceramics, compared to HA, and the maintenance of a 
phase composition with a high degree of bioactivity / bioreabsorbability; for this reason, a 
series of HA pellets were obtained by sintering at 1300-1500 °C. 
Composite bodies were also prepared, starting with γ-Ca2SiO4 as reinforcement; γ-Ca2SiO4 
was synthesized following the above described procedure and mixed with HA powder; an 
initial concentration of 20 wt% was chosen for the first experiments. The specific surface 
area of the two powders was measured by BET method, and they resulted comparable 
(HA: 3.93; γ-Ca2SiO4: 3.62 m2/g). The two powders were mixed in a polyethylene jar with 
water and zirconia grinding media for 24 hours; the water was eliminated by freeze drying 
and the final powder dried and sieved under 150 μm. 
Batches of 25-30 g of powder mixture were sintered through FHP at the same conditions as 
HA, the only difference was in the dwell times at the final temperature (Table 4.IV), as this 
parameter depended only on the end of the sample shrinkage, obtained by the continuously 
recording of the shrinkage curve. The presence of the reinforcing phase induced 
differences in the shrinkage kinetics of HA. A reference sample was also prepared, by 
sintering pure γ-Ca2SiO4 powder at 1500 °C. Apart from this latter sample, hot-pressed at 
30 MPa, all samples were obtained under a pressure of ∼1.5 MPa. 
Table 4.IV. Samples to be mechanically tested obtained by FHP. 
Material T (°C) Dwell(min) Density(g·cm-3) Rel. Density 
HA 1300 °C 40 2.76 0.87 
HA 1400 °C 18 2.98 0.94 
HA 1500 °C 3 2.93 0.93 
γ-Ca2SiO4 1500 °C 2 3.17 0.96 
HA+ γ-Ca2SiO4 1300 °C 39 2.30 0.72 
HA+ γ-Ca2SiO4 1400 °C 33 2.83 0.89 
HA+ γ-Ca2SiO4 1500 °C 12 3.03 0.95 
After sintering, the samples were characterized by XRD, density measurement and SEM 
observations; a mechanical characterization was also performed, in order to assess whether 
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the presence of the reinforcing phase was effective. The main property investigated was the 
material resistance to the flexure: this measurement was carried out by obtaining rectified 
bar in a defined size (in our case, they were 25 x 2 x 2.5 mm) from the sintered samples; 
the bars were subjected to flexure under an increasing pressure up to rupture (see Fig. 4.15) 
and the recorded stress-deformation profile can give information on the elastic properties 
of the material.  
 
Figure 4.15. Scheme of the flexural strength test performed on sample bars. 
The actual point of rupture gives information on the flexural strength of the material. This 
property is not only related to the intrinsic microstructural features of the sample, as the 
starting point of the rupture is always a crack occurring at a defect size (pore, flaw, etc…), 
thus a careful preparation of the samples is of great importance. Anyway, the assessment of 
flexural strength is of great relevance in view of the possible clinical applications: in order 
to implant a bone substitute in a load-bearing site without any external fixation (which has 
to be removed in a second, painful, surgical intervention), the scaffold must bear the 
biomechanical loads which in vivo normally occur in that site [Ritchie]. A wider 
mechanical characterization was performed, by analysing some selected materials by 
nanoindentation methods. In these measurements, a nanosized Berkovich indenter (see Fig. 
4.16) exerted a pressure of 50 mN on several points of the polished sample surface. 
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Figure 4.16. Geometry of a Berkovich indenter tip. 
The load-displacement curves (Fig. 4.17) were built during load and unload and analyzed 
for the achievement of the elastic modulus of the material.  
 
 
Figure 4.17. Example of a load-displacement curve during loading and unloading. 
The elastic modulus found by the analysis of the load-displacement curves in the flexural 
strength tests is related to the behaviour of the overall sample; in fact the response of the 
bar to the mechanical solicitation is influenced by the microstructure of the whole sample, 
included pores and flaws. Conversely, the elastic modulus found by nanoindentation tests 
is related to the investigation of very smaller volume (few μm3), so that the response is 
independent on the macroscopic defects of the sample but it is more related to the intrinsic 
behaviour of the material investigated. 
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4.6.2 Physical-chemical characterization 
The analysis of the densification curves of HA during heating at 1500 °C reveals 
that heating rate influenced the densification path; moreover the onset of the densification 
was at higher temperatures, increasing the heating rate: 1220 °C, 1320 °C and 1500 °C, 
respectively. At 100 °C /min, the final temperature is reached before the starting of the 
shrinkage; in consequence, the first part of the related curve is approximately a unique 
straight line (Fig. 4.18), so characteristic of a single sintering mechanism57,58. In the 
remaining curves, the slope changed with time, as different temperatures are related to 
different sintering kinetics.  
 
Figure 4.18. Comparison between densification curves of HA at different heating rates. 
As a consequence, the permanence at the final temperature is higher at the lowest heating 
rates (see also Table 4.III, Experiments F4-F6); finally, on the basis of the microstructural 
features also, 30 °C/min was selected as the most suitable heating rate. 
The XRD analysis of the pure γ-Ca2SiO4 sintered at 1500 °C is showed in Fig. 4.19: γ-
polymorph completely transformed in the β-form of Ca2SiO4, due to the characteristics of 
the starting γ powder, which prevented the recrystallization of γ-Ca2SiO4. 
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Figure 4.19. XRD spectrum of γ-Ca2SiO4 treated at 1500 °C by FHP. 
In fact, as its specific surface was 3.62 m2/g, obtained by BET measurement, it was 
possible to estimate the average grain size as ~0.6 μm, supposing that particles have the 
same shape (see also Chapter 2): thus, on the basis of the researches of Chan53 and Hong54, 
this reduced grain size can have yielded the stability of the β-polymorph during cooling, as 
also stated above. This finding seems in contrast with the SEM image of the as-synthesized 
γ-Ca2SiO4 (Fig. 4.20), in which the average grain size appears larger than 10 μm, 
recognized as the limit size for β-polymorph stabilization. Anyway, the irregular grains of 
γ-Ca2SiO4 are often made by smaller lath-like units, weakly bounded to form larger 
particles53; in this case, the physical effect responsible of the β-Ca2SiO4 stabilization 
applies to these smaller sub-particles. 
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Figure 4.20. Morphology of as-obtained γ-Ca2SiO4. 
In composite samples, fired in the range 1300-1500 °C, HA remained stable even at 1500 
°C and no other silicate phase were present, apart from HA and Ca2SiO4 (Fig. 4.21): the 
only modification was, as in the pure Ca2SiO4 sample, the changing in the β- polymorph 
and its stabilization at room temperature. 
 
Figure 4.21. Comparison between XRD of HA and HA / Ca2SiO4 composite. 
The analysis of sample morphology and local composition was performed by SEM-EDS, 
after polishing and chemical etching of the surface. Figs. 4.22 and 4.23 show the 
microstructure of HA and composite samples after FHP sintering at different temperatures. 
HA samples exhibited increasing grain sizes as higher the sintering temperature (Fig. 
4.22); anyway, the grain size is limited up to 1400 °C, so that it can be considered the limit 
 145
Chapter 4. Development of Reinforced HA-based Biomaterials 
⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯ 
 
temperature for HA-based materials, in view of load-bearing applications. In fact a reduced 
grain size yields reduced defect size also so that mechanical properties can improve. 
 
Figure 4.22. Microstructures of HA obtained by FHP at different temperatures.  
a): 1500 °C; b) 1400 °C; c) 1300 °C. 
The composites reveal a higher pore fraction compared to HA (Fig. 4.23), anyway it is 
evident that a denser microstructure is achieved when sintering at 1500 °C, otherwise a too 
much extended porosity is found in the sample, also confirmed by the density 
measurements (see Tab. 4.IV), with consequent depletion of the mechanical resistance (see 
later, Table 4.V). 
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Figure 4.23. Microstructures of composites obtained by FHP at different temperatures. a): 
1500 °C; b) 1400 °C; c) 1300 °C. 
EDS analyses confirm that silicon was present in the whole composite in concentrations 
~1.6 at% (see Fig. 4.24) and ∼1.8 wt%. The average Ca/P molar ratio is ∼1.70 and Si/P 
ratio is ∼0.10. 
 
Figure 4.24. EDS analysis performed on several grains of HA-β-Ca2SiO4 composite sintered 
at 1500 °C by FHP. 
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Thus, although it was hard to identify the HA and silicate grains by their morphology, it 
was found that the FHP sintering technique can yield dense materials characterized by a 
chemical homogeneity, and a silicon content related to the amount of Ca2SiO4 in the initial 
mixture, so that a complete control of the final phase composition is achievable. 
4.6.3 Mechanical characterization 
Mechanical tests were performed on the sintered HA and composite samples, Table 
4.V shows the results in terms of flexural strength.  
Table 4.V. Results of flexural strength tests performed on HA and composite. 
Material Temperature (°C) Relative density (%) σbend (MPa) 
HA 1300 0.87 34 ± 2 
HA 1400 0.94 47 ± 2 
HA 1500 0.93 42 ± 7 
β-Ca2SiO4 1500 0.96 171 ± 4 
HA \ β-Ca2SiO4  1300 0.72 36 ± 5 
HA \ β-Ca2SiO4  1400 0.89 57 ± 8 
HA \ β-Ca2SiO4  1500 0.95 70 ± 7 
Both relative density and σb values of HA are the highest in the sample sintered at 1400 °C. 
HA sintered at 1500 °C shows similar σb values but the uncertainty in the measurement is 
higher. This finding is in agreement with the grain growth observed in this sample, much 
higher than in HA sintered at lower temperatures, and with the increasing instability of HA 
at 1500 °C, confirmed by its poorly resolved XRD spectrum (Fig. 4.21). 
The effect of the reinforcing phase, γ-Ca2SiO4 transformed in the β-polymorph, was 
positive for flexural strength: the σb values exhibited by the composite are higher than 
those of HA at all temperatures; the highest resistance is exhibited by the composite 
sintered at 1500 °C, confirming that a so high temperature is needed to achieve the 
consolidation of both phases. Anyway, the optimal temperature could be slightly below 
1500 °C to find a compromise between the starting of HA phase degradation and the 
maximum level of strength exhibited by the reinforcing phase. 
Table 4.VI shows the results of nanoindentation analysis for some selected samples: the 
procedure for obtaining the final data is described elsewhere59.  
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Table 4.VI. Results of nanoindentation tests on HA and composite. 
Material Relative density Young modulus 
(GPa) 
Nano-hardness  
(GPa) 
HA 1500 °C 0.93 113 ± 3 4.7 ± 0.3 
HA 1400 °C 0.94 113 ± 3 5.0 ± 0.3 
HA+ β-CS 1500 °C 0.95 121 ± 12 5.7 ± 1.4 
β-CS 1500 °C 0.96 124 ± 6 5.1 ± 1.1 
The elastic properties and hardness of HA are not significantly affected by the sintering 
temperature; the presence of the reinforcement slightly increases both Young modulus and 
hardness, even if the dispersion of data is higher, as an effect of the increased number of 
defects in the sample microstructure, due to the coexistence of two different phases. 
The elastic properties obtained by the load-displacement behaviour of HA and the 
composite during the flexural strength test gave quite different results, compared to 
nanoindentation (Table 4.VII): elastic modulus is strongly reduced, as well as the hardness.  
Table 4.VII. Mechanical behaviour of HA and composite materials under macroscopic 
investigation. 
Material Relative 
density 
Young modulus 
(GPa) 
KIC 
(MPa⋅m1/2) 
Hardness 
(GPa) 
HA 1500 °C 0.93 70 ± 5 0.75 ± 0.05 3.3 ± 0.1 
HA 1400 °C 0.94 64 ± 5 0.87 ± 0.22 3.2 ± 0.1 
HA+ β-CS 1500 °C 0.95 73 ± 5 0.71 ± 0.09 4.1 ± 0.1 
β-CS 1500 °C 0.96 69 ± 3 2.92 ± 0.36 4.4 ± 0.9 
The reduction of rigidity and hardness is due to the different volume of material 
investigated: the nanoindenter penetrates few tenths of nanometers, sensing a volume of 
some μm3, so that it can be considered free of defects and nearly free of pores; the breaking 
of a bar of macroscopic size involves the whole sample instead, including pores and 
defects. 
Thus, it can be assumed that porosity is responsible for the loss of rigidity. The fracture 
toughness, indicated by KIC, was obtained by the Chevron notch method60. KC expresses 
the resistance of a material against different deformations under loading; in particular KIC 
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is the resistance to a tensile-opening loading56 and it is one of the possible loading which 
naturally occurs in vivo.  
The mechanical properties exhibited by the composites are in the range of cortical bone, 
concerning the fracture toughness and Young modulus, especially considering that in 
porous materials the elastic behaviour can be enhanced; the fracture toughness should be 
slightly raised, especially for some specific bone portions to be substituted (see also 
Ritchie et al. 56).  
The reason for matching the stiffness of the implant material to bone is that in this 
condition stress transfer is allowed from the implant to the surrounding bone in loading 
conditions. Known as Wolff’s law61, this effect stimulates the surrounding bone for 
continued bone remodelling, a part of which includes bone deposition onto the biomaterial 
surface. 
Flexural strength values are still insufficient for many load-bearing applications. Anyway, 
HA alone can exhibit much higher values, previous suitable treatment of calcinations and 
agglomeration2,9,62; the sinterability of HA powders is in fact strictly related to their 
morphology and chemical composition. The presence of volatile moieties, as water and 
carbonate, which decompose and evaporate at high temperatures, are an obstacle to powder 
densification and it can provoke cracks after the residual porosity is too tight to allow their 
evaporation. For this reason HA powder is usually calcined at intermediate temperatures 
(600-1000 °C) to eliminate these volatile species. Moreover, the fine grain size of as-
prepared HA makes this powder very hydrophilic and large agglomerates of particle easily 
form; in this condition the achievement of an homogeneous mixture with other powders is 
more difficult. Thus, following the treatment of calcination, the powder surface also 
modifies: its hydrophilicity decreases up to 300 °C, where water is prevented from being 
re-asdsorbed on the surface63; above 600 °C the HA particles start to grow through a 
superficial transport mechanism without an actual densification64; the true densification 
starts at ∼850 °C, where larger particles grow at the expenses of the smallest ones. HA 
used in the present work was calcined at 1000 °C, in order to make its specific surface area 
similar to that of γ-Ca2SiO4 and allow a better powder mixture; anyway the calcining at 
1000 °C does not favour mechanical properties after sintering at conventional temperatures 
(1250 °C), while it could favour the sintering at higher temperatures, as reported by 
previous studies on kinetics of HA sintering58,62. 
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Anyway, at 1000 °C grain coalescence starts to be evident in HA; grains form hard 
agglomerates, which do not easily break under the cold compaction in pellet, so to be not 
suitable for the achievement of optimal green bodies. As the green body is not sufficiently 
dense and compact, the final sintered body will exhibit a higher number of defects, like 
residual pores, affecting the final mechanical properties. Thus, a lower temperature of 
calcination is likely to be more effective in yielding more resistant HA ceramics62, in 
consequence, the composite also will exhibit a higher strength. 
For these first tests, a concentration of 20 wt% of the reinforcement was selected; this 
choice was purely arbitrary, to investigate the feasibility of research in this field. The 
results in term of chemical-physical and mechanical properties are promising to investigate 
the biologic behaviour of these materials; on the basis of the in vitro / in vivo 
investigations, the optimal concentrations of the reinforcing phase, determining the 
bioactive properties of the final material, will be set up.  
4.7 Conclusions 
It was demonstrated that calcium silicates are a promising class of materials for the 
development of bioactive ceramic composites with HA, characterized by improved 
mechanical strength so to represent a potential biomaterial for load-bearing applications. 
Moreover, there was some evidence of silicon incorporation in HA structure, in biological-
like amounts, following the thermal treatments of consolidation. A more detailed 
observation of the sample morphology and investigation of the local phase composition is 
needed to confirm this finding; the increased bioactivity, due to the increased solubility of 
substituted HA, has to be ascertained through solubility tests performed on sintered solids 
and by tests of cell cultures in vitro and cell response in vivo.  
The positive result of the cytotoxicity tests encourages the development of materials based 
on HA / silico-carnotite mixtures. Chemically, the material can exhibit an increased 
bioactivity and reabsorbability compared to stoichiometric HA, due to the presence of 
silicon; the control of the phase stoichiometry is allowed by the virtual absence of any 
secondary phases, so that substituted HA characterized by tailored amount of silicon can be 
achieved.  
Sintered bodies are destined to be employed as three-dimensional bone substitutes; thus, 
the future activity will be devoted to the development of dense and porous bodies to be 
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implanted in animals; the amount and quality of the formed bone will be analyzed, as well 
as the kinetic of its formation on the surface and inside the pores of the bioceramic. For 
this reason, the architecture of the bone substitute will be accurately designed and suitable 
technological procedures should be optimized and applied for this purpose. 
The enhancement of the mechanical properties is fundamental in this field; a proper 
osteointegration is achieved when the biomechanical loads are well distributed in the 
synthetic scaffold and the surrounding bone. If an increased bioactivity of the composites 
HA / calcium silicates will be assessed, they will represent a new wide field of 
investigation for the development of HA-based high-resistant materials with a variety of 
compositions. In fact, many different second phases, beyond the ones investigated in this 
work and belonging to the calcium silicate system, can be investigated: a number of these 
materials have shown a good bioactivity in vitro and in vivo; these materials also contain 
magnesium (bredigite, diospide, etc..), so they can express a potentially superior 
bioactivity, in terms of quality of cell response; their mechanical properties are similar but 
the solid state interactions occurring when mixed with HA at high temperatures are still 
unpredicted. For each material, a wide range of investigation has to be carried out: 
1) The assessment of the reactivity between HA and the second phase at different 
temperatures and atmospheric conditions. This implies a full chemical-physical 
investigation of the ceramic powders employed, in terms of chemical composition, 
thermal behaviour, grain morphology and size, and of the final materials, in the 
bulk and on the surface. 
2) The assessment of the mechanical strength and its relationship with the 
microstructure, which strongly depends on the sintering treatment itself. Thus, the 
sintering cycle must be set up according to an optimized microstructure, in terms of 
density and grain size, with a minimal formation of defects. For this purpose 
thermo-analytical and microscopic investigations will be carried out on powders 
and sintered materials, in feed-back with a complete assessment of the mechanical 
properties, on a micro- and a macro-scale. 
3) The assessment of the bioactivity and resorbability of the composite and its 
relationship with the chemical composition at the implant surface. For this purpose, 
solubility tests in SBF will be performed; a deeper investigation will involve cell 
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culture on the surface of powders and consolidated bodies and when particularly 
promising, small animals (rabbits, goats, sheep) will be employed for scaffold 
implantation and subsequent analysis of the newly formed tissues, in term of bone 
mineral qualification and quantification; scaffolds can also be previously cultivated 
with stem cells and / or growth factors to enhance the osteointegration.  
4) The in vivo behaviour of 3D scaffolds, especially concerning osteointegration, 
strongly depends on the scaffold morphology, in particular pore size and 
interconnectivity. Thus, suitable technologies will be developed for porous bodies 
manufacturing; for this purpose, a full characterization of the powders will be 
needed, in term of morphology, size, and surface charge, to be achieved through 
techniques like BET, electro-acoustic spectroscopy and sedimentography. On this 
basis, the different technological procedures (foaming, impregnation, freeze-drying, 
biomimetic syntheses, etc..) will be optimized for the achievement of ceramic 
bodies characterized by suitable porosities and pore interconnection; the 
employment of a composite implies the presence of at least two powders, which 
can have different morphological and surface properties; for this purpose 
preliminary treatments of homogenization can include spray-drying techniques to 
obtain spherical granulates prior forming and sintering. It has been shown, in the 
case of silico-carnotite and also in part with dicalcium silicate, that sintering can 
make react HA and the second phase, giving rise to a powder with more uniform 
characteristics; in this case, the set-up of ceramic suspensions is made easier. 
The picture deriving by the interactions at high temperature of HA with bioactive calcium 
silicates is thus rather complex, as it includes a wide number of materials characterized by 
similar properties but exhibiting very different effects when heated in mixture with HA. 
The inter-relationship between physico-chemical, mechanical and biological properties, 
makes necessary a careful investigation of the properties of the raw materials and the 
effects on their interaction at high temperature at a chemical, microstructural and 
mechanical level; these three effects strongly reflect in a complicated manner on the 
biologic performances, which are the ultimate reason for the development of these 
composite materials. 
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CHAPTER 5 
 
HIERARCHICALLY ORGANIZED 
STRUCTURES AS BONE SCAFFOLDS 
5.1 Introduction 
As already discussed in the previous Chapters, the morphology of 3D bone 
scaffolds, in term of pores size distribution and pores interconnectivity is fundamental for 
an efficient osteoconduction, i.e. cell habitation and proliferation even in the inner part of 
the scaffold. 
In a different perspective, the scaffold morphology should approach to the complex 
morphology of natural bone, which also allows an efficient distribution of the mechanical 
loads to the smallest trabeculae, where the strain-sensing mechanism exhibited by the 
osteocytes can take place and activate the permanent bone remodelling process (see also 
Chapter 1). This mechanism allows the continuous re-arrangement of the bone tissue in 
presence of biophysical stimuli from the environment, so that the local damage is 
minimized and the functionality of the bone as a whole is optimized. 
Thus, only a scaffold exhibiting a structure with a high degree of hierarchy can be able to 
yield the optimal biophysical response, after implantation in vivo; such a solution is 
particularly required in the healing of long bone disease, where the biomechanical loads 
are more complex and intense, so that the development of hierarchically organized bone 
scaffolds would represent a breakthrough in the knowledge in this field, surpassing the 
current solutions in the field of synthetic bone substitutes. 
In fact, during the last few decades, a variety of scaffolds characterized by complex 
structures have been developed and launched on the market,  reaching a good compromise 
in term of mimicking the micro and macro-porosity of natural bone. Indeed, open-pore 
geometries with highly porous surface and microstructure allowing cell in-growth and 
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reorganization and providing the necessary space for neovascularization have been 
obtained.  
Regrettably, the current production processes do not allow to generate an organised 
hierarchical structure, owing to limitations in the currently available processing 
technology. Therefore, surgeons are now forced to use cadaver bones from tissue banks, 
just because it can be loaded as soon as they are implanted. In general, acceptable clinical 
results have been obtained so far, but no suitable solution have been found yet for 
regenerating long and load-bearing bone segments. 
One of the most advanced 3D processing technologies is Rapid Prototyping (e.g 
stereolithography, laser sintering etc), which allows to generate porous structures with 
designed geometry out of virtually any material. Porous scaffolds designed in 
hydroxyapatite with a strut thickness of a few hundred micrometers have been obtained. 
However the rapid prototyping techniques so far developed have not enough spatial 
resolution to reproduce the complex hierarchical structure of bone and the resulting 
scaffolds have very poor bio-mechanical properties. 
Natural bio-structures usually have properties that in most of the cases significantly surpass 
those of analogous synthetically manufactured materials with similar phase compositions. 
Most of the structural materials used by Nature are polymers or composites of polymers 
and ceramic particles. Such materials would not be the first choice of an engineer who 
intends to build very stiff and long-lived mechanical structures. Nevertheless, Nature 
makes the best out of the limitations in the chemical environment, adverse temperatures 
and uses polymers and composites to build trees and skeletons1. Thus, the solutions 
developed by Nature can serve as a source of inspiration2 for manufacturing synthetic 
hierarchical structures with superior functional properties. 
5.2 Wood structures as templates for bone scaffolds 
The vegetable kingdom includes a great variety of hierarchical tissue structures 
with impressive biomechanical properties; for example, some tree branches can support the 
weight of an entire house, and others can be bent and stretched into any shape. 
At the macroscopic level, spruce wood can be considered as a cellular solid, mainly 
composed of parallel hollow tubes, the wood cells. As an example, the hierarchical 
structure of spruce wood is shown in Fig. 5.1. The wood cells are clearly visible and they 
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have a thicker cell wall in latewood than in earlywood, within each annual ring. The cell 
wall is a fibre composite made of cellulose microfibrils embedded into a matrix of 
hemicelluloses and lignin3. 
 
Figure 5.1. Hierarchical structure of wood. 
Typically, the cell-wall consists of several layers (S1, S2, . . .), where the S2 is by far the 
thickest. While the cellulose microfibrils in the S1-layer run at almost 90° to the cell axis3, 
the cellulose microfibrils in the S2 layer are more parallel to it, with microfibril angles 
ranging from 0° to about 45°. 
In summary, wood can be regarded as a cellular material at the scale of hundred 
micrometers to centimetres. Parameters which can be varied at this hierarchical level (and, 
therefore, used for adaptation to biological and mechanical needs) are the diameter and 
shape of the cell cross-section, as well as the thickness of the cell wall. In particular, the 
ratio of cell-wall thickness to cell diameter is directly related to the apparent density of 
wood which, in turn is an important determinant of the performance of light weight 
structures. The stem is further organized in annual rings with alternating layers of thin- and 
thick-walled cells. This creates a fairly complex structure with layers of alternating density. 
At the lower hierarchical level, the complexity increases even further since the wall of 
individual cells is a fibre composite. The orientation of the cellulose fibril direction with 
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respect to the cell axis has a major influence on the mechanical properties of the tissue as a 
whole, and – depending on the (biological or mechanical) needs – the microfibril angle can 
be adjusted locally. 
In this respect, native or semi-processed wood and plant habits may be successfully used as 
templates for generating ceramic materials through transformation processes, involving 
pyrolysis and chemical reactions (with solid, liquid or gaseous phases); this materials, 
which might be called “lignocers”, can exhibit a hierarchic structure very close to the one 
of the original wood. 
The mechanical properties of wood itself are remarkable: in the Ashby diagram reported in 
Fig. 5.2, wood exhibits improved performances compared to the polymeric materials 
currently used in engineering, although wood itself is a polymeric material, also due to its 
very low density. 
 
Figure 5.2. Comparison between mechanical performances of different classes of materials. 
5.3 Ceramization of native vegetable structures 
Preliminary investigation on ceramization processes of native wood structures has 
led to the development of porous bodies in silicon carbide4-9 by wood pyrolysis and 
subsequent infiltration with melted silicon; BioSiC® technology was also developed10-12 
with similar technology, to manufacture porous biocompatible ceramic bodies, 
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characterized by very good mechanical performances and morphology very well 
resembling the cortical human bone. 
The pyrolysis of wood is commonly carried out in inert atmosphere and temperature 
varying from 800 to 2000 °C, so to decompose all the organic components; thus, it is 
accompanied by the thermal degradation of cellulose, hemicellulose and lignin as its main 
components of the wood and a subsequent conversion into a carbon structure. The 
mechanism of cellulose thermal decomposition was suggested as follows: 
 
• Desorption of adsorbed water (< 150 °C) 
• Dehydration of the cellulose crystal water (150 - 240 °C) 
• Chain scissions, breaking C-O and C-C bonds (240 - 400 °C) 
• Aromatization (> 400 °C) 
 
The resulting product is a carbon preform, maintaining the morphological arrangement of 
the native wood. Starting by the carbon preform, through a sequence of infiltration and/or 
electrochemical processes, ceramic materials showing uniform as well as non-uniform 
(hierarchical) pore structures can be obtained. 
Moreover, on the basis of the structure of the native vegetable, different morphologies can 
be obtained by setting up the different steps of the ceramization process, so to develop 
scaffolds for bone substitution with a suitable structure-morphology to reach improved  
biomechanical performance. Finally, by developing material synthesis and assembly 
processes able to mimic biological principles and hierarchic morphology, it is possible to 
pave the way for realizing prosthetic devices which could get closer to the extraordinary 
performance of human bones. 
In order to achieve bone scaffolds merging the biomimetic, mechanical and morphological 
features of the bone tissue, the idea was to obtain apatite-based materials, starting by 
pyrolyzed wood structure through a series of reaction with calcium- and phosphate-
containing reactants: The reactions are carried out at high and ambient temperatures 
leading to increasingly complex materials, approaching apatite phase by following the 
pathway displayed in Fig. 5.3.  
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Figure 5.3. Reaction pathway to obtain hydroxyapatite scaffolds starting by native wood. 
In detail, starting from vegetal raw materials, selected on the basis of their structure (pine-
wood and larch-wood for initial experimentations), a treatment of pyrolysis yielded carbon 
templates, which were subsequently infiltrated by vapour or liquid phase calcium to 
produce calcium carbide (carburization); after, porous calcium oxide was obtained by a 
further process of oxidation and subsequently transformed in calcium carbonate by 
reaction with carbon dioxide. All these steps were carried out by thermal and hydrothermal 
reactions in controlled environment; finally the final step was reached through a 
phosphation treatment in which porous calcium carbonate was transformed in 
hydroxyapatite. The set up of the transformation of the carbon preform was carried out by 
using commercial raw materials: calcium carbide powder for testing the oxidation and 
carbonation processes and calcium carbonate powder for testing the phosphation process.  
The phase composition and morphology of raw, intermediate and final materials, as well as 
the correspondence between the initial and final microstructure for each step were 
investigated by X-ray diffraction (XRD: CuKα radiation, Miniflex Rigaku) and scanning 
electron microscopy (SEM: Stereoscan 360, Leica, Cambridge) with energy dispersion 
spectroscopy (EDS: INCA 300, Oxford Instruments). 
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Pyrolysis 
Native woods (mainly larch-wood and pine-wood) of different pore size 
distribution and composition were used, in form of parallelepiped specimens (about 1 cm3 
in volume). The pyrolysis process was performed on woods in their native form, after 
preliminary drying at at 80°C in ventilated oven. The selected temperature for pyrolysis 
was 1000°C in Argon atmosphere; during the pyrolysis process, in order to prevent the 
cracking of the carbon template due to the release of volatile moieties (H2O, CO and CO2), 
a slow heating rate of 1 °C/min was applied up to the final temperature; the specimens 
were hold at the final temperature for 1 hour, and after cooled at -2°C/h.  
Anisotropic shrinkage in axial, tangential and radial directions was associated with the 
pyrolysis process, according to the starting pore arrangement. Despite the large weight loss 
during pyrolysis, the carbon template reflected the microstructure and morphology of the 
native specimen.  
Carburization  
Spherical metallic calcium particles (in small spheres, ~2 mm diameter size) or 
calcium hydride powder (CaH2) were employed as a calcium source for carburization 
process on the carbon preforms.  
The carburization was carried out by infiltration of liquid or vapour calcium into the 
porous carbon template, involving a suitable heating treatment where the calcium reacted 
with the carbon surface and diffused into the core of its structure. Different thermal cycles 
were investigated to achieve selectively liquid or vapour phase infiltration, as well as the 
arrangement of samples and reactants inside the furnace chamber. A furnace equipped with 
graphite heating elements was employed for carburization process, performed in argon 
flux, similarly as in the pyrolysis process 
The chemical reaction involving the carbon template and liquid or gaseous calcium to form 
calcium carbide ceramics is:  
2C + Ca → CaC2           1). 
In the liquid phase method, spontaneous infiltration was achieved by immersing the carbon 
preform into the calcium source, so that melted calcium penetrated into the pores and 
canals by capillarity; in the vapour phase method, the carbon preform and calcium are 
separated and the reaction occur only by solid-gas interaction. The thermal cycle was set 
up to allow the slow the melting and subsequent evaporation of the calcium (Fig. 5.4).  
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Figure 5.4. Typical thermal cycle in carburization process. 
In these processes, the most influent parameters on the formation of the products and the 
final sample structure were found to be the local carbon morphology, the calcium / carbon 
ratio, the furnace final temperature and dwell time.  
To check whether complete reaction occurred, small pieces of samples were plunged in 
water: calcium carbide strongly reacts with water, forming white calcium hydroxide and 
acetylene gas, so the absence of any residual black un-reacted carbon indicate the complete 
conversion of carbon in calcium carbide.  
After the process, the final calcium carbide structure exhibited an improved toughness 
compared to the carbon preform, but it is easily degraded by moisture following the 
reaction:  
CaC2 + 2H2O →Ca(OH)2 + C2H2         2),  
so that, once extracted by the furnace, the pieces must be preserved in inert gas 
environment or vacuum conditions.  
In liquid phase infiltration, the porous carbon preform was put in a graphite 
crucible and covered by the calcium source (Fig. 5.5A). The crucible was closed and 
positioned inside the furnace chamber. Some graphite felt was put around the crucible in 
order to avoid the corrosion of the graphite heating elements by the evaporating calcium.  
The thermal cycle was set up in order to achieve the melting of calcium (melting point of 
Ca: 839 °C) and its spontaneous infiltration in the porous carbon preform along different 
orientations (axial and radial). Firstly, the temperature was rapidly raised up to 800 °C, 
while the subsequent step was carried out at a reduced heating rate to allow the slow 
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melting of calcium: in fact, as the calcium source is often surrounded by a thin layer of 
calcium oxide, due to the exposure to atmosphere, the melted core has to overcome this 
layer, so that an excessively rapid decrease of the metal viscosity provokes the violent 
expulsion of the metal from the core, resulting detrimental for a careful control of the 
carburization process.  
The final steps of the thermal cycle of carburization were set up in the range of 1550-1850 
°C (higher than boiling point of calcium, 1484 °C), with the purpose of eliminating the 
excess of calcium by evaporation.  
The final temperature was reached after gradually raising at 1 °C/min; the dwell time was 1 
hour to allow the complete reaction of calcium with the carbon structure and the 
evaporation of the not reacted calcium. All the processes occurred under Argon 
atmosphere, preserving the calcium source by oxidation, the ignition of pyrolysed wood 
and the hydration of the formed calcium carbide.  
Thermal shock may cause collapse of the carbon network when penetration of liquid 
calcium is too rapid. The un-reacted calcium partly remained into the pore channels so that 
Ca(OH)2 phase, formed after exposure to the moisture, was observed. The residual calcium 
content depends on the total porosity, the pore channel diameter distribution and the 
deviation of calcium amount from the stoichiometry (eq.1).  
In vapour phase reaction, the carbon preform was placed above the calcium 
source. The thermal cycle was set up in order to achieve the evaporation of calcium (above 
1484 °C), with final temperatures in the same range of the liquid phase process, 1550-1850 
°C.  
The ideal temperature was found to be 1650 °C: below this temperature the reaction is not 
complete and part of the starting carbon remain un-reacted, while too high temperatures 
can provoke the deformation of the calcium carbide network.  
A typical experiment was set up as follows: a graphite cylindrical crucible was filled with 
calcium granules; another crucible was prepared as follows: its lateral walls were drilled 
right through, in the same way a piece of pyrolysed wood was also drilled. A supporting 
wire (thickness: 0.9 mm) was used, passing through the wood and the crucible; the crucible 
so prepared was overturned and positioned upon the crucible filled with calcium. A 
reaction chamber was so created, forming a closed environment where calcium is at the 
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bottom part and the pyrolysed wood suspended at the top by the supporting wire (Fig. 5.5 
B).  
 
Figure 5.5. Sample arrangement in calcium infiltration. A: liquid phase; B: gaseous phase. 
Oxidation  
Preliminary experiments to transform calcium carbide in calcium oxide were 
performed, using commercial CaC2 powder.  
The oxidation process allows the conversion of calcium carbide to calcium oxide in moist 
air after suitable thermal cycle in furnace chamber.  
It is assumable that the involving mechanisms are two: hydration of calcium carbide by 
water in air and, at the same time, the de-hydration of the new formed calcium hydroxide 
above its decomposition temperature (about 480 °C).  
The hypothesized chemical reactions involved in the oxidation process are indicated 
below:  
CaC2 + 2H2O →Ca(OH)2 + C2H2        3),  
Ca(OH)2 →CaO + H2O          4). 
Total reaction: CaC2 + H2O →CaO + C2H2       5).  
The steps were performed via thermal cycles according to the characteristics of the 
reactions:  
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- fast heating up to 500 °C (10 °C/min) to reduce the hydration of the CaC2 on the basis of 
the reaction 1) and to minimize the formation of Ca(OH)2, which is detrimental for the 
maintenance of the original preform structure.  
- once the formation of Ca(OH)2 is hampered by the high temperature (> 480 °C), a slow 
heating from 500 to 1000 °C (2 °C/min) was performed: in this step the reaction 2) is 
favoured and the formation of CaO is extensive. The slow heating rate reduced the 
structural deformation of the original CaC2 porous ceramic.  
Carbonation  
Porous calcium carbonate structures were obtained from calcium oxide via either 
the flux of gaseous CO2 inside the furnace chamber or via the addition of compressed CO2 
into a high-pressure closed autoclave. The chemical reaction involved in both the processes 
was the following:  
CaO + CO2 →CaCO3  
In the experiment carried out in furnace, a gas flow of CO2 (1 l/min) is put in contact with 
CaO porous ceramic at temperatures between 500 and 700°C and the carbonation reaction 
takes place to form CaCO3. This temperature range is ideal to avoid the hydration of CaO 
(below 480 °C) and the decomposition of CaCO3 (above 750-800 °C).  
In autoclave, the full conversion of CaO in CaCO3 was obtained by high pressure 
treatments in autoclave. The employment of high pressure values allowed the penetration 
of CO2 across the layer of the new formed CaCO3 up to the core of the CaO structure, also 
increasing the rate of carbonation.  
Typical conditions for carbonation by autoclave were 300-400 °C for temperature and 10-
20 bar for pressure.  
Phosphation  
Initial tests to transform calcium carbonate to calcium phosphate-based ceramics 
were performed using KH2PO4 as a phosphate source; both CaCO3 commercial powder and 
CaCO3 templates coming from the ceramization process described above were used, 
following the reaction:  
10CaCO3 + 6KH2PO4 →Ca10(PO4)6(OH)2 + ...  
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The CaCO3 piece was put inside KH2PO4 solution (CO3/PO4 molar ratio 1:3) and the 
reactions were carried out in autoclave, at 200 °C and 12 bar in water vapour 
(hydrothermal conditions).  
5.4 The European Project TEM-PLANT 
 The topics and activities described in this Chapter are one of the main subject of a 
STRP European Project (NMP4-CT-2006-033277), entitled New Bio-ceramization 
processes applied to vegetable hierarchical structures -TEM-PLANT and coordinated 
by ISTEC-CNR (Faenza, Italy). 
Started on 1st October 2006, with a foreseen duration of four years, the purpose of TEM-
PLANT is to develop bone and ligament substitutes, taking advantage of the hierarchical 
architecture exhibited by native structures like wood, plants, lianas, etc. The starting 
materials will be converted in rigid bone scaffolds through treatments of ceramization and 
in elastic ligament-like composites by controlled fibration of biopolymers like collagen and 
cellulose. The project involve nine partners from European countries, including ISTEC-
CNR, which are experts in wood science, material science, organic and inorganic bio-
composites; moreover expertises in cytotoxicity tests as well as orthopaedics are also 
present to guarantee a suitable assessment of the in vitro and in vivo performances of the 
obtained materials. 
5.5 Characterization of the transformed woods 
Pyrolysis 
After the pyrolysis treatment, black pieces were obtained, strongly reduced in 
volume. SEM observations revealed a porous microstructure reproducing the features of 
the original wood (Fig. 5.6). XRD analysis confirmed that the only phase present was 
amorphous carbon (Fig. 5.7). 
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Figure 5.6. Morphology of pyrolyzed larch-wood. 
 
Figure 5.7. XRD spectrum of pyrolyzed wood. 
Carburization 
Local phase analysis was performed on the sample struts by EDS, and the presence 
of calcium was confirmed in the regions characterized by an altered morphology. XRD 
performed on samples as extracted by furnace (Fig. 5.8) revealed the presence of peaks 
belonging to two different polymorphs of calcium carbide (ICDD cards n° 51-1167 and 1-
962).  
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Figure 5.8. XRD spectrum of transforming CaC2 wood-like structure, when exposed to air. 
Anyway, in few minutes of exposure to the environment, from the extraction by the 
furnace to the complete analysis of the sample, calcium carbide started to oxidise, partially 
transforming in calcium hydroxide. Contrary to the sharp peaks of CaC2 phase, Ca(OH)2 
exhibited broaden XRD reflections, confirming that this phase was in course of formation 
by hydration of CaC2 due to the presence of water vapour in the environment.  
The process of liquid infiltration provoked the formation of elongated CaC2 crystals on the 
surface of the internal wall of pores (Fig.5.9), as confirmed by XRD and local elemental 
analysis by SEM-EDS. 
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Figure 5.9. Formation of calcium carbide into the pores of carbon preform. 
Nevertheless, the transformation process was not uniform, thus some regions exhibited an 
extensive formation of CaC2  (Fig. 5.10), and others showed only a limited carburization, 
leaving wide non-reacted areas in the inner part of the sample (Fig. 5.11). 
 
Figure 5.10. Extensive formation of CaC2 particles into the pore of carbon preform. 
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Figure 5.11. Incomplete carburization in liquid-phase infiltration. 
The process of reaction with gaseous calcium yielded better results, compared with liquid 
phase infiltration. In fact, the microstructure of the resulting sample was more similar to 
the original carbon preform (Fig. 5.12), even though the strut thickness increased, due to 
the volume expansion following the transformation CÆCaC2.  
As well as the samples obtained by liquid infiltration, the moisture provoked the fast 
transformation of calcium carbide into calcium hydroxide, so that the pieces had to be 
immediately stored under inert gas, after extraction by the furnace.  
 
Figure 5.12. SEM micrographs of pyrolysed wood before and after the transformation in 
CaC2.  
The increase of the struts thickness between pores was found to be related to the amount of 
calcium used for the carburization reaction. A molar ratio Ca/C = 1 has given the best 
results in terms of similar thickness between carbon and calcium carbide final structure 
(Fig. 5.13).  
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Figure 5.13. Calcium carbide obtained by initial molar ratio Ca/C >> 1 and Ca/C = 1.  
XRD and SEM-EDS analyses confirmed the extensive formation of calcium carbide phase 
in the wood structure and on the struts, contrary to what occurred in the case of liquid 
phase reaction. After the Ca-vapour infiltration and reaction process, the CaC2 material 
reproduced the cellular morphology of native wood.  
The nucleation and growth of CaC2 yielded the formation of a continuous CaC2 layer in 
both liquid and vapour phase processes. Anyway, following the liquid phase process, some 
areas contained calcium or calcium-oxide filling the pores and cavities of the initial wood 
structure and isolated regions of amorphous, residual carbon, covered by the grains of the 
re-condensed calcium. The reaction by vapour phase yielded more homogeneous samples: 
in fact, as the carbon preform was in contact with gaseous calcium only, the filling of pores 
was strongly reduced and all calcium could react with carbon to give CaC2. The calcium 
not reacting with carbon was captured by the graphite felt surrounding the crucible and did 
not accumulate inside the preform.  
Oxidation 
The comparison of the X-ray diffraction spectra of CaC2 after two different heating 
treatments (1000 °C for 2 hours and 700 °C for 24 hours) showed that the reaction to form 
CaO was completed in the first case, while after treatment at 700 °C impurities of Ca(OH)2 
were still present even after 24 hours of treatment (Fig. 5.14).  
No calcium carbide nor any unreacted carbon during carburization process remained in the 
core of the material synthesized through reactions described in equations 3) and 4) (see 
Section 5.2): the total reaction (5) was completed and the residual carbon burned out 
during heat treatment at 700-1000 °C in air.  
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Other final temperatures were tested, in the range 600-1000 °C in step of 100 °C; anyway, 
complete oxidation reactions occurred only after 12 hours of treatment at 800 °C.  
 
Figure 5.14. Comparison between XRD analyses of two different thermal cycles to obtain 
CaO.  
The oxidation process, applied on porous calcium carbide pieces, yielded porous calcium 
oxide materials, retaining the original structure of the carbon preform (Fig. 5.15). 
 
Figure 5.15. SEM micrographs of calcium oxide porous template. 
Carbonation 
XRD analysis (Fig. 5.16) identified CaCO3 as the main phase under all the operated 
different working conditions. Anyway, XRD reflections belonging to residual Ca(OH)2 
were also found.  
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Figure 5.16. XRD analysis after carbonation process by autoclave (400°C, 22bar PCO2, 24 
hours).  
Thus, the carbonation of the calcium oxide porous bodies did not proceed up to the 
complete conversion in CaCO3: a maximum of about 90 vol% was achieved after 24 hours 
(Fig. 5.17).  
The gas–solid CO2–CaO reaction was supposed to proceed through two rate-controlling 
regimes: at the initial stage the reaction rapidly occurred by a heterogeneous surface 
reaction kinetic. Following this initial stage, as a compact layer of CaCO3 is formed on the 
surface of CaO, the rate of reaction decreased due to the diffusion limitation of CO2 
through the CaCO3 layer.  
 
Figure 5.17. Carbonation percentage vs time of reaction in kiln (700°C). 
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In fact, as the reaction proceeded, the deposition of newly formed CaCO3 layer reduced the 
permeability and this fact had an impact on the diffusion of CO2. Thus, the complete 
conversion of CaO-template into porous CaCO3 should depend not only on the temperature 
employed but also on the gas pressure in the autoclave, to allow the full reaction of CO2 
with the inner part of CaO template. 
Anyway, the process of CaO conversion in CaCO3 did not alter the morphology of porous 
samples obtained by pyrolysis-carburization-oxidation path. The original morphology and 
porosity of the carbon preform was retained and no further cracking of the struts was 
observed, compared to carburized and oxidised pieces (Fig. 5.18).  
 
Figure 5.18. SEM micrograph calcium carbonate structure.  
 
Phosphation  
Both CaCO3 commercial powder and porous pieces transformed in hydroxyapatite, 
after the treatment of phosphation in autoclave, as confirmed by the XRD spectrum in Fig. 
5.19.  
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Figure 5.19. XRD analysis after hydrothermal treatment of calcium carbonate in phosphate-
saturated atmosphere.  
The final piece retained its original porosity and microstructure, so that the reaction path 
devoted to transform porous vegetable structure in porous HA bodies was successful. 
Further characterization should be performed on HA pieces obtained following this route, 
in particular devoted to a deep morphological investigations and mechanical 
characterization, in order to assess whether the hierarchic arrangement of the final HA 
body is able to yield increased mechanical strength compared to porous HA bodies 
obtained by conventional manufacturing methods. 
Since the porous HA was obtained by reaction of transformation, the mechanical strength 
can result affected by the presence of cracks and flaws occurred into the struts; anyway, the 
strength of these materials can be increased by suitable sintering treatments to improve the 
densification of the consolidated parts. 
5.6 Conclusions 
Ceramisation process to obtain HA porous ceramics starting from wood templates 
was successfully performed following five different steps of chemical-physical 
transformations.  
The different steps were set up and optimized to maintain the original wood morphology; 
anyway, the whole process can require adjustments on the basis of the microstructure of 
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the selected wood. In fact, woods characterized by more open porosity (like rattan for 
example) can also exhibit an increased strut weakness, so to be damaged during the 
transformation processes. 
The feasibility of the process has been anyway demonstrated, so that the future activity 
shall be devoted to the selection of opportune wood structures, on the basis of the bone 
portion to be substituted. In fact, there exists a huge variety of woods, characterized by 
different density, pore size and pore orientation, yielding different potential mechanical 
strengths, so to be employed as substitutes of cortical and trabecular bone. Pore size and 
interconnection must be carefully considered in order to be adequate for an efficient 
osteoconduction, especially considering the reduction in size following the treatment of 
ceramization.  
Finally, since the ceramization process was successful, the set up of the process parameters 
can drive to the achievement of bone substitutes which are biomimetic from a 
morphological point of view, with potentially improved biomechanical performances, so to 
pave the way for the development of substitutes for long and load-bearing bone portion.  
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FINAL CONCLUSIONS AND 
FUTURE PERSPECTIVES 
In the present work, the achievement of biomimetic bone substitutes has been 
pursued under three different perspectives. 
In a biochemical perspective, methodologies were set up and optimized, to obtain 
biomimetic HA powders characterized by multiple atomic substitutions, involving the 
most relevant ions present in the biological environment (carbonate, magnesium, 
silicon) in adequate amounts for the stimulation of the natural processes of bone 
regeneration. Particular care has been devoted to the effect of silicon on the physical-
chemical properties and solubility behaviour of the Si-doped HA powders. 
In view of structural applications, consolidation techniques have been developed and 
applied on mixtures of hydroxyapatite and bioactive calcium silicates, with the purpose 
of obtaining bioactive materials characterized by improved mechanical resistance, for 
the development of bioactive load-bearing scaffolds. The presence of silicon in these 
materials was kept in consideration also to improve the biomimetism of the whole 
composite. There was evidence of possible ion migration in HA, during the thermal 
treatments of consolidation of bulk materials; if confirmed, this effect might be 
exploited on a large variety of calcium silicates also containing magnesium and 
characterized by different mechanical properties and reactivity with HA, still largely 
unexplored. 
Finally, the problem of the morphological biomimetism has been faced, by taking 
Nature as starting point to develop synthetic structures characterized by hierarchically 
organized morphologies. In the present work, new methodologies have been explored 
and applied to different wood structures to obtain porous hydroxyapatite ceramics 
maintaining the same morphology of the native woods. The results are novel, as the 
experimented techniques involved very complex transformations, in five different steps; 
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in the past, similar procedures have been applied on woods for transformation in silicon 
carbide, which involved only a single-step process after pyrolysis. 
The results obtained in the present work were positive in all the three different areas of 
investigation. The conclusions that can be drawn is that only at the convergence of the 
three different fields it is possible to find out the best solutions to develop the ideal 
bone-like scaffold. Thus, the future activity should be devoted to solve the problems at 
the borderline between the different research lines, which hamper this convergence; in 
particular: 
• as hydroxyapatite becomes more biomimetic, it also becomes more chemically 
unstable when heated at high temperatures, so that the development of composites with 
a controlled phase composition becomes more challenging. In this case, the employment 
of bioactive reinforcing phases containing ions influent for the HA biomimetism can 
help to solve this problem, as already demonstrated in this work. 
• from a morphological / structural point of view, the achievement of porous structures 
obtained by the transformation of native woods is promising for the development of 
scaffolds exhibiting an increased biomimetism. In this case, the problem is still widely 
open, as many different woods should be selected and tested on the basis of the desired 
structure and also the effective increase of mechanical performances and 
osteoconductive properties is still to be assessed. Following, a further increase of the 
chemical biomimetism of these porous materials can be needed, so that specific 
methodologies for incorporating ions like magnesium and silicon in the wood-derived 
structures should be developed. 
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